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Abstract
The natural product analysis of New Zealand red algae has been neglected in recent years,
and there is obvious scope for the chemical re-evaluation of New Zealand marine red
algae. This study describes the isolation and structure elucidation of 12 new and eight
known compounds from four different genera of red algae. To aid in this process, 34 red
algae were screened in order to generate a digital HSQC spectra mask, a screening tool
developed by the VUW Marine Natural Products group to identify extracts of interest
for further analysis. All 34 algal extracts were screened using the HSQC mask and four
extracts were identified as interesting and analysed in detail. Examination of extracts of
the red algae Plocamium costatum and Ballia callitricha lead to the isolation of three
known metabolites.
Eleven new oxylipins, labillarides A–K (60–70), are reported from the alga Phacelocar-
pus labillardieri. Labillarides A–H (60–67) are polyunsaturated α-pyrone macrocycles,
all of which show similarities to the previously reported compounds isolated from
southern Australian collections of the algae. Labillarides E–H (64–67) are of particular
interest as they represent the two diastereomeric pairs associated with variation at the
C-3 and C-8 chiral centres. Labillarides I (68) and J (69) are related enol macrocycles
while labillaride K (70) is a furan-3-one oxylipin, all of which have biogenic significance
to the macrocyclic α-pyrones. Labillarides A (60), B (61) and I (68) exhibit moderate
cytotoxicity while labillaride C (62) shows moderate antibacterial activity.
A new nitrogenous bromophenol, colensolide A (124), was isolated from the alga
Osmundaria colensoi along with five known bromophenols. The presence of nitrogen-
containing sidechains in bromophenols is unusual but not unprecedented. The bicyclic
nitrogenous moiety observed in colensolide A (124) is proposed to be of histidine origin.
Several of the known bromophenols exhibit antibacterial activity and one shows moderate
cytotoxicity.
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Chapter 1
Introduction
1.1 Natural Products
Throughout the millennia, humans have relied on nature for their basic needs; from
food, shelter and clothing, to flavours, fragrances and medicines.1 In particular, the
use of natural products as medicinal agents presumably predates recorded history. The
earliest known records date back to around 2600 BC and were written on clay tablets
in cuneiform, the earliest known form of written expression.1 Some of the most famous
written records include the Ebers papyrus dating from about 1500 BC, which detailed
plants and some animal organs and minerals used in Egyptian medicine, the Chinese
Materia Medica, with the first recording dating from about 1100 BC, and various
documents detailing the Indian Ayurvedic system, dating from about 1000 BC.1,2 These
early texts describe numerous plants and other natural remedies that have been sources
of extremely important modern medicines. The Ebers papyrus, for example, indicates the
use of willow leaves as an antipyretic, and early English herbalists also recommended the
use of teas made from willow bark for treatment of fever. The active compound, salicin
(1), was identified in the mid 1800s, however it was its derivatives, salicylic acid (2) and
acetylsalicylic acid (aspirin, 3), that were commercialised in the late 1800s.3 Over 100
years later, aspirin is considered the most successful drug worldwide.4
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1.2 The Golden Age of Natural Products
Following the fortuitous discovery of penicillin G (4) from the fungus Penicillium notatum
by Fleming in 1929, and the recognition of its many uses in the 1940s, a new age of
medicine and what has been referred to as the “Golden Age” of antibiotics intensified
the investigation of natural products.1 From the 1940s to the 1970s, micro-organisms
were examined in detail, and were found to be prolific sources of structurally diverse
bioactive metabolites, many of which form important parts of the pharmaceutical industry
today.1,2 From antibacterial compounds such as the penicillins, aminoglycosides and
tetracyclines, and antiparasitic drugs such as the ivermectins, to immunosuppressive
agents such as rapamycin (5), micro-organisms became, and continue to be, excellent
sources of antibiotics.1
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1.3 Modern Drug Discovery
Following the early successes in drug discovery and development programs based on
natural products, many pharmaceutical companies moved away from natural product
discovery in the 1990s and early 2000s.5 The development of high throughput screening
(HTS) put a strain on natural product programs as they struggled to provide the sheer
numbers of compounds desired for HTS. Similarly, the introduction of combinatorial
chemistry and its promotion as a better approach to creating large sets of “drug-like”
compounds led to diminishing numbers of natural product discovery programs in the
2
pharmaceutical industry.5
The “chemical space” occupied by natural products is now considered both more varied
and more drug-like than that of combinatorial chemical collections.6 Despite being
the most productive source of leads for new drugs, natural products are still currently
out of fashion with the pharmaceutical industry, who continue to favour combinatorial
techniques.6 Interestingly, combinatorial chemistry has not proved very fruitful so far,
with only one de novo new compound approved for drug use. Sorafenib (Nexavar, 6) is
an anti-tumor compound produced by Bayer and was approved by the United States of
America Food and Drug Administration Agency (FDA) in 2005.7
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The authors of a recently published statistical comparison between three classes of
compounds, marketed drugs, combinatorial compounds, and natural products, suggested
that “by mimicking certain distribution properties of natural compounds, combinatorial
products might be made that are substantially more diverse and have greater biological
relevance.”8 This statement was based on the assumption that most natural products
have a function, and the biosynthetic routes which generate these metabolites have co-
evolved with the specific receptor systems which they target. It is therefore thought that
combinatorial chemistry must also evolve beyond “synthetic feasibility” to focus on the
creation of compounds with desired biological function.8
Despite the trends in the pharmaceutical industry away from natural product discovery, the
field has continued to deliver new drugs and drug leads. In the 25 years from January 1981
to June 2006, nearly two thirds of the small molecule new drugs approved world-wide
were natural products, natural product derivatives, synthetic mimics of natural product
action, or derivatives from natural product pharmacophores.7 Newman and Cragg et
al. have published several reviews on natural products as sources of new drugs.2,7,9 In
their most recent review, they summarise their findings by stating “we strongly advocate
expanding, not decreasing, the exploration of Nature as a source of novel active agents that
3
may serve as the leads and scaffolds for elaboration into desperately needed efficacious
drugs for a multitude of disease indications.”7
1.4 Marine Natural Products
Marine natural products chemistry has been described as “a child of the 1970s”.10
Following the development of the first inexpensive and reliable SCUBA apparatus by
Jacques Cousteau in the 1940s, natural products chemists and biologists began to consider
the marine environment as an untapped resource.11 More than 70% of Earth’s surface is
covered by oceans and experts estimate that marine biological diversity is higher than
that of the tropical rain forests.12 Furthermore, plants and many marine invertebrates that
lack physical forms of protection are sessile and therefore require chemical defenses that
enable an individual organism to establish a particular niche and thrive there.11 These
natural products released into the water are rapidly diluted and therefore need to be highly
potent to have any effect.12 It is this defense strategy, necessary to survive in the highly
competitive marine environment, that results in a tremendous diversity of highly toxic
compounds affecting numerous biological targets and therefore making these organisms
of great interest to natural products chemists.13
Since the 1970s, more than 15,000 structurally diverse natural products with varying
bioactivites have been reported from marine microbes, algae and invertebrates.5 A
clear indication of the potential for drug development from marine natural products,
or compounds derived from them, is the number of compounds currently in clinical or
pre-clinical trials for treatments of a large variety of diseases. As of early 2004, 44
marine-derived natural products were in clinical and pre-clinical trials, including three
in Phase III. Since then, the cone snail toxin known as Prialt (ziconotide, 7) has been
approved by the FDA, making 7 the first “direct from the sea” compound to become a
licensed pharmaceutical.7 Isolated from the venom of the marine snail Conus magus, 7 is a
very potent and highly selective blocker of mammalian neuronal N-type voltage-sensitive
calcium channels, inhibiting the activity of a subset of neurons including pain-sensing
primary nociceptors, making it an ideal treatment for severe chronic pain.14
4
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The isolation of the C-nucleosides spongouridine (8) and spongothymidine (9) from
the Caribbean sponge Cryptotheca crypta in the early 1950s is considered to be the
first notable discovery of biologically-active compounds from marine sources.2 Found
to exhibit antiviral activity, studies of 8 and 9 eventually led to the development
of cytosine arabinoside (Ara-C, 10) as a commercialised antileukemic agent.11 The
structurally related antiviral compound adenine arabinoside (Ara-A, 11) was synthesised
and produced commercially and later found in the Mediterranean gorgonian Eunicella
cavolini.11 Compounds 10 and 11 are argued by some to be the first drugs derived form
the marine environment,12 though Prialt (7) provided the first direct transition from a
marine organism to man.7
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New Zealand Marine Biodiversity
New Zealand has an extremely biologically diverse marine environment, influenced by
its geographical location, range and complexity of habitats, and the number of major
ocean currents that pass within its Exclusive Economic Zone (EEZ). Spanning over 30◦
of latitude from subtropical to subantarctic waters, and extending from the shallows to the
deep seas, New Zealand’s EEZ encompasses more than 4.2 million km2, around 15 times
its land area (see Figure 1.1).15
There are an estimated 22,000-23,000 species inhabiting New Zealand’s marine environ-
ment, less than 12,000 of which have been identified.15 New Zealand has a particularly
5
Figure 1.1. New Zealand Exclusive Economic Zone (outlined in solid white). Image
courtesy of National Institute of Water and Atmospheric Research (NIWA).
rich diversity of marine macro-algae, supporting over 600 species from 80 families,16
making this a viable source for marine natural product evaluation.
1.5 Marine Red Algae
Algae are abundant and ancient organisms that can be found in virtually every ecosystem
on Earth.17 From tiny single-celled species 1 µm in diameter to giant kelp over 50 m
long, the term algae encompasses a diverse range of organisms which fossil records show
were living at least 500 million years ago.18 Algae are polyphyletic as they do not fall
within a single group linked by a common ancestor and therefore cannot be given a
formal unified placement within biological nomenclature.17 The taxonomic descriptions
and the relationships of major evolutionary lineages remain controversial and are subject
to ongoing research.18
The composition and amount of photosynthetic pigments give algae their wide variety of
colours and, for several algal groups, their common names such as brown, red and green
algae (Figure 1.2).17 Red algae (phylum Rhodophyta) are unicellular to multicellular
6
organisms. Most red algae are pink to deep red in colour due the the presence of large
quantities of the red accessory pigment phycoerythrin, which obscures the chlorophyll a
and any other pigments present (including chlorophyll b and carotenoids).19,20 It is
generally accepted that most marine algae need a minimum irradiance of 0.05-0.1% of the
available surface light in order to survive. Red algae, however, have been found growing
on a seamount in the Bahamas 268 m deep, where the light is estimated to be as low as
0.0005% of the surface light levels.20 It is thought to be the pigment composition of red
seaweeds, in particular the phycoerythrin concentrations, that allows the absorption of the
spectrum of light which pentrates deeper waters.20
Figure 1.2. A variety of red, green and brown marine algae at low tide.
Currently, the phylum Rhodophyta is divided into two subphyla, six classes, five sub-
classes, 33 orders, 94 families and over 910 genera.21 There are over 6000 species of
Rhodophyta classified, which are common inhabitants of tropical and temperate coastal
marine waters.19 Red algae are the only algae to have a complete lack of flagellate
stages, and are also distinctive in their use of floridean starch as their food reserve.22
The taxonomy of Rhodophyta to the order level is shown in Table 1.1 with blue entries
representing the orders examined in detail in this study.
Red Algal Natural Products
Seaweeds, particularly red algae, were among the first group of marine organisms to be
investigated around the middle of the 20th century, largely due to their ease of accessibility
7
Table 1.1. Taxonomic classification of phylum Rhodophyta to the order level as
presented in AlgaeBase.21
Phylum Sub-phylum Class Sub-class Order
Rhodophyta
Cyanidophytina Cyanidiophyceae Cyanidiales
Rhodophytina
Bangiophyceae Bangiophycidae BangialesGoniotrichales
Compsopogonophyceae
Compsopogonales
Erythropeltidales
Rhodochaetales
Florideophyceae
Ahnfeltiophycidae Ahnfeltiales
Hildenbrandiophycidae Hildenbrandiales
Nemaliophycidae Nemaliales
Rhodymeniophycidae
Acrochaetiales
Acrosymphytales
Balbianiales
Balliales
Batrachospermales
Bonnemaisoniales
Ceramiales
Colaconematales
Corallinales
Gelidiales
Gigartinales
Gracilariales
Halymeniales
Nemastomatales
Palmariales
Pihiellales
Plocamiales
Rhodogorgonales
Rhodymeniales
Sebdeniales
Thoreales
Rhodellophyceae PorphyridialesRhodellales
Stylonematophyceae Stylonematales
8
prior to the introduction of SCUBA. Recently, there has been a renewed interest in
seaweeds, however there is a distinct lack of work on algae from the southern hemisphere,
where there is a diverse range of algae quite different to those found in more tropical and
northerly locations.23
Marine macro-algae are known to produce a plethora of secondary metabolites, many of
which are halogenated. Common compounds include terpenoids such as the squalene-
derived polyether compounds thyrsiferol (12), thyrsiferol 23-acetate (13) and venustatriol
(14), isolated from the genus Laurencia.24–26 These compounds have a range of potent
biological activities, venustatriol (14) exhibits potent antiviral activity,26 while thyrsiferol
23-acetate (13) possesses in vitro cytotoxicity toward P388 murine leukaemia (ED50 =
0.5 nM)25 and selective inhibition of the protein serine/threonine phosphatase PP2A (IC50
= 4–16 µM).27
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Halogenated sesquiterpenes are prevalent in red algae, such as the chamigrenes 15–
17.28,29 The tribrominated chamigrene 15 is cytotoxic in the NCI 60-cell line human
tumour screen and has displayed potent activity against the NCI/ADR-RES breast cancer
cell line.28
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Nitrogen containing compounds such as indoles are also frequently reported. Recent
examples of bioactive indoles include five sulfur-containing polybromoindoles from
Laurencia brongniartii (18–22), of which 21 was active against P388 cells and HT-29
9
cells, while 22 was active against P388 cells.30 A further five bisindoles (23–27) were
reported from a Japanese collection of the same alga in the same year.31 Oxylipins, such
as 28 and 29 from Rhodymenia pertusa,32 are highly prevalent and are discussed in detail
in Chapter 3. Bromophenols also represent a significant group of red algal metabolites,
such as the aldose reductase inhibitors 30–32,33 and are discussed in detail in Chapter 4.
N
H
R2
R3
Br
R1
Br
N
H
H
N
R1
Br
Br
Br
Br
R2
18 R1 = Br R2 = SMe R3 = SOMe
19 R1 = H R2 = SOMe R3 = Br
20 R1 = H R2 = SOMe R3 = SOMe
21 R1 = SMe R2 = SOMe
22 R1 = SOMe R2 = SOMe
27 R1 = SMe R2 = Br
N
H
N
SMe
Br
Br
Br
MeS Br
R2
Br
R1 ∆
O
OH
HO OH
23 R1 = H R2 = H
24 R1 = H R2 = Br
25 R1 = Br R2 = H
26 R1 = Br R2 = Br
28
29 ∆ saturated
Br
Br
HO
OH
Br
O
Br
Br
OH
OH
Br
Br
HO
OH
Br Br
R
Br
OH
OH
30 31 R = Br
32 R = H
New Zealand Red Algal Natural Products
A total of 24 new compounds have been reported from New Zealand red algae in
eight papers mainly from the University of Canterbury Marine Chemistry group, dating
from 1978 to 1994.24,34–40 The metabolites include a large number of halogenated
monoterpenes (such as 33 and 34) and sesquiterpenes (35 and 36),37,40 halogenated
furanones (such as 37 and 38),39 and C15 acetogenins (such as 39–43).36,40
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The study of natural products from New Zealand marine macro-algae, and red algae
in particular, has been neglected in recent years. When this study began, the most
recent reported new compounds from a New Zealand macro-algae was a series of C15
acetogenins and sesquiterpenes from a species of the red alga Laurencia, reported in
1994.40 In 2007, Sansom et al. reported two new compounds from the New Zealand
brown alga Pertihalia capillaris.41 With this information in hand, coupled with unusual
activity-independent screening and isolation style employed by the Victoria University of
Wellington Marine Natural Products group, there was obvious scope for the re-evaluation
of New Zealand marine red algae.
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Chapter 2
Red Algae Screening
2.1 Methods of Natural Product Screening and Isolation
The general paradigm used for identifying novel compounds from crude natural product
extracts has not significantly changed in the past few decades.5 The most common
technique employed, bioassay guided isolation, involves testing extracts of biological
material for a specific activity. Extracts with positive biological activity are iteratively
fractionated and the fractions tested in the bioassay until a pure compound is isolated. The
major advantage of this method is the isolation of a compound with guaranteed biological
activity against the desired target.
This “tried and true” technique has served the field of natural products extremely well,
however it has several disadvantages. The screening and isolation technique is, by
definition, very narrowly focused on one activity. Bioassay processing time and cost
can be significant, meaning the isolation process is often slow and expensive. The assay
process is destructive, consuming valuable quantities of the active compound at each step
of isolation and dereplication of known compounds is not possible in a purely bioassay
guided isolation. Finally, an organism may produce multiple interesting bioactive
secondary metabolites in differing quantities, and those found in higher concentrations
can “mask” the activity of the minor metabolites present in the organism.
The efficient analysis of crude extracts requires sensitive techniques. For this reason,
mass spectroscopy (MS) and LC-MS analysis are widely used.42 In contrast to MS,
NMR is a non-destructive method for mixture analysis, however it has not, until recently,
been considered a feasible technique due to its relative insensitivity. Advances in
microcoil and cryogenic technology for NMR probes, however, has significantly reduced
the sample mass requirements, making NMR screening much more viable.43 Compared
to MS analysis, 2D NMR spectroscopic investigation offers more detailed structural
12
information, a great advantage in the detection of novel chemotypes. New approaches
to screening and isolating natural products entailing NMR spectroscopic analysis have
been reported, including diffusion-ordered spectroscopy (DOSY) and characterisation of
crude or semipurified extracts using routine NMR spectra.42
Taggi et al. reported the use of 1D and 2D NMR spectroscopic analysis of unpurified
spider venom in the identification and isolation of a family of unusual sulfated nucleoside
derivatives.44 It was found that sufficient data to identify some or all of the components
of interest could be acquired from 1D and 2D NMR spectra of a mixture. When this was
not the case, preliminary structural information was used to develop purification schemes
specific to the functionality of the compounds of interest. Such individualised purification
schemes increased the efficiency of fractionation and reduced the likelihood of changing
the unknown structures in vitro resulting in artefacts of isolation.
The complexity of 2D spectra has been a limiting factor in the use of NMR spectroscopy
in the characterisation of crude extracts.42 Schroeder et al. have recently developed a
screening system involving the stacking of DQF-COSY spectra of fungal extracts in an
effort to make use of this complexity.42 This technique distinguished signals present in
only one spectrum from signals common to several spectra. The multiplicative stacking
with spectra of extracts of one fungal strain derived from seven culturing protocols and
four media controls lead to the isolation of two new natural products. The results were
validated by comparison with LC-MS analysis of the the same extracts. Interestingly, it
was found that the method of ionisation (positive ESI) strongly skewed the representation
of the actual compositions, validating the NMR technique over the use of LC-MS for
semi-quantitative analysis in this instance.
There are several examples of the use of diffusion-edited NMR experiments in the derepli-
cation of known compounds.45,46 This technique “takes advantage of the variance in
translational diffusion of organic compounds as a function of their molecular size.”45 By
measuring DOSY spectra of semi-purified fractions, known components were identified
along with unknown components with a unique 1H NMR profile.46 This work led to the
isolation of two new bromopyrrole alkaloids from a marine sponge.46
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2.2 VUW Screening
Over the last 12 years, the Victoria University of Wellington (VUW) Marine Natural
Products group have developed an in-house NMR screening protocol born out of a novel
isolation procedure developed for crude extracts - cyclic loading. This protocol has
evolved from a 1D NMR-based screening system into one using a digitised 2D NMR
mask, utilising the functional information that can be obtained from an HSQC spectrum
to distinguish between correlations of interesting secondary metabolites and those of
common components within semi-purified extracts.
Cyclic Loading
Crude extracts of marine organisms contain a wide array of compounds with varying
polarity ranging from very polar salts, proteins and sugars, to non-polar fats and steroids.
This characteristic, coupled with the fact that the extract is usually saturated, makes
these mixtures problematic to work with due to their propensity to precipitate with any
adjustment of polarity or concentration. The initial fractionation of an extract is therefore
often considered the most challenging part of an isolation procedure.47
The compounds of interest to natural products chemists, biologically active secondary
metabolites, often possess a mixture of both polar and non-polar properties in order to
traverse both hydrophilic and hydrophobic environments, and are therefore generally
amphiphilic. This allows the compounds to be both partially water soluble and easily
transported across cell membranes and other biological barriers. The components of
biological extracts can therefore be thought to belong in one of three groups; the polar
salts, proteins and sugars at one extreme, the non-polar fats and steroids at the other
extreme, and the compounds of mid-polarity in between. Few primary metabolites are
found in the mid-polarity group, making this “mass window” an ideal target for the first
stage of fractionation of a crude extract.
West and Northcote developed cyclic loading in 1996 to aid in the fractionation
of an extract.48 In its initial form, this technique involves passing a crude extract
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through a column of poly(styrene-divinylbenzene) (PSDVB) resin, allowing the non-polar
metabolites to be adsorbed to the stationary phase. The eluent is then sequentially diluted
with H2O in order to increase its polarity, and is then passed through the same column,
forcing more polar compounds to adsorb to the column. This technique is repeated until
all compounds of interest have adsorbed to the stationary phase – typically achieved by
a four-fold dilution of the original solvent concentration (see Figure 2.1). The principle
behind this approach is that as the eluent is progressively made more polar by dilution
with H2O, mid-polarity compounds will have more of an affinity for the stationary phase
and will therefore adsorb to the column.49
= Polar metabolite
= Non-polar metabolite
Cyclic loading
H2O
= Medium polarity metabolite
Extract passed 
through PSDVB
Eluent diluted 
with H2O
Diluted eluent 
passed back 
through column
Repeat until all 
metabolites of 
interest are adsorbed
Figure 2.1. Cyclic loading.
Once loading has been completed, the column is eluted using a stepped or gradient
system of increasing organic solvent (MeOH or Me2CO) in H2O, such that the increasing
organic modifier concentration partitions the variety of compounds from the initial crude
extract according to polarity.48 The mid-polarity metabolites are targeted during the cyclic
loading process by first desalting the column with H2O, and then batch eluting with
mixes of increasing organic solvent modifiers, typically 30%, 75% and 100% Me2CO
in H2O. Biologically active amphiphilic metabolites tend to elute in the mid-polarity
fraction (75% Me2CO). This process is not perfect and in practice the 75% Me2CO
fraction will often contain some primary metabolites of little interest, while potentially
15
interesting compounds are sometimes found in the 30% and 100% Me2CO fractions. It is,
however, a useful first step in order to provide some insight into the secondary metabolite
composition of the extract as a whole.49
A common problem encountered during reversed-phase chromatographic fractionation is
that mixtures of organic solvents and H2O are notoriously problematic to concentrate
under reduced pressure due to their propensity to froth or “bump”. This problem is
overcome by an extension of the cyclic loading method, backloading. Fractions are
cyclic loaded onto a smaller column of PSDVB which can then be eluted with a pure
organic solvent, eliminating the H2O content and therefore enabling easier concentration
by evaporation under reduced pressure.
Development of the NMR Screening Protocol
The in-house NMR screening protocol instigated by the VUW Marine Natural Products
Group has been used for the screening of sponge extracts, or more correctly semi-purified
extracts, for several years. The screening protocol was based on the search for novel
structures, and on the assumption that novel structures often have novel activities that can
be determined after isolation, rather than using a bioassay guided isolation. Also, in-house
methods are preferable to external assays with respect to speed, economy and accuracy
of results.47 However, a major problem with NMR screening is the inability to dissolve
crude marine extracts in any one solvent due to the large range of polarities observed in
the mixture of primary and secondary metabolites. This issue was overcome by the use
of cyclic loading as the first stage of fractionation.
The concept of the screening protocol was to distinguish between common and unusual
correlations present in the NMR spectra of semi-purified sponge extracts by analysing the
soluble 75% Me2CO fraction. Initial work involved only the analysis of
1H NMR spectra,
however this system was found to be rather limited as many of the semi-purified extracts
screened still contained large amounts of primary metabolites, the signals of which
obscured most of the other resonances below 5.5 ppm in the 1D 1H NMR spectrum.47
At this point, the protocol was extended to using 2D NMR spectra, specifically COSY
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and HSQC, to introduce a second dimension in which to separate the resonances.
A paper mask was generated for both the COSY and HSQC spectra by correlating a
number of screen spectra to produce a mask sheet showing positions of correlations
of common metabolite resonances. New COSY or HSQC spectra generated from a
sponge screen were overlaid on the relevant mask sheet and any unusual correlations were
marked. The individual screen was then assessed, considering signal strength, number and
uniqueness of interesting peaks, available mass and organism recollectability.
Although the principal of the paper mask was successful,47 it became evident that the
manual interpretation of the complex spectra was difficult and prone to error, especially
in crowded regions of the spectrum. Also, the effectiveness of the masks themselves
were limited as only 10-20 spectra were used to generate the mask sheets. A more robust
system was required in which the mask would continue to develop as more organisms
were screened. Such detailed analysis is better performed by a computer, and therefore a
digital mask was proposed.
HSQC Mask
A digital HSQC mask was developed by our laboratory for the screening of sponge
extracts. COSY, HSQC and HMBC experiments were considered for the NMR screening
method. The HSQC experiment was preferred to the quicker COSY experiment due to
the increase in functional information obtained from the carbon data. The HMBC was
discounted due to the complexity of the data and the time required to obtain a reasonable
spectrum, however this experiment is now being re-evaluated as a screening tool.
To construct the mask, the HSQC data is exported and added together to generate a
digital mask. Through adding the NMR data sets together, the generated mask displays
common correlations as strong peaks while the less common correlations are weak. This
is illustrated in Figure 2.2, where the common peaks are shown in white, and uncommon
peaks appear as blue. It is important to note that the intensity of the peaks in the original
HSQC spectra are not considered when the mask is generated. The mask simply adds
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“1” if a peak exists in a particular region, or adds “0” if it is absent. Once the mask is
generated, HSQC spectra of newly screened extracts are added to the mask.
The initial HSQC data of red algal extracts were screened with the existing sponge HSQC
mask. This proved unsatisfactory as all the HSQC spectra analysed appeared to be
very interesting with respect to common sponge metabolites. It became evident that the
resonances of common metabolites in red algal extracts were significantly different to
those observed in sponge extracts; the mask is phylum specific. Thirty-four red algae
were therefore screened in order to generate an algal HSQC mask. Figure 2.3 shows the
sponge HSQC mask applied to a seemingly interesting algal extract (a), and the algal mask
applied to the same data showing, in fact, very few unique correlations (b), illustrating this
phylum specificity. When the mask has been applied to an HSQC, common correlations
are displayed in green, while unusual correlations are red.
2.3 Algal Screening
A standard protocol for the screening of sponge extracts through 2D NMR experiments
was developed by our laboratory (see Appendix A).47–49 This protocol involves the
extraction of ∼100 g (wet weight) of sponge material and analysis of the 2D NMR data
of the 75% Me2CO fraction following cyclic loading. In this study, it was found that
the procedure was easily adapted to macro-algae though, with the acquisition of a more
powerful NMR instrument, less material was required in order to obtain reasonable NMR
data. This increase in sensitivity coupled with the finding that the red algal 75% fractions
were, on average, slightly richer than those of the sponge extracts meant that the screening
protocol could be applied to as little as 2 g of macro-algae.
In this study, 34 algal extracts were screened using the HSQC mask and four extracts were
analysed in detail. Two of these led to the isolation of novel compounds and are detailed
in later chapters (Phacelocarpus labillardieri, see Chapter 3, Osmundaria colensoi, see
Chapter 4). The remaining two extracts are discussed briefly here.
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(a) Common correlations in the algal HSQC mask.
(b) The full algal HSQC mask.
Figure 2.2. Algal HSQC mask showing the common correlations in white and the
uncommon correlations in blue.
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(a) Sponge HSQC mask applied to Curdiea coriacea.
(b) Algal HSQC mask applied to Curdiea coriacea.
Figure 2.3. HSQC mask of C. coriacea showing the common correlations in green and
the unusual correlations in red.
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Plocamium costatum
The spectra obtained from screening Plocamium costatum (126 g, collected from
Doubtless Bay, Northland, Figure 2.4) was recognised as being interesting using the
HSQC mask (Figure 2.5). Inspection of the screening NMR spectra revealed what
appeared to be one major compound (Figure 2.6).
One further step of purification of the 75% Me2CO fraction lead to the isolation of the
known monoterpene costatone (44). Originally isolated in 1976 from two separate South
Australian collections of P. costatum, 44 was first synthesised in 1984.50–52 The NMR
assignment of 44 is well documented in the literature, therefore it is unnecessary to give a
Figure 2.4. Plocamium costatum. Image courtesy of Malcolm Francis.
Figure 2.5. HSQC mask of P. costatum showing the common correlations in green and
the unusual correlations in red.
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(a) 1H spectrum (b) COSY spectrum
Figure 2.6. NMR spectra of the 75% Me2CO in H2O screening fraction of P. costatum.
detailed analysis of the sample isolated in this study. Full NMR data for 44 can be found
in Appendix B. The optical rotation of the isolated sample of 44 ([α]25D −48.0 (c 1.12,
CH2Cl2)) was in excellent agreement with that reported in literature ([α]
25
D −54.0 (c 1.02,
CHCl3)),
51 suggesting the same absolute configuration. As costatone (44) accounted for
all the correlations of interest present in the screen spectra, further analysis of the extract
was discontinued.
O
HO
Br
Cl
Cl
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44
Ballia callitricha
The screen spectra of an Owhiro Bay, Wellington collection of Ballia callitricha (Figure
2.7) displayed interesting resonances attributed to aromatics and low strength resonances
in the aliphatic region (Figure 2.8).
A largescale extraction of the red algae was performed (664 g), from which the known
compounds, 1H-indole-3-carboxaldehyde (45) and (E)-N-formyl-3-(1H-indol-3-yl)prop-
2-enamide (46), were isolated. Compound 45 has long been known as a synthetic
compound, but has also been isolated from various cruciferous vegetables as well as
from the marine environment.53–56 Compound 46 was first reported in 1992 from the red
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Figure 2.7. Ballia callitricha. Image courtesy of Malcolm Francis.
Figure 2.8. HSQC mask of B. callitricha showing the common correlations in green and
the unusual correlations in red.
alga Chondria sp., along with chondriamides A (47) and B (48).56 Both 45 and 46 were
considered possible oxidation products of chondriamide A (47), as the two were formed
when a methanolic solution of 47 was left standing overnight.56
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OO
N
H
N
H
O
H
N
R
45 46 47 R = H
48 R = OH
A detailed analysis of the NMR data obtained in this study led to the reassignment of two
olefinic methines in (E)-N-formyl-3-(1H-indol-3-yl)prop-2-enamide (46). Specifically,
23
the assignment of the 1H and 13C resonances for C-10 and C-11 were interchanged. The
revised NMR data is presented in Table 2.1.
Table 2.1. 13C (150 MHz) and 1H (600 MHz) NMR data (CD3OD) for
(E)-N-formyl-3-(1H-indol-3-yl)prop-2-enamide (46).
5
6
7
8
9
4
N
H1
2
3
10
11
12 N
H13
12' H
OO
46
13C or 15N 1H HMBC
Pos δ (ppm) mult δ (ppm) mult J (Hz) COSY (1H to 13C or 15N)
1 −240.5 NH
2 133.7 CH 7.75 s 1,3,7*,8,9,10
3 114.2 C
4 121.3 CH 7.92 d 7.4 5 3,6,8,9
5 122.5 CH 7.22 td 7.2, 1.4 4,6 7,9
6 124.1 CH 7.25 td 7.2, 1.4 5,7 4,7
7 113.3 CH 7.46 d 7.3 6 5,9
8 139.4 C
9 126.5 C
10 141.7 CH 8.09 d 15.9 11 2,3,9,11,12
11 112.5 CH 6.62 d 15.1 10 3,12
12 169.5 C
13 † NH
12′ 165.2 CH 9.21 s
*Long-range correlation.
†Not observed.
Further examination of the fractions generated during this isolation indicated that all peaks
of interest were clearly related indole-containing compounds. Indoles are well studied
both as natural products and as synthetic compounds and therefore analysis of the extract
was discontinued. Full NMR data for 1H-indole-3-carboxaldehyde (45) can be found in
Appendix B.
2.4 Summary
Over the past 12 years, the VUW Marine Natural Products group have developed a unique
in-house NMR screening protocol. In this study, 34 red algal extracts were screened in
order to generate a digital algal HSQC mask which was used to analyse the extracts using
the NMR based screening protocol. Four extracts were analysed in detail, two of which
are discussed in subsequent chapters. The remaining two extracts produced three known
compounds, costatone (44), 1H-indole-3-carboxaldehyde (45) and (E)-N-formyl-3-(1H-
indol-3-yl)prop-2-enamide (46).
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Chapter 3
Labillarides A to K: Eleven New Oxylipins from
Phacelocarpus labillardieri
3.1 Phacelocarpus labillardieri
In this study, extracts of a number of specimens of the New Zealand marine macro-algae
Phacelocarpus labillardieri [(Mertens ex Turner) J. Agardh] (Figure 3.1) were examined.
P. labillardieri, of the monotypic family Phacelocarpaceae, is found primarily in the
southern hemisphere, with a northern distribution in New Zealand waters (taxonomy see
Table 3.1). It is an erect plant and is characterised by narrow, parallel-sided fronds with
“marginal teeth of even length giving a minute saw-edge.”57
The NMR spectra obtained from screening P. labillardieri with our standard protocol
displayed a large number of clusters recognised as being of great interest using the HSQC
mask (Figure 3.2). These included two clusters of olefinic methines centred around δH 5.5
and δC 130, and δH 6.0 and δC 100, respectively.
There have been a number of compounds reported from Australian specimens of
Phacelocarpus labillardieri, most of which form a novel group of polyunsaturated
macrocycles containing α- and γ-pyrones. In 1982, the first of the macrocyclic γ-pyrone
Figure 3.1. Phacelocarpus labillardieri. Image courtesy of Malcolm Francis.
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Table 3.1. Taxonomic classification of genus Phacelocarpus from order Gigartinales as
presented by AlgaeBase.21
Order Family Genus
Gigartinales
Acrotylaceae . . .
Areschougiaceae . . .
Blinksiaceae . . .
Calosiphonaceae . . .
Catenellopsidaceae . . .
Caulacanthaceae . . .
Chondriellaceae . . .
Corynocystaceae . . .
Corynomorphaceae . . .
Crossocarpaceae . . .
Cruoriaceae . . .
Cubiculosporaceae . . .
Cystocloniaceae . . .
Dicranemataceae . . .
Dumontiaceae . . .
Endocladiaceae . . .
Furcellariaceae . . .
Gainiaceae . . .
Gigartinaceae . . .
Gloiosiphoniaceae . . .
Haemeschariaceae . . .
Hypneaceae . . .
Kallymeniaceae . . .
Mychodeaceae . . .
Mychodeophyllaceae . . .
Nizymeniaceae . . .
Peyssonneliaceae . . .
Phacelocarpaceae Phacelocarpus
Phyllophoraceae . . .
Polyidaceae . . .
Pseudoanemoniaceae . . .
Rhizophyllidaceae . . .
Rissoellaceae . . .
Sarcodiaceae . . .
Solieriaceae . . .
Sphaerococcaceae . . .
Stictosporaceae . . .
Tichocarpaceae . . .
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Figure 3.2. HSQC mask showing the common correlations in green and the unusual
correlations in red.
group were reported from southern Australian collections of P. labillardieri (49–51),
along with a straight-chain α-pyrone (52).58 The geometry of the enol-ether double bond
of 49 was not confirmed until 1986, when the NMR data reported for 49 was compared
with those of four new related compounds reported by Shin et al. from another Australian
collection of P. labillardieri. The four new compounds consisted of the (E) γ-pyrone (53)
and α-pyrone (54) enol-ether isomers of 49, a dibrominated macrocyclic α-pyrone (55)
and a hydroxylated γ-pyrone (56) macrocycle.59 In 1990, 57, the dibrominated analogue
of 50, was reported from a Tasmanian collection of P. labillardieri.60 Compound 57 was
reported along with the isolation of β-farnesene (58), a common terrestrial sesquiterpene
which is rarely reported from marine organisms. Finally, the tenth member of this class,
a macrocyclic γ-pyrone (59), was reported in 1995 from a South Australian collection
of P. peperocarpus (now considered a synonym of P. labillardieri).61 The (Z) geometry
of the enol-ether of 50 was also confirmed in this study. The geometry of the enol-ether
of 56 remains undetermined. In 2003, the use of ring closing alkyne metathesis allowed
the synthesis of a model of the core structure of the macrocyclic pyrone derivatives.62 To
date, there has been no report of a total synthesis to confirm the proposed structure of any
of these macrocyclic compounds.
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Very little biological activity has been reported for this class of compounds, though some
crude extracts of P. labillardieri were shown to exhibit neuromuscular blocking activity,
which may be due to pyrones of this type.58 Compound 49 has been shown to act as a
potent deterrent to marine herbivorous shellfish, snails and other gastropods, implying its
likely involvement in the chemical defense of the algae against predators.63 Moreover, a
study of phospholipase A2 inhibitors from marine algae revealed that 51 exhibited potent
activity (93% inhibition of bee venom PLA2 at 4.4 µM).64
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3.2 Isolation
Purification of the screen extract and two further bulk extracts of collections of P.
labillardieri from Rimariki Island, Northland, by a series of reversed-phase (PSDVB)
and normal-phase (DIOL) chromatographic steps ultimately led to the isolation of eight
new α-pyrone macrocycles, named labillarides A–H (60–67), two enol macrocycles,
labillarides I and J (68 and 69) and a furan-3-one oxylipin, labillaride K (70).
The NMR spectra of an extract of P. labillardieri obtained from the single bench-top
reversed-phase chromatographic separation (PSDVB) typical to our screening protocol
(Section 2.2), indicated the presence of one major constituent with lower levels of
structurally-related compounds (Figure 3.3).
(a) 1H spectrum (b) HSQC spectrum
Figure 3.3. NMR spectra of a semi-purified fraction of P. labillardieri.
Several different bench-top chromatographic techniques were employed in the attempts
to isolate the compounds of interest. Further reversed-phase (PSDVB) chromatography
gave poor separation, suggesting reasonably non-polar compounds. In contrast, normal-
phase media appeared to give good separation on silica gel TLC plates. However,
chromatography on silica gel led to degradation of material, suggesting acid-sensitivity. It
was therefore found that the best results were achieved on DIOL in both the early stages
of separation and in the final steps of isolation by HPLC.
The overall isolation strategy involved an initial reversed-phase (PSDVB) separation,
followed by two open column DIOL steps to yield several non-polar fractions from the
first stage (CH2Cl2) and polar fractions from the 50% MeOH in CH2Cl2 strip. Fractions
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were then either purified further by bench-top DIOL using mixtures of CH2Cl2 in pet.
ether or EtOAc in CH2Cl2 as the mobile phase, or purified directly by DIOL HPLC using
varying mixtures of IPA in hexane to yield labillarides A–K (60–70) (Scheme 3.1).
30% 75%
HP20
100% Me2COH2O
P. labillardieri
Extracted twice 
in MeOH
CH2Cl2
DIOL
50% MeOH 
in CH2Cl2
Labillarides A-D and I-K
DIOL HPLC DIOL HPLC
Labillarides E-H
Scheme 3.1. Schematic of the overall isolation strategy for labillarides A–K (60–70).
After the initial purification of the screen extract and the first bulk extract, it was
discovered that pure labillarides A–D quickly degraded when stored above −20 ◦C. To
counter this instability, samples obtained during the purification of the second bulk extract
were stored in liquid nitrogen. An overview of the actual individual isolation procedures
for these 11 metabolites is presented in Scheme 3.2.
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3.3 Labillaride A
Labillaride A (60) was isolated as a colourless oil (11.8 mg in total). Positive-ion
mode HRESIMS analysis of 60 gave rise to a single pseudomolecular ion indicative
of a molecular formula of C22H30O3 (343.2280 [M + H]
+, ∆ 3.6 ppm), requiring eight
double-bond equivalents. The 13C NMR spectrum contained only 21 distinct resonances
while the 1H NMR spectrum in CDCl3 accounted for all 30 protons. The absence of one
resonance in the 13C NMR spectrum suggested symmetry or overlap within the molecule.
A multiplicity-edited HSQC experiment confirmed correlations between all the observed
proton resonances and carbon resonances indicating that all protons were attached to
carbon. Identifiable features of the NMR spectra included three strongly deshielded non-
protonated carbons (δC 166.7, 165.4 and 170.0), two strongly shielded olefinic methines
[(δC 91.5, δH 5.41) and (δC 99.5, δH 5.97)], six typical olefinic methines [(δC 122.7,
δH 5.35), (δC 127.3, δH 6.39), (δC 127.3, δH 5.96), (δC 128.7, δH 5.54), (δC 134.4, δH 5.47)
and (δC 135.4, δH 5.54)], a deshielded oxymethine (δC 78.5, δH 4.78) and a methyl triplet
(δC 14.3, δH 0.98, t, 7.5 Hz).
Beginning at the methyl terminus, analysis of 1H – 1H coupling led to the construction
of the 1,5,7-triene containing substructure (C-1 to C-13) (see Figure 3.4). A series of
sequential COSY correlations starting from the methyl triplet (C-1: δC 14.3, δH 0.98)
to a methylene (C-2: δC 20.9, δH 2.06) to an olefinic methine (C-3: δC 135.4, δH 5.54)
to a second olefinic methine (C-4: δC 122.7, δH 5.35) established the first section of
the substructure. The geometry of the double bond was determined to be (Z) on the
basis of the observed coupling constants (10.3 Hz, H-3 and 10.7 Hz, H-4) and an NOE
enhancement between H2-2 and H-5. Further COSY correlations from H-4 to a methylene
(C-5: δC 33.4, δH 2.46) to a deshielded oxymethine (C-6: δC 78.5, δH 4.78) to a olefinic
methine (C-7: δC 128.7, δH 5.54) and to a further olefinic methine (C-8: δC 127.3, δH 6.39)
extended this substructure to a second double bond. The coupling constants (15.6 Hz, H-7
and 15.4 Hz, H-8) defined ∆7-8 as (E). Observed NOE enhancements between H-6 and
H-8 confirmed this assignment. Finally, a series of sequential COSY correlations starting
from H-8 to a fifth olefinic methine (C-9: δC 127.3, δH 5.96) to the final typical olefinic
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methine (C-10: δC 134.4, δH 5.47) to three methylenes in turn [(C-11: δC 26.5, δH 2.16
and 2.06), (C-12: δC 27.7, δH 1.43 and 1.24) and (C-13: δC 27.5, δH 1.35 and 1.18)]
completed the substructure. The geometry of the third double bond was defined as (Z) by
the coupling constants of 10.7 and 10.9 Hz for H-9 and H-10 respectively, and through
observed NOE enhancements between H-8 and H2-11. Observed HMBC correlations
confirmed this substructure (see Table 3.3).
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Figure 3.4. Selected COSY correlations and NOE enhancements establishing the
1,5,7-triene substructure of labillaride A (60).
An α-pyrone containing substructure was established from a distinctive deshielded
methylene (C-17: δC 33.0, δH 2.52) which exhibited a COSY correlation to a second
methylene (C-16: δC 26.1, δH 1.73). An HMBC correlation from H2-16 to a downfield
non-protonated carbon (C-18: δC 166.7) along with HMBC correlations from H2-17 to
C-18 and a strongly shielded olefinic methine (C-19: δC 99.5, δH 5.97) suggested the
presence of a highly-polarised double bond. Reciprocal HMBC correlations from H-19
to C-17 and C-18 confirmed this connectivity (see Figure 3.5).
18
19
1716
H H H
H H
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Figure 3.5. Selected COSY and HMBC correlations establishing part of the α-pyrone
containing substructure of labillaride A (60).
Further HMBC correlations from H-19 to a second downfield non-protonated carbon
(C-20: δC 170.0) and to a second heavily shielded olefinic methine (C-21: δC 91.5,
δH 5.41) along with a pseudo-allylic COSY correlation between H-19 and H-21 suggested
a second polarised double bond. The polarised nature of the two double bonds is
consistent with oxygen attachment at C-18 and C-20. Finally, HMBC correlations from
H-21 to the third deshielded non-protonated carbon (C-22: δC 165.4) completed the
connectivity of the carbon chain. With no further olefinic carbons available to complete
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a third double bond, C-22 was assigned as a carbonyl. The upfield nature of the C-22
resonance suggested an α,β-unsaturated ester moiety, and with a precedence for α-pyrone
containing compounds from this organism, a connection was made between C-18 and
C-22 through a lactone linkage (see Figure 3.6). The γ-pyrone alternative was dismissed
due to the lack of a ketone carbonyl 13C resonance around 180 ppm, as observed in the
known γ-pyrone compounds.59
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Figure 3.6. Selected COSY and HMBC correlations establishing the α-pyrone
containing substructure of labillaride A (60).
The chemical shifts assigned to the α-pyrone moiety of 60 compare very favourably to
those of the only known compound (54) containing an equivalent α-pyrone, with the
exception of the C-21 olefinic methine (see Table 3.2). In the original isolation paper, the
authors state that a comparison of the 13C chemical shifts of 54 to 4-methoxy-6-methyl-
2-pyrone (71) “gave excellent agreement”.59 A review of the literature found that the
chemical shift of the olefinic methine at the α-position of the lactone carbonyl in 71, at
δC 87.0, is in fact considerably closer to that of 60 (δC 91.5) than 54 (δC 114.2). These
discrepancies suggest an error in tabulating the data of 54 in the original isolation paper,
and is consistent with the chemical shift assignment of labillaride A (60).
Table 3.2. Chemical shift differences of the α-pyrone moiety of the known compound
(54) and labillaride A (60).
O
18
19
20
2122
O
O17
54* 60 Difference
Pos mult δC δH δC δH δC δH
δ (ppm) δ (ppm) δ (ppm) δ (ppm) ∆δ (ppm) ∆δ (ppm)
17 CH2 32.3 2.48 33.1 2.52 -0.8 -0.04
18 C 165.1 166.7 -1.6
19 CH 99.0 5.89 99.6 5.97 -0.6 -0.08
20 C 169.0 170.1 -1.1
21 CH 114.2 5.20 91.5 5.41 22.7 -0.21
22 C 166.9 165.3 1.6
*Shin, J.; Paul, V. J.; Fenical, W. Tetrahedron Lett. 1986, 27, 5189–5192.
Two carbons, four protons and one double-bond equivalent remained unaccounted for in
the structure. The multiplicity-edited HSQC displayed a large, unresolvable correlation
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at δC 27.1 and δH 1.23 which was initially assigned as one methylene pair. However,
closer inspection of the 13C NMR spectrum suggested this resonance may account for
both remaining carbons due to its apparent double-intensity compared to those of other
methylenes in the same region (see Figure 3.7). The intensity of a 13C signal is influenced
by such things as the nuclear Overhauser effect (NOE) and relaxation time (T1). Unlike
1H NMR spectra, the integrated peak areas are not a reliable indicator of the number
of carbons the peaks represent as relaxation times vary over a wide range and the NOE
response is not the same for all 13C nuclei.65 However, a comparison may be possible
between carbons in similar chemical environments, assuming they have similar relaxation
delays and NOE influences. Due to the high resolution of 1H broadband decoupled
carbon resonances, their relative integrations can be approximated from their relative
heights. The approximate double-intensity of the δC 27.1 resonance led us to propose
the coincidence of the 13C chemical shifts of two carbons. The unresolvable correlation
in the HSQC was therefore assigned as two methylene pairs with overlap in both the
carbon and proton dimensions. This was further supported by the relative integration of
the multiplet at ∼1.23 ppm in the 1H NMR spectrum.
Figure 3.7. Methylene region of the 13C NMR spectrum of labillaride A (60).
The overlapping of the chemical shifts for these methylenes suggested their presence in
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a short alkyl chain. COSY correlations observed from δH 1.23 to H-13a, H-13b and
H2-16 suggested that C-13 and C-16 were connected via at least one of the methylene
pairs. No further COSY correlations involving δH 1.23 were observed, suggesting that
the two methylenes were in fact next to each other. This proposal is supported by the
observation of HSQC-TOCSY correlations from H2-16 to δH 1.23, H-13a and H-13b.
Similarly, selective excitation of H2-16 in a series of 1D-TOCSY experiments with
increasing mixing times sequentially revealed [H2-15 and H2-14], H-13a , H-13b and
then H-12a and H-12b. Further support of the assignment of the alkyl chain between
C-13 and C-16 was obtained from an HMBC correlation from H2-16 to resonances at
δC 27.1, and from δH 1.23 to C-13 (see Figure 3.8). Finally, with all three oxygens of the
molecular formula accounted for in the α-pyrone substructure, an ether bridge between
C-6 and C-20 was proposed, connecting the two substructures. This was supported by an
HMBC correlation from H-6 to C-20.
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Figure 3.8. Selected TOCSY and HMBC correlations connecting the substructures of
labillaride A (60), completing the alkyl chain.
Formation of the macrocyclic ring accounted for all of the elements of the molecular
formula. The five double bonds, the ester carbonyl and the macrocycle accounted for
seven of the eight required double-bond equivalents and thus confirmed a lactone linkage,
satisfying the molecular formula. The final structure of labillaride A is therefore proposed
to be 60. NMR data for 60 is presented in Table 3.3.
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3.4 Labillaride B
A total of 17.3 mg of labillaride B (61) was isolated as a colourless oil. Positive-ion mode
HRESIMS analysis of 61 showed a characteristic pseudomolecular ion cluster ([M + H]+ :
[M + 2 + H]+; 1 : 1) indicative of the presence of bromine and consistent with a molecular
formula of C22H31O3Br (423.1522 [M + H]
+, ∆ 1.7 ppm), requiring seven double-bond
equivalents. The 13C NMR spectrum contained 22 distinct carbon resonances while
the 1H NMR spectrum accounted for all 31 protons, which a multiplicity-edited HSQC
experiment confirmed were all attached to carbon. Identifiable features of the NMR
spectra again included three strongly deshielded non-protonated carbons (δC 165.0, 166.8
and 170.2), two strongly shielded olefinic methines [(δC 91.2, δH 5.49) and (δC 99.3,
δH 5.90)], four typical olefinic methines [(δC 124.7, δH 5.53), (δC 125.1, δH 5.33),
(δC 133.7, δH 5.50) and (δC 135.7, δH 5.75)], a deshielded oxymethine (δC 76.9, δH 5.08)
and a methyl triplet (δC 14.3, δH 0.99, t, 7.6 Hz).
The structure of 61 was elucidated in a similar fashion to labillaride A (60), beginning at
the methyl terminus. A COSY correlation from the methyl triplet (C-1: δC 14.3, δH 0.99)
to a methylene (C-2: δC 20.9, δH 2.10) to an olefinic methine (C-3: δC 133.7, δH 5.50)
to a second olefinic methine (C-4: δC 125.1, δH 5.33) to a methylene (C-5: δC 27.0,
δH 2.99 and 2.96) to a third olefinic methine (C-6: δC 135.7, δH 5.75) to the final typical
olefinic methine (C-7: δC 124.7, δH 5.53) to a deshielded oxymethine (C8: δC 76.9,
δH 5.08) to a deshielded methine (C-9: δC 54.1, δH 4.18) to a methylene (C-10: δC 33.3,
δH 2.02 and 1.08) to a second methylene (C-11: δC 22.0, δH 1.55 and 1.16) established a
diene substructure (Figure 3.9, substructure A). The geometry of both double bonds were
determined to be (Z) on the basis of the observed 1H – 1H coupling constants between
H-3 and H-4, and H-6 and H-7 (10.6 and 10.9 Hz, respectively). Both assignments were
supported by observed NOE enhancements from H2-5 to H2-2 and between H2-5 and H-8.
Again, a distinctive deshielded methylene (C-17: δC 34.3, δH 2.67 and 2.35) was used
to establish an α-pyrone substructure. A series of sequential COSY correlations were
observed starting from both proton resonances of CH2-17 to a second methylene (C-16:
δC 24.7, δH 1.83 and 1.61) to a third methylene (C-15: δC 27.1, δH 1.48 and 1.14). HMBC
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Figure 3.9. Selected COSY and HMBC correlations and NOE enhancements
establishing two substructures of labillaride B (61).
correlations from both proton resonances of CH2-16 to a deshielded non-protonated
carbon (C-18: δC 166.8) along with an HMBC correlation from both proton resonances of
CH2-17 to a strongly shielded olefinic methine (C-19: δC 99.3, δH 5.90) again suggested a
highly-polarised double bond. HMBC correlations from H-19 to a second downfield non-
protonated carbon (C-20: δC 170.2) and to a second strongly shielded olefinic methine
(C-21, δC 91.2, δH 5.49) along with a pseudo-allylic COSY correlation between H-19 and
H-21 established a second highly-polarised double bond. Finally, an HMBC correlation
from H-21 to the final non-protonated carbonyl carbon (C-22: δC 165.0) completed the
connectivity of the carbon chain and suggested an α-pyrone substructure the same as
labillaride A (60). The highly-polarised nature of the two double bonds is consistent with
oxygen attachment at C-18 and C-20, while the deshielded nature of the C-22 carbonyl
once again suggested a lactone moiety (Figure 3.9, substructure B). No long-range HMBC
correlations were observed from either the proton resonances of CH2-17 or CH-19 to
C-22, however the carbon and proton chemical shifts of the α-pyrone system compared
very favourably with those of labillaride A (see Table 3.4).
Table 3.4. Chemical shift differences of the α-pyrone moiety for labillarides A (60) and
B (61).
O
18
19
20
2122
O
O17
Labillaride A (60) Labillaride B (61) Difference
Pos mult δC δH δC δH δC δH
δ (ppm) δ (ppm) δ (ppm) δ (ppm) ∆δ (ppm) ∆δ (ppm)
17a CH2 33.1 2.52 34.3
2.67 -1.2 -0.1517b 2.35 0.17
18 C 166.7 166.8 -0.1
19 CH 99.6 5.97 99.3 5.90 0.3 0.07
20 C 170.1 170.2 -0.1
21 CH 91.5 5.41 91.2 5.49 0.3 -0.08
22 C 165.3 165.0 0.3
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An HMBC correlation from H-8 to C-20 established an enol ether oxygen bridge between
these centres, as in labillaride A (60). With only three diastereotopic methylene pairs
and a bromine left to assign, the bromine atom was tentatively assigned to position C-9
based on the somewhat downfield 13C chemical shift. One-bond carbon-proton coupling
constants are dependent on a variety of factors, including increasing with dihedral angular
distortion and substitution of electron-withdrawing groups.66 This precedence supported
the attachment of bromine, an electronegative atom, to C-9, resulting in a large 1JCH value
for this carbon (155 Hz). The value also compared favourably with that observed for the
methine position of 2-bromobutane (152 Hz).
Analysis of the HMBC spectrum of labillaride B (61), along with 1D-TOCSY and HSQC-
TOCSY experiments, led to the construction of the macrocycle connecting the alkyl
chains of the diene and α-pyrone substructures. An HMBC correlation from both proton
resonances of CH2-10 to a methylene (C-12: δC 25.9, δH 1.34 and 1.26) positioned
this carbon next to C-11. Further HMBC correlations from both proton resonances of
CH2-11 to a methylene (C-13: δC 26.4, δH 1.14 and 1.01), and from H-12a to the final
methylene (C-14: δC 26.8, δH 1.34 and 1.24) suggested the linear arrangement of C-10 to
C-14, accounting for all proton and carbon resonances. An HMBC correlation from both
proton resonances of CH2-16 to C-14 positioned this carbon next to the C-15 methylene,
completing the macrocyclic ring (Figure 3.10).
Selective excitation of H-9 in a series of 1D-TOCSY experiments with increasing mixing
times sequentially revealed H-10a,b, H-11a,b and then H-12a,b. Similarly, selective
excitation of H-17a sequentially revealed H-16a,b, H-15a,b H-14a,b and then H-13a,b.
These data supported the linear arrangement of C-11 to C-15. The assignment of this
alkyl chain was also supported by an HSQC-TOCSY experiment with a mixing time
of 80 ms. The HSQC-TOCSY experiment displays the TOCSY data differentiated
by the 13C chemical shifts of the carbons to which the excited protons are attached.
TOCSY correlations were observed from the proton resonances of CH2-10 to H-12a and
H-12b, from the proton resonances of CH2-12 to H-14a and H-14b, and from the proton
resonances of CH2-14 to H-16a and H-16b.
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Figure 3.10. Selected TOCSY and HMBC correlations connecting the substructures of
labillaride B (61).
The relative configuration of labillaride B (61) was tentatively assigned on the basis of
3JHH values and NOE enhancements observed in a series of 1D-NOESY experiments.
The 1H – 1H coupling constants of 8.7 Hz for H-8 and 8.5 Hz for H-9 implied a dihedral
angle of either approximately 0◦ or 180◦ between these vicinal protons. The eclipsed
conformation with the protons at a dihedral angle of 0◦ was discounted on the basis of the
significant steric hindrance expected due to the overlap of several large functional groups.
The anti conformer was therefore considered more reasonable (Figure 3.11).
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Figure 3.11. Steric hindrance discounting an eclipsed relationship between H-8 and H-9
in both possible relative configurations of labillaride B (61).
Similarly, the coupling constants of 4.4 Hz for H-9 to H2-10, 4.7 Hz for H-10a to H-9,
and 5.0 Hz for H-10b to H-9 suggested a dihedral angle of either approximately 45◦ or
135◦ for each vicinal relationship. Selective excitation of H-8 showed a very strong NOE
enhancement to H-11b, which could only be achieved when each of the proton resonances
of CH2-10 were in a gauche relationship to H-9 (dihedral angle of ∼45◦) (Figure 3.12).
Selective excitation of H-9 showed NOE enhancements to H-7 and H-19. With a relative
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Figure 3.12. The selected NOE enhancement establishing a gauche relationship between
H-9 and H-10a, and H-10b in both possible relative configurations of labillaride B (61).
configuration of R*, R* or R*, S*, and considering the two conformer restrictions detailed
above, these NOE enhancements force the structure into one of two configurations, shown
in Figure 3.13. The figure shows that the R*, R* diastereomer would force either the
bromine atom (as in the figure) or∆6,7 into the macrocycle, causing considerable electron
repulsion. This diastereomer is therefore considered possible but unlikely to adopt one
of these two confirmations. In contrast, the R*, S* diastereomer is more plausible as
the structure places the bromine atom in a more favourable position outside of the ring,
while satisfying the NOE enhancements observed. The relative configuration is therefore
tentatively assigned as R*, S*, though there is not enough evidence to be conclusive. The
final structure of labillaride B is therefore tentatively determined to be 61. NMR data for
61 is presented in Table 3.5.
R*,R* R*,S*
Figure 3.13. Selected NOE enhancements suggesting the R*,S* relative configuration of
labillaride B (61).
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3.5 Labillaride C
Positive-ion mode HRESIMS analysis of the colourless oil labillaride C (62) (151.2 mg
isolated in total) gave rise to a single pseudomolecular ion indicative of the molecular
formula C22H30O3 (343.2259 [M + H]
+, ∆ 2.7 ppm), requiring eight double-bond
equivalents. The 1H NMR spectrum in CDCl3 accounted for all 30 protons, including
a broad singlet which integrated for one proton. The multiplicity-edited HSQC spectrum
showed no connectivity of this proton resonance to carbon, indicating an exchangeable
proton. The 13C NMR spectrum contained 22 distinct carbon resonances, including
three strongly deshielded non-protonated carbons (δC 165.6, 166.6 and 166.7), a strongly
shielded olefinic non-protonated carbon (δC 107.2), a strongly shielded olefinic methine
(δC 102.5, δH 6.45), six typical olefinic methines [(δC 127.4, δH 5.34), (δC 128.4, δH 5.40),
(δC 130.8, δH 5.19), (δC 131.0, δH 5.92), (δC 132.0, δH 5.38) and (δC 133.2, δH 5.67)] and
a methyl triplet (δC 14.5, δH 0.95, t, 7.5 Hz).
Beginning at the methyl terminus, analysis of 1H – 1H coupling led to the construction
of the 1,4,7-triene substructure (C-1 to C-17). A series of sequential COSY correlations
starting from the methyl triplet (C-1: δC 14.5, δH 0.95) to a methylene (C-2: δC 20.6,
δH 2.07) to an olefinic methine (C-3: δC 132.0, δH 5.38) to a second olefinic methine (C-4:
δC 127.4, δH 5.34) and then to a methylene (C-5: δC 25.86, δH 3.01 and 2.90) established
the first section. The geometry of the double bond was determined to be (Z) on the
basis of the observed coupling constant of 10.7 Hz for H-3, and an NOE enhancement
between H2-2 and H2-5. Further COSY correlations from both proton resonances of
CH2-5 to a third olefinic methine (C-6: δC 128.4, δH 5.40) to a fourth olefinic methine
(C-7: δC 131.0, δH 5.92) to a methine (C-8: δC 30.6, δH 4.76) to an olefinic methine (C-9:
δC 133.2, δH 5.67) to the final typical olefinic methine (C-10: δC 130.8, δH 5.19) extended
this substructure to the third double bond. Coupling constants (10.5 Hz, H-6; 10.4 Hz,
H-7; 11.0 Hz, H-9; 11.2 Hz, H-10) defined both ∆6-7 and ∆9-10 as (Z). Observed NOE
enhancements between H2-5 and H-8, and H-8 and H2-11 confirmed these assignments.
A long alkyl chain was constructed through a series of sequential COSY correlations
starting from H-10 to a linear chain of seven methylenes [(C-11: δC 26.9, δH 1.95 and
1.85), (C-12: δC 29.0, δH 1.25 and 1.13), (C-13: δC 27.3, δH 0.94), (C-14: δC 29.3,
44
δH 0.86), (C-15: δC 25.91, δH 1.42 and 1.33), (C-16: δC 28.4, δH 1.87 and 1.38) and
(C-17: δC 33.6, δH 2.47 and 2.36)] to complete the triene substructure (Figure 3.14).
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Figure 3.14. Selected COSY correlations and NOE enhancements establishing the
1,4,7-triene substructure of labillaride C (62).
An α-pyrone substructure was established from the C-16 and C-17 methylenes. HMBC
correlations from H-16a to a deshielded non-protonated carbon (C-18: δC 165.6) and from
both proton resonances of CH2-17 to a shielded olefinic methine (C-19: δC 102.5, δH 6.45)
established the first highly-polarised double bond in the now characteristic α-pyrone
substructure. HMBC correlations from H-19 to the second deshielded non-protonated
(C-20: δC 166.6) and shielded non-protonated (C-21: δC 107.3) carbons suggested
the presence of the second highly-polarised double bond, supporting the attachment of
oxygen at C-18 and C-20. HMBC correlations from H-7 and H-9 to C-21 established
the direct connection between C-8 and C-21. This connectivity was supported by HMBC
correlations from H-8 to C-21 and the final carbon resonance (C-22: δC 165.3). With no
further olefinic carbons left unaccounted for, C-22 was again assigned as a ester carbonyl
completing the α-pyrone substructure through a lactone linkage to C-18 (see Figure 3.15).
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Figure 3.15. Selected HMBC correlations establishing the α-pyrone substructure of
labillaride C (62).
Every carbon resonance was now accounted for, while the α-pyrone, triene and macro-
cyclic moieties accounted for all eight double-bond equivalents. The final remaining
proton from the molecular formula unaccounted for was satisfied by assigning position
C-20 as an alcohol. The final structure of labillaride C is therefore as proposed to be 62.
NMR data for 62 is presented in Table 3.6.
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3.6 Labillaride D
Labillaride D (63) was isolated as a colourless oil (20.4 mg isolated in total). Positive-
ion mode HRESIMS showed a single pseudomolecular ion indicative of the molecular
formula C22H30O3 (365.2093 [M + Na]
+, ∆ 0.0 ppm). The structure was elucidated in
the same fashion as labillaride C (62). Again, the 1H and 13C NMR spectra in CDCl3
accounted for all 30 protons and 22 carbons respectively, while the multiplicity-edited
HSQC experiment confirmed one broad proton singlet to be exchangeable due to its lack
of connectivity to carbon. The only major difference in the NMR data of 63 compared to
62 was a larger coupling constant for two of the olefinic methines [(δC 128.9, δH 5.53) and
(δC 130.7, δH 5.86), both with a 15.3 Hz coupling constant], suggesting an (E) geometry
across a double bond.
Analysis of the 2D NMR spectra of 63 allowed the construction of the structure of
labillaride D (Figure 3.16). A series of sequential COSY correlations starting from the
methyl triplet terminus (δC 14.4, δH 0.94) constructed a 1,4,7-triene substructure (C-1 to
C-17) very similar to that of 62. The geometry of ∆3-4 and ∆9-10 were determined to be
(Z) on the basis of the observed coupling constants (10.6 Hz, H-3; 10.8 Hz, H-4; 10.5 Hz,
H-9; 10.6 Hz, H-10 ), and NOE enhancements from H2-5 to H2-2, and from H-8 to H2-11.
The coupling constants (15.3 Hz for both H-6 and H-7) defined∆6-7 as (E), confirmed by
an observed NOE enhancement from H-8 to H-6.
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Figure 3.16. Selected COSY and HMBC correlations and NOE enhancements
establishing the structure of labillaride D (63).
HMBC correlations were used to construct an α-pyrone moiety once again. HMBC
47
correlations from both proton resonances of CH2-16 to a deshielded non-protonated
carbon (C-18: δC 165.8) and from both proton resonances of CH2-17 to a shielded olefinic
methine (C-19: δC 101.5, δH 6.13) established the first highly-polarised double bond.
HMBC correlations from H-19 to the two carbons of the second highly-polarised double
bond [(C-20: δC 164.8) and (C-21: δC 106.8)] supported the attachment of oxygen at C-18
and C-20, expanding the α-pyrone to the second double bond. No HMBC correlations to
C-22 were observed, however the clear similarities to labillaride C (62) led to the confident
assignment of the α-pyrone ring. HMBC correlations were observed from H-8 into the
α-pyrone ring, indicating the same carbon bridge connectivity from the long carbon chain
as 62.
The final structure of labillaride D is therefore shown in 63, the ∆6-7 (E) isomer of
labillaride C (62). NMR data for 63 is presented in Table 3.7.
Labillarides C (62) and D (63) are the first reported macrocyclic pyrones of this nature to
exhibit a carbon-to-carbon bridge from the alkyl chain into the pyrone moiety (direct C-8
to C-21 connectivity).
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3.7 Labillaride E
Labillaride E (64) was isolated as a colourless oil (2.0 mg isolated in total). Positive-
ion mode HRESIMS analysis of 64 gave rise to two pseudomolecular ions indicative
of the molecular formula C22H30O5 (375.2163 [M + H]
+, ∆ 0.7 ppm, and 397.2005
[M + Na]+,∆ 4.8 ppm), requiring eight double-bond equivalents. The 13C NMR spectrum
contained 22 distinct resonances while the multiplicity-edited HSQC spectrum, as well as
establishing direct 1H to 13C connectivity, accounted for 28 of the 30 protons indicating
the presence of two exchangeable protons. Identifiable features of the NMR spectra in
CDCl3 included three strongly deshielded non-protonated carbons (δC 162.5, 170.2 and
171.0), a strongly shielded olefinic non-protonated carbon (δC 99.7), a strongly shielded
olefinic methine (δC 96.3, δH 5.98), four typical olefinic methines [(δC 127.0, δH 5.73),
(δC 129.5, δH 5.63), (δC 134.9, δH 5.51) and (δC 136.1, δH 5.84)], three oxymethines
[(δC 70.8, δH 4.30), (δC 73.3, δH 4.05) and (δC 89.5, δH 5.42)], an allylic methine (δC 51.3,
δH 3.15) and a methyl triplet (δC 9.8, δH 0.92, t, 7.4 Hz).
Analysis of the 1H – 1H coupling established a 17 carbon, 1,6-diene substructure (C-1 to
C-17). A series of sequential COSY correlations starting from the methyl triplet (C-1:
δC 9.8, δH 0.92) to a methylene (C-2: δC 30.0, δH 1.56) to an oxymethine (C-3: δC 73.3,
δH 4.05) to an olefinic methine (C-4: δC 136.1, δH 5.84) to a second olefinic methine
(C-5: δC 127.0, δH 5.73) established the first section of the substructure. Coupling
constants (15.4 Hz, H-4 and H-5) and observed NOE enhancements between H-3 and
H-5 defined∆4-5 as (E). Further COSY correlations from H-5 to a deshielded oxymethine
(C-6: δC 89.5, δH 5.45) to a deshielded methine (C-7: δC 51.3, δC 3.15) to an oxymethine
(C-8: δC 70.8, δH 4.30) to an olefinic methine (C-9: δC 129.5, δH 5.63) to the fourth typical
olefinic methine (C-10: δC 134.9, δH 5.51) to a linear chain of seven methylenes [(C-11:
δC 27.2, δH 2.09 and 2.00), (C-12: δC 29.4, δH 1.22), (C-13: δC 27.5, δH 1.00 and 0.90),
(C-14: δC 29.3, δH 1.09 and 1.00), (C-15: δC 26.4, δH 1.20), (C-16: δC 26.2, δH 1.72 and
1.63) and (C-17: δC 35.2, δH 2.62 and 2.27)] completed the long alkyl-chain substructure.
Selective excitation of H-17b in a series of 1D-TOCSY experiments with increasing
mixing times sequentially revealed H-17b, H-16a and H-16b, H2-15, H-14a and H-14b,
H-13a and H-13b, H2-12 and then H-11a and H-11b, supporting the assignment of the
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C-11 to C-17 alkyl chain. Coupling constants (10.5 Hz, H-9 and 10.8 Hz, H-10) and an
observed NOE enhancement from H-8 to H-11b defined ∆9-10 as (Z) (Figure 3.17).
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Figure 3.17. Selected COSY correlations establishing the 1,6-diene substructure of
labillaride E (64).
As before, an α-pyrone substructure was constructed starting from the distinctive C-16
and C-17 methylenes. HMBC correlations from both proton resonances of CH2-16 to
a deshielded non-protonated carbon (C-18: δC 170.2) and from both proton resonances
of CH2-17 to a strongly shielded methine (C-19: δC 96.3, δH 5.98) indicated the first of
the two highly-polarised double bonds. HMBC correlations from H-19 to the second
downfield non-protonated carbon (C-20: δC 171.0) and to a strongly shielded non-
protonated carbon (C-21: δC 99.7) suggested the second highly-polarised double bond,
supporting the attachment of oxygen at C-18 and C-20. Crosspeak intensities in HMBC
experiments depend on the magnitude of long-range coupling.67 The standard HMBC
experiment employed by this group has a coherence transfer delay optimised for 8 Hz.
Here, an HMBC experiment optimised for a coherence transfer delay of 4 Hz was
performed with the hope of seeing four-bond HMBC correlations, which typically have
smaller 13C – 1H coupling constants. This spectrum revealed HMBC correlations from H-
17b and H-19 to the final deshielded non-protonated lactone carbonyl (C-22: δC 162.5).
Once again, this supported an α-pyrone moiety, with an oxygen bridge connecting C-18
and C-22 (see Figure 3.18).
nJCH = 8 Hz
nJCH = 4 Hz
O
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O
O1716
H H
H Hb H
Figure 3.18. Selected HMBC correlations establishing the α-pyrone substructure of
labillaride E (64).
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HMBC correlations from both H-6 and H-8 to C-21 were observed, establishing
connectivity between C-7 and C-21. This was confirmed by HMBC correlations from
H-7 to C-20, C-21 and C-22, and a weak homo-allylic COSY correlation between H-7
and H-19. A further HMBC correlation from H-6 to C-20 indicated a second connectivity
from the alkyl chain into the pyrone ring through an oxygen bridge between C-6 and C-20,
forming a dihydrofuran (see Figure 3.19).
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Figure 3.19. Selected COSY and HMBC correlations connecting the substructures of
labillaride E (64).
The dihydrofuro[3,2-c]pyran-4-one moiety is present, though uncommon, in terrestrial
organisms. To the author’s knowledge, no such examples have been reported from the
marine environment. Phelligridimer A (72), a macrocyclic metabolite reported in 2005
from the Chinese medicinal fungus Phellinus igniarius, is one of the few compounds
of natural origin to contain this moiety.68 The 13C chemical shifts of the dihydrofuro[3,2-
c]pyran-4-one fragment of 64 compared very favourably to those of 72, with the exception
of the non-protonated carbon at positions C-18 and C-6 in 64 and 72, respectively (see
Table 3.8). This is most likely due the differing substituents at this position, specifically
an alkyl chain in 64 as opposed to a conjugated alkene in 72.
O
O
O
OHO
OH
OH
O OH
O
O
O
OH
HO
HO
HO
OH
OH
O
O
72
All detected carbon resonances were now accounted for. The presence of the dihydro-
furo[3,2-c]pyran-4-one ring system accounted for five of the eight double-bond equiva-
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Table 3.8. 13C chemical shift differences of dihydrofuro[3,2-c]pyran-4-one moiety for
labillaride E (64) and phelligridimer A (72).
O
18
19
20
21
22
O
O
6
7 O1
6
5
4
3
2
O
O
8'
7'
64 72
Labillaride E (65) Phelligridimer A (72)* Difference
mult Pos δC δ (ppm) Pos δC δ (ppm) δC ∆δ (ppm)
C 22 162.5 2 163.0 -0.5
C 21 99.7 3 99.3 0.4
C 20 171.0 4 170.4 0.6
CH 19 96.3 5 95.0 1.3
C 18 170.2 6 162.8 7.4
CH 7 51.2 7′ 51.4 -0.2
CH 6 89.5 8′ 89.6 -0.1
*Wang, Y.; Wang, S.-J.; Mo, S.-Y.; Li, S.; Yang, Y.-C.; Shi, J.-G. Org. Lett. 2005, 7, 47334736.
lents, while the diene chain and macrocycle completed the requirements of the molecular
formula. The final two protons from the molecular formula unaccounted for were satisfied
by assigning positions C-3 and C-8 as alcohols.
The 1H NMR spectrum of labillaride E (64) showed H-7 to be split into a doublet of
doublets of 9.2 and 1.6 Hz. The large splitting was assumed to be due to coupling to
H-8, while the very small splitting appeared to be due to vicinal coupling to H-6. The
broad doublet 1H signal of H-6 was suspected of being broadened by this small coupling
to H-7, supporting the claim. A series of homonuclear decoupled 1H NMR experiments
were performed in order to prove this assignment. Selective decoupling of H-6 caused
the doublet of doublets of H-7 to collapse into a doublet of 9.2 Hz, while selective
decoupling of H-8 caused H-7 to collapse into a broad singlet (see Figure 3.20). The
decoupled experiments therefore confirmed the allocation of the 1.6 Hz to the vicinal
coupling between H-6 and H-7.
The vicinal coupling constants for cyclopentene (3Jcis = 7.4 Hz, 3Jtrans = 4.6 Hz) and
dihydrofuran (3Jcis = 10.7 Hz, 3Jtrans = 8.3 Hz) show very little variation between the cis
and trans values.69 The vicinal coupling constant of 6.5 Hz between H-7′ and H-8′ in
phelligridimer A (72) led Shi et al. to assign a trans orientation of the two protons of
the dihydrofuro[3,2-c]pyran-4-one moiety, supported by several NOE enhancements.68
These reported coupling constants show no similarity to the 1.6 Hz observed between
H-6 and H-7 in 64, therefore further examination was required.
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Figure 3.20. 1H NMR spectrum of H-7 of labillaride E (64) (red) and homonuclear
decoupled 1H NMR spectra of H-7 selectively decoupled at H-6 (blue) and H-8 (green).
The small coupling constant observed between H-6 and H-7 (1.6 Hz) suggested a dihedral
angle close to 90◦. This could only be achieved when the protons were held reasonably
rigid in a trans relationship, with the large side-chain sitting on the opposite face of the
ring to the bulky macrocycle. NOE enhancements between H-6 and H-8 supported this
trans assignment (see Figure 3.21). The assignment of cis or trans relationships on five-
membered rings are notoriously difficult. In this case, however, the trans assignment
is fairly confidently made due to the deviation from the normal 3JHH values seen in
dihydrofuran rings. The final structure of labillaride E is therefore proposed to be 64.
NMR data for 64 is presented in both CDCl3 (Table 3.9) and C6D6 (Table 3.10).
trans cis
Figure 3.21. The selected NOE enhancement supporting the trans assignment of H-6
and H-7 in labillaride E (64).
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3.8 Isolation of Labillaride E Isomers
During the purification of the second bulk extract of Phacelocarpus labillardieri, a sample
of what was thought to be labillaride E (64) appeared to exhibit “twinning” of some
signals in the 1H NMR spectrum, as shown in Figure 3.22. Further purification by normal-
phase (DIOL) HPLC gave two separable compounds, labillarides F (65) and G (66), which
showed minor differences both to each other and to 64 in the 1H NMR spectra (see Figure
3.23 for spectra obtained in CDCl3 and Figure 3.24 for spectra obtained in C6D6). At this
point, the fractions on either side of the original labillaride E (64) sample were inspected
more closely and it was found that the later eluting fraction appeared to also contain a
mixture of very similar compounds. Purification of this fraction by normal-phase HPLC
(DIOL) produced a fourth compound (labillaride H, 67) along with additional 64.
Figure 3.22. 1H NMR spectra of labillaride E (64) (red) and the mixture of labillarides F
(65) and G (66) (cyan).
To confirm that all four samples were different compounds, several HPLC injections were
performed using various combinations of the four samples. It was found that when
injected individually under identical HPLC conditions (analytical DIOL column with
7% IPA in hexanes as the mobile phase at a flow rate of 1 mL/min), each compound
exhibited a different retention time: 32.7, 31.6, 33.4 and 30.3 min for 64, 65, 66 and
67, respectively. Interestingly, when combinations of two pure compounds of equal
concentration were injected, only one peak was observed for a combination of 64 and
66, and a combination of 65 and 67, while two peaks were observed with all four other
two-compound combinations (see Figure 3.25). When all four compounds were injected,
only two peaks were observed, supporting the idea that labillarides E (64) and G (66), and
F (65) and H (67) co-elute when co-injected.
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Figure 3.23. 1H NMR spectra of labillarides E (64) (red), F (65) (green), G (66) (blue)
and H (67) (black) (CDCl3, 1.3 mg mL-1).
Figure 3.24. 1H NMR spectra of labillarides E (64) (red), F (65) (green), G (66) (blue)
and H (67) (black) (C6D6, 1.6 mg mL-1).
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Figure 3.25. Single wavelength (300 nm) traces of HPLC injections of labillarides E
(66), F (65), G (66) and H (67).
All four compounds have exceptionally similar chromophores (see Figure 3.26), indi-
cating likely structural similarities. This fact, supported by the remarkably similar 1H
NMR spectra and identical HRESIMS data, suggested labillarides F (65), G (66) and H
(67) are very similar stereoisomers of labillaride E (64). This number of isomers was
not unreasonable, as 64 contains four chiral centres which gives rise to eight possible
diastereomeric pairs. It is important to note that had 64 originally been isolated with 66,
or had 65 been isolated with 67, their final separations would have been very challenging
due to their propensities to co-elute.
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Figure 3.26. UV traces of labillarides E (64) (red), F (65) (green), G (66) (blue) and H
(67) (black).
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3.9 Labillaride F
Positive-ion mode HRESIMS analysis of the colourless oil labillaride F (65) (0.4 mg
isolated in total) gave rise to two pseudomolecular ions indicative of the molecular
formula C22H30O5 (375.2162 [M + H]
+, ∆ 1.2 ppm, and 397.1990 [M + Na]+, ∆
1.1 ppm), requiring eight double-bond equivalents. The 1H and 13C NMR spectra in
CDCl3 were almost identical to that of labillaride E (64), including identifiable features
such as three strongly deshielded non-protonated carbons (δC 161.9, 169.8 and 170.8), a
strongly shielded olefinic non-protonated carbon (δC 100.2), a strongly shielded olefinic
methine (δC 95.9, δH 5.48) and three oxymethines [(δC 71.1, δH 4.27), (δC 72.7, δH 3.79)
and (δC 90.1, δH 5.50)].
The planar structure of 65 was elucidated in an identical fashion as 64, through a series
of COSY, NOE and HMBC correlations (see Figure 3.27). A series of sequential COSY
correlations starting from a methyl triplet constructed a 17 carbon, 1,6-diene chain (C-1
to C-17). The coupling constant of 15.4 Hz between H-4 and H-5 defined ∆4-5 as
(E), supported by the observation of an NOE enhancement between H-3 and H-5. The
geometry of the second double bond was determined to be (Z) on the basis of observed
1H – 1H coupling constants (10.6 Hz, H-9 and 10.7 Hz, H-10). An NOE enhancement
from H-8 to H-11b was observed, confirming this assignment as identical to 64.
HMBC correlations from H2-16 to C-18 and H2-17 to C-19, and an allylic COSY
correlation observed between H2-17 and H-19 confirmed the presence of the first highly-
polarised double bond. HMBC correlations from H-19 to C-20 and C-21 established
the second highly-polarised double bond, while an HMBC experiment optimised for an
nJCH of 4 Hz revealed a correlation from H2-17 to C-22. Once again, this supported an
α-pyrone moiety with an ester oxygen bridge connecting C-18 and C-22. Finally, HMBC
correlations from H-6 and H-8 to C-21, from H-7 to C-20, C-21 and C-22, and from
H-6 to C-20 established the five-membered heterocycle. The final two protons from the
molecular formula unaccounted for were satisfied by assigning positions C-3 and C-8
as alcohols. Thus 65 is constitutionally related to 64 and the double bond geometry is
conserved.
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Figure 3.27. Selected COSY and HMBC correlations and NOE enhancements
establishing the structure of labillaride F (65).
As with labillaride E (64), the relative configuration of 65 was difficult to assign. A
small coupling constant observed between the vicinal protons H-6 and H-7 (1.6 Hz)
combined with observed NOE enhancements between H-5 and H-8 again suggested a
trans relationship. The final structure of labillaride F is therefore proposed to be 65.
NMR data for 65 is presented in Table 3.11.
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3.10 Labillaride G
The observation of pseudomolecular ions of the colourless oil labillaride G (66) (0.4 mg
isolated in total) by HRESIMS indicated a molecular formula of C22H30O5 (375.2158
[M + H]+,∆ 2.1 ppm and 397.1986 [M + Na]+,∆ 0.2 ppm), requiring eight double-bond
equivalents. As with labillaride F (65), the 1H and 13C NMR spectra of 66 were almost
identical to those of labillaride E (64).
The planar structure of 66 was elucidated in an identical fashion as 64 and 65, through a
series of COSY, NOE and HMBC correlations (see Figure 3.28). Analysis of the 1H – 1H
coupling established the 17 carbon 1,6-diene. HMBC correlations from H2-16 to C-18,
from H2-17 to C-19 and C-22, and from H-19 to C-20 and C-21 established the α-pyrone
ring. HMBC correlations from H-6 to C-20, and from H-6 and H-8 to C-21 constructed
the five-membered heterocycle. The geometry of the first double bond was determined
to be (E) on the basis of the observed 1H to 1H coupling constant between H-4 and
H-5 of 15.6 Hz. NOE enhancements between H-3 and H-5 confirmed this assignment.
Coupling constants (10.2 Hz, H-9 and 10.6 Hz, H-10) defined ∆9-10 as (Z), confirmed by
an observed NOE enhancement between H-8 and H2-11a.
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Figure 3.28. Selected COSY and HMBC correlations and NOE enhancements
establishing the structure of labillaride G (66).
Once more, the relative configuration of 66 was difficult to assign though a small vicinal
coupling constant observed between H-6 and H-7 (1.8 Hz) and NOE enhancement
between H-6 and H-8 implied a trans relationship between these protons. The final
structure of labillaride G is therefore determined to be 66. NMR data for 66 is presented
in Table 3.12.
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3.11 Labillaride H
The observation of a pseudomolecular ion of the colourless oil labillaride H (67) (1.2 mg
isolated in total) by HRESIMS once again indicated a molecular formula of C22H30O5
(397.1991 [M + Na]+, ∆ 0.0 ppm), requiring eight double-bond equivalents. As with
labillaride F (65) and G (66), the 1H and 13C NMR spectra of 67 were almost identical to
those of labillaride E (64).
For the final time, the planar structure of 67 was elucidated in an identical fashion as
64, 65 and 66, through a series of COSY, NOE and HMBC correlations (see Figure
3.28). Analysis of the 1H – 1H coupling established the 17 carbon 1,6-diene while
HMBC correlations established the α-pyrone ring and the five-membered heterocycle.
The geometry of double bonds (∆4-5 = E, ∆9-10 = Z) were determined on the basis of the
observed 1H to 1H coupling constants and NOE enhancements.
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Figure 3.29. Selected COSY and HMBC correlations and NOE enhancements
establishing the structure of labillaride H (67).
Finally, the relative configuration of 67 was again difficult to assign though a small
vicinal coupling constant observed between H-6 and H-7 (1.4 Hz) and NOE enhancement
between H-6 and H-8 implied a trans relationship between these protons. The final
structure of labillaride H is therefore determined to be 67. NMR data for 67 is presented
in Table 3.13.
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Acetylation of Labillaride H
A synthetic derivative was prepared in order to prove the two alcohol moieties in the
proposed skeleton of labillarides E–H (64–67). Labillaride H (67) was reacted with acetic
anhydride in pyridine overnight. The positive-ion HRESIMS of the reaction product gave
rise to a pseudomolecular ion indicative of a formula of C26H34O7 (481.2201 [M + Na]
+,
∆ 0.1 ppm), a mass increase of 84 Da, consistent with diacetylation. The NMR spectra
of the product of the reaction were similar to that of 67 with the additional presence of
two overlapping acetate methyl signals [(C-24: δC 20.65, δH 1.63) and (C-26: δC 20.69,
δH 1.63)]. The observed change in the chemical shifts of the associated methine protons is
entirely consistent with acetylation at centres C-3 and C-8. Similarly, HMBC correlations
from H-3 to an ester carbonyl (C-23: δC 169.4) and from H-8 to a second ester carbonyl
(C-25: δC 169.6) confirmed acetylation of the C-3 and C-8 hydroxyls to form 3,8-diacetyl-
labillaride H (73). NMR data for 73 are presented in Table 3.14.
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3.12 Discussion of Isomers Labillarides E to H
Structure elucidation clearly established labillarides E–H (64–67) to be constitutionally
the same; all four compounds possessed the same atom connectivity. Analysis of the
coupling constants and NOE data showed no change in the double bond stereoisomerism.
Furthermore, the 1H and 13C chemical shifts of the pyrone and alkyl-chain part of the
macrocycle were almost identical, thus discounting the possibility of rotamers due to
restricted rotation in this portion of the molecule. This therefore leads to the conclusion
that 64–67 are diastereoisomers associated with the four chiral centres of the structures.
Furthermore, the coupling constants between H-6 and H-7 are nearly identical in all
four isomers, strongly suggesting conservation of their trans relative configuration. It is
therefore proposed that 64–67 represent the four possible relative diastereomers involving
the chiral centres C-3 and C-8, assuming the relative configuration of C-6 and C-7 is
conserved.
An attempt to determine the absolute configuration of the secondary alcohols of labillar-
ides E and H (64 and 67) using Mosher’s method was unsuccessful due to lack of material
(for experimental detail, see Chapter 6).70 Therefore, any configurational assignment was
based on NMR data alone. Examination of the 1H chemical shifts in CDCl3 showed
almost no perceivable differences. Benzene is often used as an alternative NMR solvent,
exploiting its ability to generate solvent-induced shifts of proton resonances in NMR
spectra.71 Therefore, the 1H NMR spectra were obtained in C6D6 in an attempt to
emphasize the very slight changes in the 1H chemical shifts. Initial results showed the
changes to be focussed around the four chiral centres, however most of these changes
were found to be more concentration-dependent rather than due to potential differences
in configuration. Figure 3.30 shows the 1H NMR spectra of labillaride H (67) at two
different concentrations, illustrating the major concentration effect on the chemical shifts
when the spectra were obtained in C6D6.
In order to ensure comparable data, the 1H NMR spectra of labillarides E–H (64–67) were
obtained at a standard concentration. These results are summarised in Table 3.15, showing
the chemical shift differences of selected 1H resonances of 65–67 when compared to
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Figure 3.30. 1H NMR spectra of labillaride H (67) in C6D6 at 4.8 mg mL-1 (bottom) and
1.6 mg mL-1 (top).
64, with the most significant differences in red. In CDCl3, the most notable change
occurred at C-3, with both 65 and 67 showing a 0.02 ppm shift of the 1H resonance at
this centre when compared to 64. The analysis was repeated in C6D6 and, again, the most
notable difference occurred around C-3 in 65 and 67 when compared to 64, suggesting
labillarides F (65) and H (67) to be C-3 epimers of labillarides E (64) and G (66).
Table 3.15. 1H chemical shift differences of labillarides F–H (65–67) as compared to
labillaride E (64).
CDCl3, 1.3 mg mL
-1 C6D6, 1.6 mg mL
-1
δH ∆δH (ppm) δH ∆δH (ppm)
Pos 64 65 66 67 64 65 66 67
O
18
19
20
2122
O
O
6
7
8
17
16
13
14
15
9
10
11
12
5
4 3
2 1
OH
OH
H
H
1 0.92 0.01 0.00 0.01 0.80 0.00 0.00 0.00
2 - - - - - - - -
3 4.05 0.02 0.00 0.02 3.68 0.04 0.00 0.02
4 5.83 0.00 0.00 0.00 5.70 0.02 0.00 0.01
5 5.74 0.00 0.00 0.00 5.61 0.01 0.00 0.00
6 5.42 0.00 0.00 0.00 5.41 0.02 0.00 0.01
7 3.15 0.00 0.00 0.00 3.25 0.01 0.00 0.00
8 4.30 0.00 0.00 0.00 4.21 0.01 0.00 0.00
9 5.63 0.00 0.00 0.00 5.80 0.01 0.00 0.00
10 5.52 0.00 0.00 0.00 5.45 0.01 0.00 0.00
Subtle chemical shift differences from labillaride E (64) were also observed around C-8
of labillaride F (65). This suggested that 65 may also be a C-8 epimer of 64, implying that
70
labillaride F (65) is 3,8-epi-labillaride E. Assuming this to be true, and as labillaride H
(67) is determined to be 3-epi-labillaride E, labillaride G (66) must, by default, be 8-epi-
labillaride E, the fourth possible diastereomer.
Enantiomers are known to co-crystallise by effectively dimerising to form an achiral
space group. The significant changes observed in the 1H NMR spectra show that the
conformations of labillarides E–H (64–67) change with concentration, particularly in non-
hydrogen bonding solvents such as C6D6, potentially due to dimerisation. With this in
mind, it is interesting to note that the stereoisomers that co-elute are those that appear
to be C-8 epimers, the variable chiral centre located in the relatively rigid portion of the
molecule. It is therefore tempting to speculate that this co-elution is due to dimerisation
through hydrogen bonding of the pseudo-enantiomeric C-8 hydroxyls.
Were it not for the twinning observed in the original mixture of labillarides F (65) and
G (66), it is likely that the different compounds would never have been identified. An
interesting point to note is that the original labillaride E (64) sample, purified by bench-
top chromatography, was repeatedly found to have quite potent cytotoxic activity against
the human leukaemia cell line HL-60 (∼600 nM). It was not until the second sample of
64 was purified by normal phase (DIOL) HPLC and tested inactive in the same assay,
that the original sample was subjected to HPLC, and it was found that the activity did not
correspond to the labillaride E (64) peak. Clearly a very minor impurity, not detected
by NMR, was responsible for the high cytotoxicity, a issue which would likely have
hampered a bioassay guided isolation of the labillarides. Work is continuing in this area
in the hope of identifying the impurity responsible for this activity.
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3.13 Labillaride I
Labillaride I (68) was isolated as a colourless oil (48.2 mg in total). Positive-ion
mode HRESIMS analysis of 68 gave rise to a pseudomolecular ion indicative of the
molecular formula C23H34O4 (375.2531 [M + H]
+, ∆ 0.4 ppm), requiring seven double-
bond equivalents. The 13C NMR spectrum contained 23 distinct resonances while the
the multiplicity-edited HSQC spectrum accounted for 33 of the 34 protons indicating
the presence of one exchangeable proton. Identifiable features of the NMR spectra in
CDCl3 included two ketone resonances (δC 191.2 and 192.5), an ester carbonyl resonance
(δC 170.1), six typical olefinic methines [(δC 126.9, δH 5.28), (δC 127.6, δH 5.12),
(δC 128.7, δH 5.12), (δC 130.1, δH 5.34), (δC 131.5, δH 5.30) and (δC 132.6, δH 5.42)],
a strongly shielded olefinic methine (δC 98.9, δH 5.98), a shielded methine (δC 62.6,
δH 3.19), an oxymethyl group (δC 52.5, δH 3.67) and a methyl triplet (δC 14.4, δH 0.99, t,
7.5 Hz).
Beginning at the methyl terminus, analysis of the 1H – 1H coupling led to the construction
of the 1,4,7-triene containing substructure (C-1 to C-13) (Figure 3.31). A series of
sequential COSY correlations starting from the methyl triplet (C-1: δC 14.4, δH 0.99)
to a methylene (C-2: δC 20.7, δH 2.10) to an olefinic methine (C-3: δC 132.6, δH 5.42)
to a second olefinic methine (C-4: δC 126.9, δH 5.28) established the first section of the
substructure. The geometry of the double bond was determined to be (Z) on the basis of
the observed coupling constant of 10.6 Hz for H-3 and H-4, and an NOE enhancement
from H2-5 to H2-2. Further COSY correlations from H-4 to a methylene (C-5: δC 26.1,
δH 2.95 and 2.89) to a olefinic methine (C-6: δC 130.1, δH 5.34) to further olefinic methine
(C-7: δC 128.7, δH 5.12) to a slightly deshielded methine (C-8: δC 39.4, δH 4.10) extended
this substructure through the second double bond. Coupling constants (10.7 Hz, H-6 and
10.2 Hz, H-7) defined ∆6-7 as (Z), supported by observed NOE enhancements between
H2-5 and H-8. Finally, a series of sequential COSY correlations starting from H-8 to
an olefinic methine (C-9: δC 127.6, δH 5.12) to the final typical olefinic methine (C-10:
δC 131.5, δH 5.30) to a methylene (C-11: δC 25.4, δH 2.35 and 1.86) to a methylene (C-12:
δC 26.5, δH 1.46 and 1.23) and finally to a third methylene (C-13: δC 26.6, δH 1.35)
72
established the 1,4,7-triene chain. The geometry of the third double bond was defined as
(Z) on the basis of coupling constants (10.2 Hz, H-9 and 10.3 Hz, H-10) and observed
NOE enhancements between H-8 and H2-11. A further COSY correlation from H-8 to a
shielded methine (C-21: δC 62.6, δH 3.19) completed the substructure.
2
134
5
67
8
910
11
12
13
COSY
NOE
H H H H21 HHaH
Figure 3.31. Selected COSY correlations establishing the 1,4,7-triene substructure of
labillaride I (68).
A second substructure was constructed starting from a distinctive slightly deshielded
methylene (C-17: δC 35.7, δH 2.36). A series of sequential COSY correlations starting
from H2-17 to a methylene (C-16: δC 23.9, δH 1.88 and 1.55) to a third methylene (C-15:
δC 25.5, δH 1.29) to the final methylene (C-14: δC 24.4, δH 1.41 and 1.18) established
the alkyl section of the second substructure. An HMBC correlation from H2-16 to a
non-protonated carbon (C-18: δC 191.2) initially suggested a shielded ketone at this
position. However, HMBC correlations from H2-17 to C-18 and a strongly shielded
olefinic methine (C-19: δC 98.9, δH 5.98) implied a highly-polarised double bond.
Reciprocal HMBC correlations from H-19 to C-17 and C-18 confirmed this connectivity.
Interestingly, the non-protonated carbon resonance has moved significantly downfield
from the equivalent position in labillarides A–H (60–67) (from∼170 ppm to∼190 ppm),
suggesting a significant change in structure at this position. A further HMBC correlation
from H-19 to the second non-protonated carbon (C-20: δC 192.5) suggested the enol
form of a 1,3-dione, stabilised by resonance and intramolecular hydrogen bonding (see
Figure 3.32). This accounted for the ∼20 ppm downfield shift of the carbon resonances
of positions C-18 and C-20 in 68 when compared to those of 60–66.72
The substructures were joined through a series of HMBC and HSQC-TOCSY correla-
tions. HMBC correlations from H-8 to C-20 and the carbonyl resonance (C-22: δC 170.1)
suggested connectivity to these two centres through C-21. This was confirmed by an
HMBC correlation from H-19 to C-21, and HMBC correlations from H-21 to C-19, C-20
and C-22. An HMBC correlation from the oxymethyl (C-23: δC 52.3, δH 3.67) to C-22
73
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Figure 3.32. Selected COSY and HMBC correlations establishing the second
substructure of labillaride I (68) in its resonance forms.
accounted for the shielded nature of C-22, a methyl ester carbonyl. HMBC correlations
from both proton resonances of CH2-12 to C-14 suggested connectivity through the C-13
and C-14 methylenes. This was confirmed by the corresponding HMBC from H2-15 to
C-13 and the observation of HSQC-TOCSY correlations from H2-12 to H2-13, H2-14,
H2-15, H2-16 and finally H2-17 (Figure 3.33).
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Figure 3.33. Selected TOCSY and HMBC correlations connecting the substructures of
labillaride I (68).
All detected carbon resonances were now accounted for. The triene, enol form of a 1,3-
dione, ester and macrocycle moieties accounted for the molecular formula, satisfying
the seven double-bond equivalents. The relative configuration of labillaride I was not
determined as all 1H – 1H coupling constants and observed NOE enhancements could be
rationalised from both stereoisomers due to the significant flexibility of the 14-membered
macrocycle. The final structure of labillaride I is therefore proposed to be 68. NMR data
for 68 is presented in Table 3.16.
In order to determine whether labillaride I (68) was methylated in vivo or as an artefact
of isolation in MeOH, the extraction and isolation was repeated replacing MeOH by
EtOH at each stage. Neither 68 or the ethylated version of 68 was detected in the 75%
Me2CO in H2O, however the 100% Me2CO fraction appeared to contain some resonances
suggestive of labillaride I (68), suggesting the possibliity that 68 may in fact be an artefact
of methanol extraction.
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3.14 Labillaride J
Positive-ion mode HRESIMS analysis of the colourless oil labillaride J (69) (2.0 mg
isolated in total) gave rise to a pseudomolecular ion indicative of the molecular formula
C21H32O2 (317.2470 [M + H]
+, ∆ 1.5 ppm). The structure of 69 was elucidated in the
same fashion as labillaride I (68). The molecular formula of 69 differs from 68 by the
loss of C2H2O2 which is consistent with the loss of MeOCO from 68. The 13C NMR
spectrum in CDCl3 contained 21 distinct resonances while the the multiplicity-edited
HSQC spectrum accounted for 31 of the 32 protons, again indicating the presence of one
exchangeable proton. The molecular formula of 69 requires six double-bond equivalents.
Again, three are accounted for by the triene chain, two by the enol form of a 1,3-dione
and finally, one by the macrocycle. Identifiable moieties included two ketone carbons
(δC 193.6 and 194.4), six typical olefinic methines [(δC 126.9, δH 5.32), (δC 127.8,
δH 5.33), (δC 130.1, δH 5.33), (δC 130.6, δH 5.16), (δC 132.0, δH 5.26) and (δC 132.5,
δH 5.43)], a strongly shielded olefinic methine (δC 100.5, δH 5.61) and a methyl triplet
(δC 14.5, δH 1.00, t, 7.5 Hz), all consistent with those observed in 68. Both the ester
carbonyl and oxymethyl groups of labillaride I (68) were absent, and a new methylene
(δC 46.0, δH 2.44 and 2.15) was observed.
Analysis of the 2D NMR spectra of 69 led to the construction of two substructures.
Beginning at the methyl terminus (C-1: δC 14.5, δH 1.00), a COSY correlation was
observed from H3-1 to a methylene (C-2: δC 20.8, δH 2.11) to an olefinic methine
(C-3: δC 132.5, δH 5.43) to a second olefinic methine at δH 5.33. Due to significant
spectral overlap at ∼δH 5.33, three olefinic methines were not distinguishable in the
COSY spectrum. HMBC correlations were therefore used to differentiate between the
three methines. An HMBC correlation from H2-2 to an olefinic methine (C-4: δC 126.9,
δH 5.32) and from H-3 to a methylene (C-5: δC 26.1, δH 2.88 and 2.84) extended the
chain through the first double bond. This connectivity was confirmed by the observation
of allylic COSY correlations from H-3 to H-5a and H-5b.
HMBC correlations from H2-5 to two olefinic methines [(C-6: δC 127.8, δH 5.33) and
(C-7: δC 132.0, δH 5.26)] established the second double bond. An HMBC from H-6 to C-4
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implied the direct connectivity between C-5 and C-6, confirming the order of the olefinic
methines. A series of sequential COSY correlations starting from H-7 to a methine (C-8:
δC 35.6, δH 3.87) to an olefinic methine (C-9: δC 130.6, δH 5.16) to the final olefinic
methine (C-10: δC 130.1, δH 5.33) to a methylene (C-11: δC 25.7, δH 2.25 and 1.84) and
finally to a second methylene (C-12: δC 27.0, δH 1.39 and 1.22) completed the triene
chain. Again, the order of the olefinic methines was confirmed by an HMBC correlation
from H2-12 to C-10. The geometry of all three double bonds were determined to be (Z)
on the basis of the observed 1H – 1H coupling constants (10.6 Hz, H-3; 10.5 Hz, H-7;
10.3 Hz, H-9) and NOE enhancements between H2-2 and H2-5, H2-5 and H-8, and finally
H-8 and H2-11. A further COSY correlation from H-8 to a methylene (C-21: δC 46.0,
δH 2.44 and 2.15) completed the substructure (Figure 3.34).
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Figure 3.34. Selected COSY and HMBC correlations and NOE enhancements
establishing the 1,4,7-triene substructure of labillaride J (69).
Starting from the distinctive slightly deshielded methylene (C-17: δC 37.4, δH 2.31), the
second substructure was constructed. A series of sequential COSY correlations starting
from H2-17 to a methylene (C-16: δC 24.1, δH 1.76 and 1.59) to a third methylene (C-15:
δC 26.0, δH 1.34) established the beginning of the substructure. As before, an HMBC
correlation from H2-16 to a non-protonated carbon (C-18: δC 194.4), from H2-17 to a
strongly shielded olefinic methine (C-19: δC 100.5, δH 5.61), and from H-19 to the last
non-protonated carbon (C-20: δC 193.6), confirmed the enol form of a 1,3-dione (see
Figure 3.35).
As with 68, the substructures of 69 were joined through a series of HMBC and
HSQC-TOCSY correlations. An HMBC correlation from H-8 to C-20 suggested
direct connectivity between C-20 and C-21. This was confirmed by reciprocal HMBC
correlations from H-19 to C-21, and from H2-21 to C-19. The two alkyl chains were
connected through the final two methylenes. An HMBC correlation from H2-11 to a
methylene (C-13: δC 26.4, δH 1.34) and from H2-13 to the final methylene (C-14: δC 25.1,
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Figure 3.35. Selected COSY and HMBC correlations establishing the second
substructure of labillaride J (69), in its resonance forms.
δH 1.35 and 1.19) extended the triene substructure. HMBC correlations from both proton
resonances of CH2-16 to C-14 connected the two alkyl chains while HSQC-TOCSY
correlations from H2-11 to H2-12 and H2-13, and from H2-17 to H2-16, H2-15 and H2-14
supported this connectivity (Figure 3.36).
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Figure 3.36. Selected TOCSY and HMBC correlations connecting the substructures of
labillaride J (69).
The molecular formula was now accounted for and labillaride J was found to be the des-
methyl ester of labillaride I. The final structure of labillaride J is therefore 69. NMR data
for 69 is presented in Table 3.17.
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3.15 Labillaride K
The observation of pseudomolecular ions of the colourless oil labillaride K (70) (0.4 mg
isolated in total) by HRESIMS indicated a molecular formula of C21H32O2 (317.2475
[M + H]+, ∆ 4.5 ppm and 339.2298 [M + Na]+, ∆ 1.1 ppm), requiring six double-bond
equivalents. The 13C NMR spectrum contained 14 distinct resonances while two further
non-protonated carbons (δC 195.6 and 203.0) were observed in the HMBC spectrum. An
irresolvable cluster of signals in the 13C NMR spectrum in the region between δC 29.3 –
29.4 was assumed to contain the remaining five resonances. The 1H NMR spectrum in
CDCl3 accounted for all 32 protons, including signals in the CH2 envelope region (δH 1.27
– 1.41) integrating for 10 protons. The multiplicity-edited HSQC showed connectivity
between those protons and the carbon cluster between δC 29.3 – 29.4, indicating five
overlapping methylenes. Other identifiable features of the NMR spectra included a
strongly shielded olefinic methine (δC 104.2, δH 5.47), six typical olefinic methines
[(δC 125.5, δH 6.32), (δC 127.1, δH 5.32), (δC 128.0, δH 5.27), (δC 128.8, δH 5.96),
(δC 132.3, δH 5.41) and (δC 135.3, δH 5.68)], an oxymethylene (δC 75.4, δH 4.49) and
a methyl triplet (δC 14.4, δH 0.98, t, 7.6 Hz).
Analysis of the 1H – 1H coupling established a 10 carbon, 1,4,6-triene substructure (C-1
to C-10). A series of sequential COSY correlations starting from the methyl triplet (C-1:
δC 14.4, δH 0.98) to a methylene (δC 20.7, δH 2.08) to an olefinic methine (C-3: δC 132.3,
δH 5.41) to a second olefinic methine (C-4: δC 127.1, δH 5.32) to a methylene (C-5:
δC 26.07, δH 2.91), to a third olefinic methine (C-6: δC 128.0, δH 5.27), to a fourth olefinic
methine (C-7: δC 128.8, δH 5.96) established the first section of the triene substructure.
The geometry of both double bonds were determined to be (Z) on the basis of the observed
1H – 1H coupling constants (10.6 Hz, H-4; 10.6 Hz, H-6; 11.1 Hz, H-7). Further COSY
correlations from H-7 to a fifth olefinic methine (C-8: δC 125.5, δH 6.32), to the final
typical olefinic methine (C-9: δC 135.3, δH 5.68) to a methylene (C-10: δC 33.0, δH 2.10)
completed the first substructure (see Figure 3.37, substructure A).
A furan-3-one substructure was constructed starting from a distinctive deshielded methy-
lene (C-17: δC 30.9, δH 2.50) which exhibited a COSY correlation to a second methylene
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Figure 3.37. Selected COSY and HMBC correlations and NOE enhancements
establishing the two substructures of labillaride K (70).
(C-16: δC 26.11, δH 1.64). An HMBC correlation from H2-16 to a non-protonated carbon
(C-18: δC 195.6) along with HMBC correlations from H2-17 to C-18 and a shielded
olefinic methine (C-19: δC 104.2, δH 5.47) suggested the presence of a highly-polarised
double bond. This connectivity was supported by an allylic COSY correlation between
H2-17 and H-19, and HMBC correlations from H-19 back to C-17 and C-18. Further
HMBC correlations were observed from H-19 to the second non-protonated carbon (C-20:
δC 203.0) and to an oxymethylene (C-21: δC 75.4, δH 4.49). The highly-polarised nature
of∆18-19 and the strongly deshielded nature of C-21 is consistent with oxygen attachment
at C-18 and C-21, while the lack of a second shielded olefinic carbon suggested a ketone
at position C-20. With only two oxygens in the molecular formula, an oxygen bridge
between C-18 and C-21 was proposed, supported by an HMBC correlation from H2-21 to
C-18, completing the furan-3-one moiety (see Figure 3.37, substructure B). The 13C and
1H chemical shifts of the five-membered ring compared favourably with 5-hexyl-furan-3-
one (74), a synthetic compound containing this furan-3-one moiety (see Table 3.18).73
Table 3.18. Chemical shift differences of the furan-3-one moiety for labillaride K (70)
and 5-hexyl-furan-3-one (74).
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70 74
Labillaride K (70) 5-Hexyl-furan-3-one (74)* Difference
mult Pos δC δH Pos δC δH δC δH
δ (ppm) δ (ppm) δ (ppm) δ (ppm) ∆δ (ppm) ∆δ (ppm)
CH2 16 26.1 1.64 7 25.9 1.67 0.2 -0.03
CH2 17 30.9 2.50 6 31.3 2.52 -0.4 -0.02
C 18 195.6 5 195.7 -0.1
CH 19 104.2 5.47 4 103.9 5.50 0.3 -0.03
C 20 203.0 3 203.0 0.0
CH2 21 75.4 4.49 2 75.2 4.51 0.2 -0.02
*Winkler, J. D.; Oh, K.; Asselin, S. M. Org. Lett. 2005, 7, 387389.
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Five methylene pairs remained unaccounted for in the structure. The chemical shifts of
each of these methylene pairs were very similar (δC 29.3 – 29.4, δH 1.27 – 1.41), indicative
of a short unresolved alkyl chain. COSY correlations observed between δH 1.27 – 1.41
and both H2-10 and H2-16 suggested that the triene and furan-3-one substructures were
connected via this alkyl chain. This proposal was supported by the observation of HMBC
correlations from H-9, H2-10, H2-16 and H2-17 to resonances at δC 29.3 – 29.4. On the
basis of this evidence C-11 – C-15 were assigned as the irresolvable clusters (δC 29.3 –
29.4, δH 1.27 – 1.41) (Figure 3.38).
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Figure 3.38. Selected COSY and HMBC correlations connecting the two substructures
of labillaride K (70).
The molecular formula was now accounted for. The final structure of labillaride K is
therefore proposed as shown in 70. NMR data for 70 is presented in Table 3.19.
Table 3.19. 13C (150 MHz) and 1H (600 MHz) NMR data (CDCl3) for labillaride K (70).
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13C 1H HMBC
Pos δ (ppm) mult 1JCH (Hz) δ (ppm) mult J (Hz) COSY (1H to 13C)
1 14.4 CH3 125 0.98 t 7.6 2 2,3
2 20.7 CH2 123 2.08 quin 7.4 1,3 1,3,4
3 132.3 CH 154 5.41 m 2,4 2,5
4 127.1 CH 158 5.32 dt 10.6,7.2 3,5 2,5,6
5 26.07 CH2 123 2.91 t 7.5 4,6,7 3,4,7,6
6 128.0 CH 160 5.27 dt 10.6,7.7 5,7 4,5,8
7 128.8 CH 154 5.96 t 11.1 5,6,8 5,8,9
8 125.5 CH 150 6.32 dd 15.0,11.0 7,9,10 6,7,10
9 135.3 CH 150 5.68 dt 15.1,7.0 8,10 7,10,11
10 33.0 CH2 125 2.10 q 7.1 9,11 8,9,11
11 – 15 29.3 – 29.4 CH2 123 1.27 – 1.41 m
16 26.11 CH2 122 1.64 quin 7.4 15,17 15,17,18
17 30.9 CH2 115 2.50 t 7.7 16,19,21* 15,16,18,19
18 195.6† C
19 104.2 CH 182 5.47 s 17 17,18,20,21
20 203.0† C
21 75.4 CH2 152 4.49 s 17* 18,20
*Long-range correlation.
†Assigned from HMBC data.
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3.16 Degradation of Labillarides A to D
As previously mentioned, it was found that labillarides A–D (60–63) quickly degraded
when stored as lyophilised oils above−20 ◦C (see Figure 3.39). Samples obtained during
the purification of the second bulk extract were therefore stored submerged in liquid
nitrogen in an effort to counter this instability.
Figure 3.39. 1H NMR spectra of labillaride D (63) pure (black) and degraded (red).
Unexpectedly, samples of labillaride B (61) stored at −196 ◦C for a little over a year
proceeded to degrade despite the precautions taken. Figure 3.40 shows the 1H NMR of
pure 61 and the degraded sample following storage in liquid nitrogen. Work is continuing
in this area in the hope of isolating the degradation product or products of labillaride B
(61).
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Figure 3.40. 1H NMR spectra of labillaride B (61) pure (black) and degraded (red).
Degradation Product of Labillarides C and D
Labillarides C (62) and D (63) quickly degraded when stored as lyophilised oils above
−20 ◦C. Interestingly, the 1H NMR spectrum of the degraded samples of both 62 and
63 appeared to exhibit similar signals. Normal-phase chromatography of the degraded
samples led to the isolation of the same degradation product (75) (see Figure 3.41).
Positive-ion mode HRESIMS analysis of the degradation product (75) gave rise to a single
pseudomolecular ion indicative of the molecular formula C21H30O3 (353.2087 [M + H]
+,
∆ 0.1 ppm), requiring seven double-bond equivalents. The 13C NMR spectrum contained
21 distinct resonances while the multiplicity-edited HSQC spectrum in CDCl3 accounted
for 29 of the 30 protons indicating the presence of one exchangeable proton. Identifiable
features of the NMR spectra included three ketone resonances (δC 195.3, 195.8 and
213.9), four typical olefinic methines [(δC 124.9, δH 5.76), (δC 129.9, δH 5.38), (δC 131.5,
δH 5.47) and (δC 131.6, δH 5.08)], a strongly shielded olefinic methine (δC 101.8, δH 5.58)
and a methyl triplet (δC 7.7, δH 1.02, t, 7.3 Hz). The two shielded ketone resonances
84
Figure 3.41. 1H NMR spectra of the purified degradation product (75) from
labillarides C (62) (black) and D (63) (blue).
and the strongly shielded olefinic methine suggested the presence of the enol form of a
1,3-dione, similar to that seen in labillarides H (68) and I (69).
A series of COSY and HMBC correlations lead to the construction of a 1,4-diene
substructure. COSY correlations from the methyl triplet (C-1: δC 7.7, δH 1.02) to a
methylene (C-2: δC 35.6, δH 2.51 and 2.58) indicated the connection between these two
centres in an isolated spin system. HMBC correlations were observed from H3-1 and both
proton resonances of CH2-2 to a ketone (C-3: δC 213.9). Further analysis of the HMBC
spectrum revealed only one other correlation from the proton resonance of a methine
(C-4: δC 47.7, δH 3.21) to the C-3 ketone, which together with the downfield nature of the
1H resonance suggested its placement on the other side of the ketone. COSY correlations
from H-4 to a methylene (C-5: δC 28.2, δH 1.99 and 2.30) and from both proton resonances
of CH2-5 to two olefinic methines [(C-6: δC 124.9, δH 5.76) and (δC 129.9, δH 5.38)]
extended the substructure through to a double bond. An HMBC correlation from H-4 to
C-6 established the direct connection between C-5 and C-6, constructing the order of C-5
to C-6 to C-7 through the double bond (see Figure 3.42).
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Figure 3.42. Selected COSY and HMBC correlations establishing part of the 1,4-diene
substructure of the degradation product (75).
Detection of a series of 1H – 1H couplings extended the substructure. COSY correlations
were observed from H-7 to a methine (C-8: δC 39.1, δH 3.23), from H-8 to an olefinic
methine (C-9: δC 131.6, δH 5.08), and from H-9 to the fourth typical olefinic methine
(C-10: δC 131.5, δH 5.47). Further COSY correlations from H-10 to a methylene
(C-11: δC 25.0, δH 1.91 and 2.06) and from the proton resonances of CH2-11 to a
second methylene (C-12: δC 27.0, δC 1.33) continued the substructure. Homo-allylic
COSY correlations between both proton resonances of CH2-5 and H-8, and allylic COSY
correlations between H-9 and both proton resonances of CH2-11 were also observed. A
further COSY correlation from H-8 to a methine (C-21: δC 50.2, δH 2.49) and from H-21
to H-4 established a cyclohexene ring, completing the substructure. This connectivity was
supported by HMBC correlations from H-5 and H-7 to C-21 and from H-4 to C-8 (see
Figure 3.43). The geometry of the two double bonds were determined to be (Z) on the
basis of the observed coupling constants (9.8 Hz, H-6 and H-7; 10.6 Hz, H-9; 9.8 Hz,
H-10) and NOE enhancements between H-8 and both proton resonances of CH2-11.
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Figure 3.43. Selected COSY and HMBC correlations completing the 1,4-diene
substructure of the degradation product (75).
The second substructure was constructed starting from a distinctive methylene (C-17:
δC 38.6, δH 2.24). A series of sequential COSY correlations starting from H2-17 to a
methylene (C-16: δC 24.2, δH 1.63 and 1.72) to a third methylene (C-15: δC 27.9, δH 1.26,
1.42) established the beginning of the substructure. HMBC correlations from both proton
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resonances of CH2-16 to a non-protonated carbon (C-18: δC 195.3), from H2-17 to a
strongly shielded olefinic methine (C-19: δC 101.8, δH 5.58), and from H-19 to the last
non-protonated carbon (C-20: δC 195.8) confirmed the presence of an enol form of a
1,3-dione as suggested by the chemical shifts (see Figure 3.44).
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Figure 3.44. Selected COSY and HMBC correlations establishing the second
substructure of the degradation product (75).
The substructures were joined by a series of HMBC and HSQC-TOCSY correlations.
An HMBC correlation from H-19 to C-21 suggested direct connectivity between C-20
and C-21. This connectivity was confirmed by HMBC correlations from H-4 to C-20,
and from H-21 to C-19 and C-20. Two methylenes remained unaccounted for in the
structure, both exhibiting very similar carbon resonances [(δC 26.07, δH 1.18 and 1.26) and
(δC 26.09, δH 1.24 and 1.32)]. HMBC correlations from both proton resonances of one of
these methylenes (C-13: δC 26.09, δH 1.24 and 1.32) to C-11 suggested direct connectivity
between C-12 and C-13. Further HMBC correlations from both proton resonances of
CH2-13 to the final methylene (C-14: δC 26.07, δH 1.18 and 1.26) and C-15 connected
the two substructures through an alkyl chain. Similarly, HMBC correlations from both
proton resonances of CH2-14 to C-12 and C-16 supported this connectivity. Finally, this
was confirmed by the observation of HSQC-TOCSY correlations from H2-15 to H-14b
and H-13b (see Figure 3.45).
The relative configuration of 75 was assigned on the basis of 3JHH values and NOE
enhancements observed in a 2D-NOESY experiment. The coupling of the proton
resonance of the methine CH-21 (t, 10.8 Hz) suggested an antiperiplanar relationship
to both H-4 and H-8, implying all three protons occupy axial positions in the cyclohexene
ring and placing the large alkyl groups in the preferred equatorial positions. Similarly, the
coupling constants of H-4 (11.6 Hz) and H-5a (11.9 Hz) again indicated an antiperiplanar
relationship between these two resonances, positioning H-5a axially. Allylic 4JHH values
are proportional to cos2φ, where φ is the dihedral angle between the C–H bond and
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Figure 3.45. Selected TOCSY and HMBC correlations connecting the degradation
product (75).
the pi-orbital of the double bond.74 Therefore the considerably stronger observed allylic
COSY correlation between H-7 and H-5a compared to that of H-7 and H-5b supported
the assignment of H-5a as axial. Finally, an observed NOE enhancement between the 1,3-
diaxial protons H-5a and H-21 supported the proposed relative configuration (see Figure
3.46).
3
8
4
21
67
H
Ha
Hb
H
22
9
H
5
Antiperiplanar
NOE
Figure 3.46. The selected NOE enhancement and antiperiplanar relationships used to
determine the relative configuration of the degradation product (75).
All proton and carbon resonances were now accounted for. The alkene, enol form of a 1,3-
dione, ketone, cyclohexene and macrocycle moieties accounted for the molecular formula,
satisfying the seven double-bond equivalents. The final structure of the degradation
product is therefore determined to be 75. NMR data for 75 is presented in Table 3.20.
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A possible degradation pathway is proposed in Scheme 3.3. The α-pyrone ring is opened
by H2O, followed by decarboxylation, oxidative attack by O2, nucleophilic opening of the
peroxide and finally, loss of OH – to form the ketone leading to the formation of 75.
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Scheme 3.3. A proposed degradation pathway of labillarides C (62) and D (63) to the
degradation product (75).
Oxylipins in general are found to be unstable when concentrated, and storage in
toluene/ethanol solutions appears to retard this degradation,75 a much more practical
storage method than the liquid nitrogen employed during this study.
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3.17 Biological Activity of Labillarides A to K
Labillarides A–K (60–70) were evaluated for cytotoxicity against the human leukaemia
cell line HL-60 and for antibacterial activity against the MC2155 strain of Mycobacterium
smegmatis at the School of Biological Sciences, VUW. Labillarides A (60), B (61) and I
(68) all showed moderate activity against HL-6076 while labillaride C (62) was the only
metabolite to exhibit antibacterial activity (see Table 3.21).77
Table 3.21. Biological activity of labillarides A–K (60–70).
Labillaride
IC50 (µM)
HL-60* M. smegmatis MC2155†
A (60) 7.7 Inactive
B (61) 6.9 Not tested
C (62) Inactive 36.5
D (63) Inactive Inactive
E (64) Inactive Inactive
F (65) Inactive Inactive
G (66) ∼12 Inactive
H (67) Inactive Inactive
I (68) 2.5 Inactive
J (69) ∼11 Inactive
K (70) ∼12 Inactive
*Tested up to 10 µM.
†Tested up to 50 µM.
3.18 Oxylipins from Marine Macro-algae
The term oxylipin was first introduced in literature in 1991 to encompass “oxygenated
compounds which are formed from fatty acids by reaction(s) involving at least one step
of mono- or dioxygenase-catalysed oxygenation.”78 Marine flora are prolific producers of
polyunsaturated fatty acids, in particular C20 and C22 ω-3 fatty acids.79 The metabolism
of these fatty acids to oxylipins was initially thought to be exclusively among red algae
(Rhodophyta), however more recent studies have shown brown (Phaeophyta) and green
(Chlorophyta) algae also produce a wide range.80
Typical examples of oxylipins include the prostaglandins PGE2 (76) and PGF2α (77),
91
and the constanolactones A (78) and B (79).81,82 The class is extensive and therefore
a detailed review of marine algal oxylipins is beyond the scope of this report. Several
reviews of oxylipins are available in literature and the focus will therefore be limited to
those containing a macrocyclic moiety.79,80,83
OHHO
O
COOH
OHHO
HO
COOH O OR1
R2
HO
H H
76 77 78 R1 = H R2 = OH
79 R1 = OH R2 = H
Other than the polyunsaturated α- and γ-pyrone macrocycles previously reported from
Phacelocarpus labillardieri and described in Section 3.1 (49–51, 53–57 and 59), there
are few examples of oxylipin macrocycles. Hybridalactone (80), along with an unnamed
minor oxylipin (81), was reported from a collection of the red alga Laurencia hybrida
in 1981.84 The correct enantiomer of 80 was synthesised in 1984 based on the absolute
configuration predicted by a biogenic proposal published earlier the same year.85,86 In
1989, ecklonialactones A (82) and B (83) were isolated from the brown alga Ecklonia
stolonifera.87 Although the extract of E. stolonifera showed no antifeedant activity, 82
exhibited weak activity compared with the control.87 The structures of the C18 compounds
82 and 83 are very similar to those of C20 metabolites 80 and 81, suggesting a similar
biogenic pathway.79
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H OH
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O
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83 ∆ saturated
Finally, eiseniachlorides A–C (84–86), eiseniaiodides A (87) and B (88), and three
unnamed oxylipins (89–91) were reported from a Japanese collection of the brown alga
Eisenia bicyclis in 2003.88 Compounds 84–89 each contain a chlorine or an iodine atom,
making these structures particularly unusual. Only three other chlorinated C18 oxylipins
have been reported to date.88 Possible biogenic pathways for 84–91 were postulated
92
starting from octadecatetraenoic acid and involving lipoxygenase enzymes in a similar
fashion to those discussed below (Section 3.19).88
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3.19 Labillaride Biogenesis
The biogenic origins of many oxylipins have been investigated.79 Many, if not all oxylipin
biogenic pathways are proposed to involve the lipoxygenases (LPOs), dioxygenase
enzymes which incorporate molecular oxygen into unsaturated fatty acids with a (Z,Z)-
1,4-pentadiene moiety.89 The most common example of such pathways is the conversion
of arachidonic acid (92) to several different hydroperoxyeicosatetraenoic acids (HPETEs)
by the 5-, 12-, and 15-LPOs (see Scheme 3.4) as part of the Arachidonic Acid Cascade.90
Further transformations of the hydroperoxide are well documented, including conversion
to an alcohol via a peroxidase (POX) reduction, or intramolecular rearrangement to form
an alcohol and an epoxide.91 Epoxidase catalysed insertion of an oxygen across a double
bond to form an epoxide also has precedence in oxylipin biogenesis.91
COOH5
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Fe3+_5-LPO_B
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Scheme 3.4. The 5-LPO-catalysed oxidation of arachidonic acid (92) to 5-HPETE
(93)90 and two proposed transformations from the hydroperoxide.
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Biogenesis of Labillarides A to H
Starting from an oxylipin premise, plausible biogenic pathways for labillarides A–H
(60–67) are proposed to start from the common α-pyrone precursor (94) formed from
the fatty acid docosahexaenoic acid (95). The pathway from 95 is initiated by an
“ene” type reaction, involving reaction of singlet oxygen with an alkene,92 producing a
hydroperoxide at C-18 followed by an intramolecular rearrangement to form an epoxide.
Lactonisation followed by dehydration, oxidation and hydrogenation (shown in Scheme
3.5) yields the α-pyrone precursor 94, numbered to coincide with the numbering of the
labillarides. The order of the steps in this scheme, as with all of those proposed below, is
flexible, for instance the oxidation may occur prior to the lactonisation.
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Scheme 3.5. A proposed biogenesis of the α-pyrone precursor (94).
An alternative pathway for the formation of this α-pyrone precursor (94) can be proposed
that involves polyketide synthase (PKS). The basic biochemical reactions of eukaryotic
fatty acid synthase (FAS) and polyketide synthase (PKS) are the same, although
the enzymes involved differ.93 The FAS pathway is a multi-step process initiated by
condensation of malonate (96) and a fatty acid with release of a CO2 molecule.93 Unlike
FAS, the predominant PKS pathway in eukaryotic organisms will accept a variety of
starter units, with malonate (96) as the propogator. The pathway then skips the reduction
95
and dehydration steps, stopping at the condensation step, resulting in linear carbon chains
with 1,3-ketone oxidation patterns (see Scheme 3.6).
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Scheme 3.6. A simplified polyketide synthase producing polyketone products.
The chloroplast fatty acids of eukaryotic algae are largely polyenoic acids, of which the
C18 ω-3 fatty acid α-linolenic acid (97) is a major constituent.94 With 97 as the starter
unit, the 1,3,5-oxidation pattern observed in 94 can be constructed through two cycles of
PKS acetate addition followed by lactonisation and dehydration to form 94 (Scheme 3.7).
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Scheme 3.7. An alternative proposed biogenesis of the α-pyrone precursor (94).
The biogenesis of labillaride A (60) from 94 is proposed to follow the mechanism outlined
in Scheme 3.8. Oxidation at∆6,7 of 94 by an epoxidase, followed by deprotonation at the
α-position of the diketone, nucleophilic opening of the epoxide and finally, dehydration
across the C-7–C-8 bond leads to the formation of 60.
Haloperoxidase enzymes were suggested in the biosynthesis of halogenated marine
natural products nearly 30 years ago.95 Since then, various haloperoxidases have been
96
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Scheme 3.8. A proposed biogenesis of labillaride A (60).
discovered in many marine organisms, of which most are the vanadium-dependent
haloperoxidases.95 Vanadium bromoperoxidases (V-BrPOs) have been isolated from all
the different classes of marine algae, including Rhodophyta. The overall reaction scheme
of V-BrPOs is summarised in Scheme 3.9, where the enzyme catalyses the oxidation of
bromide by hydrogen peroxide to produce a bromonium ion, or a biological equivalent.
This bromonium ion can then either react with an organic substrate (R), or with another
equivalent of hydrogen peroxide.95
Br + H2O2
V-BrPO "Br+" - like intermediate + 2H2O 
(i.e. HOBr, Br2, Br3, Enz-Br)
H2O2
1O2 + Br
R-H
R-Br
Scheme 3.9. Overall reaction scheme of vanadium bromoperoxidases.95
The formation of labillaride B (61) is proposed to involve an intramolecular cyclisation
catalysed by vanadium bromoperoxidase, similar to that proposed for the cyclisation of
laurediols.96–98 The α-pyrone precursor (94) undergoes a 1,3-H migration, followed by
deprotonation at the α-position of the diketone and tautomerisation resulting in an enolate.
Nucleophilic attack by the oxygen at C-8 of the double bond followed by attack of the
double bond onto the bromonium ion, or a biological equivalent, results in the formation
of 61 (Scheme 3.10).
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Scheme 3.10. A proposed biogenesis of labillaride B (61).
Labillarides C (62) and D (63) are proposed to follow a similar lipoxygenase-initiated
mechanism (Scheme 3.11). A peroxidase reduction of the hydroperoxide at C-6 results in
an alcohol which is converted to a good leaving group by substitution with a phosphate
ion, or similar moiety. Deprotonation at the α-position of the diketone followed by
nucleophilic attack by the carbanion at the C-8 double bond and loss of the leaving group
results in the formation of 62 or 63.
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Scheme 3.11. A proposed biogenesis of labillarides C (62) and D (63).
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In an analogous fashion, labillarides E–H (64–67) are proposed to follow the mechanism
outlined in Scheme 3.12. A hydroperoxide formation from a lipoxygenase at C-3 and
subsequent reduction by a peroxidase followed by a second lipoxygenase product at
C-6 which undergoes an intramolecular rearrangement to form an epoxide, establishes
the C-3 and C-8 alcohols. Deprotonation at the α-position of the diketone followed
by nucleophilic attack by the carbanion at the epoxide is followed by conversion of the
alcohol to a good leaving group. A second deprotonation at the α-position to the diketone
followed by enolisation results in nucleophilic attack by the oxygen at the C-6 position,
ejecting the leaving group, completing the formation of the 64–67 framework.
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Scheme 3.12. A proposed biogenesis of labillarides E–H (64–67).
Biogenesis of Labillarides I and J
A possible biogenic pathway for labillarides I (68) and J (69), which could alternatively
be artifacts of isolation, can also be proposed starting from labillaride C (62). The α-
99
pyrone ring is opened by H2O, resulting in the common precursor which can undergo
either methylation to form 68, or decarboxylation and tautomerisation to form 69 (see
Scheme 3.13).
methylation
-CO2
tautomerisation
OO H O
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OO H O
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OH OH
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62
68 69
Scheme 3.13. A proposed biogenesis of labillarides I (68) and J (69).
Biogenesis of Labillaride K
There are very few natural products with a furanone moiety reported in the literature.
Interestingly, all organisms that reportedly produce furan-3-one metabolites also produce
4-hydroxy-α-pyrones.99 During the isolation of pseudopyronines A (98) and B (99), Kong
et al. found 99 to be unstable, degrading to 100 when left sitting in CDCl3 in an NMR
tube for 10 days.99
O
O
OHn
98 n = 4
99 n = 6
O
O
HO
100
A possible mechanism for the formation of a furan-3-one from an α-pyrone was proposed
100
by Kong et al. (Scheme 3.14). The pyrone is oxidised by oxygen from the air to
form a peroxide, which was observed in the NMR tube of the degraded sample of 99.
The unstable peroxide intermediate is then proposed to be hydrolysed during HPLC
purification, followed by oxidative decarboxylation and cyclisation.
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Scheme 3.14. A possible mechanism for the formation of a furan-3-one from a
α-pyrone, as proposed by Kong et al.99
By analogy, a plausible biogenesis of labillaride K (70) can be proposed assuming Nature
could exploit such a process with a final biological reduction of the hemiacetal (see
Scheme 3.15). Once more, a lipoxygenase initiated pathway from the α-pyrone precursor
(94) produces a hydroperoxide at C-21 followed by an ester hydrolysis, decarboxylation
and loss of H2O. Cyclisation is followed by reduction of the hemiacetal and, finally, a
1,3-H migration to form 70.
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Scheme 3.15. A proposed biogenesis of labillaride K (70).
101
Scheme 3.16 shows an overview of the proposed biogenic pathways of labillarides A–
K (60–70) from the fatty acids docosahexaenoic acid (95) or α-linolenic acid (97).
Similar schemes could be proposed for the known pyrones 49–57 and 59 from either
docosahexaenoic acid (95) or eicosapentaenoic acid, the C20 ω-3 fatty acid equivalent.
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Scheme 3.16. An overview of the proposed biogenic pathways of labillarides A–K
(60–70).
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3.20 Summary
Oxylipins are wide-spread in red algae, however macrocyclic versions are rather unusual.
In particular, the nine novel polyunsaturated α- and γ-pyrone macrocycles reported
from southern Australian specimens of Phacelocarpus labillardieri between 1982 and
1995 represent a unique group of metabolites.58–61 In this study, several collections of
P. labillardieri from the northern coastal regions of the North Island of New Zealand
led to the isolation of 11 new compounds, eight of which are related α-pyrone containing
macrocyclic metabolites (labillarides A–H, 60–67), adding to this repertoire. Of particular
interest are labillarides C (62) and D (63), which introduce the first examples of direct
carbon-to-carbon bridged macrocycles into this family of compounds, and the unusual
tricyclic labillarides E–H (64–67), which possess the rare dihydrofuro[3,2,-c]pyran-4-one
moiety. Also isolated were two enol macrocycles (labillarides I and J, 68 and 69) and
a new furan-3-one (labillaride K, 70), which are biogenically related to the macrocyclic
pyrones. It is interesting to note that a small Wellington collection of P. labillardieri
was examined by NMR spectroscopy and found to contain lower concentrations of the
labillarides isolated from the Northland collections, and again with no sign of the known
compounds previously isolated from southern Australian sources. These differences
between the Australian and New Zealand studies of what has been reported as the same
species may indicate a different taxonomic status.
The stability of several of the labillarides was problematic. It was found that though
frozen collections of the alga, as well as extracts and crude mixtures of compounds,
were quite stable, once purified some of the labillarides are remarkably unstable when
stored as a solid or in an oil. This issue has been noted for oxylipins and a solution
is to store such compounds in toluene/ethanol solutions.75 Interestingly, the tricyclic
oxylipins labillarides E–H (64–67) did not exhibit the same instability, showing no
obvious degradation by NMR analysis following over two years of storage in a 4 ◦C
fridge.
All labillarides were tested for biological activity against the human leukaemia cell
line HL-60 and for antibacterial activity against the MC2155 strain of Mycobacterium
103
smegmatis. Labillarides A (60), B (61) and I (68) exhibit moderate cytotoxicity while
labillaride C (62) shows moderate antibacterial activity. Initial tests of labillaride E
(64) showed repeatable potent cytotoxicity (∼600 nM), however this activity was not
observed when a second sample was purified by a slightly different isolation route.
Upon re-purification of the original sample, despite no detection of another major
constituent by HPLC, the activity did not track with 64. Such issues are not restricted
to NMR guided isolation. In 1995, a P-388 bioassay guided separation lead to the
isolation of phakellistatin 11 (101) (ED50 0.2 µg mL-1) from the Micronesian sponge
Phakellia sp., however a synthetic sample of 102 did not exhibit this potent activity (ED50
>10 µg mL-1).100,101 It was found that the natural sample carried trace amounts (too small
for usual NMR and chromatographic detection) of an unidentified exceptionally potent
impurity.
Finally, Labillarides E–H (64–67) display significant changes in their 1H NMR spectra
with changes in either concentration or solvent. Were it not for the HPLC results showing
different retention times and only two examples of co-elution, it would have been very
easy to dismiss the subtle chemical shift variations observed between the samples, as
considerably larger changes could be induced by changing the concentration or solvent.
This demonstrates the need for more than a single method to determine if samples are
identical, with HPLC being crucial in this case.
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Chapter 4
Colensolide A: A New Nitrogenous Bromophenol from
Osmundaria colensoi
4.1 Osmundaria colensoi
In this study, an extract of the New Zealand marine red alga Osmundaria colensoi [(J.D.
Hooker & Harvey) R.E. Norris] (Figure 4.1, taxonomy see Table 4.1) was examined. The
spectra obtained from screening O. colensoi with our standard protocol was recognised
as being extremely interesting using the HSQC mask (Figure 4.2). Of particular note was
the cluster of shielded aromatic methines centred around δH 7 and δC 115.
There have been no compounds reported to date specifically from Osmundaria colensoi,
though there has been a variety of compounds isolated from different species of
Osmundaria and Vidalia, which is now considered a synonym of Osmundaria.21,102 Sterol
distribution studies of several species of Osmundaria and Vidalia have been reported on
two occasions.103,104 Similarly, the free protein amino acid profiles of V. volubilis were
reported in 1977,105 and the carotenoid content of a New Zealand collection of V. colensoi
was summarised in 1987.106 In 1982 an S-methyl compound (103) was reported from
several red algae, including V. volubilis.107 Re-examination of the hydrophilic fraction of
Figure 4.1. Osmundaria colensoi. Image courtesy of Malcolm Francis.
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Table 4.1. Taxonomic classification of genus Osmundaria from order Ceramiales as
presented by AlgaeBase.21
Order Family Sub-family Tribe Genus
Ceramiales
Ceramiaceae
Callithamnioideae
Callithamnieae . . .
Gymnothamnieae . . .
Ptiloteae . . .
Rhodocallideae . . .
Ceramioideae
Antithamnieae . . .
Bornetieae . . .
Ceramieae . . .
Ceramioideae . . .
Crouanieae . . .
Dasyphileae . . .
Dohrnielleae . . .
Griffithsieae . . .
Heterothamnieae . . .
Pterothamnieae . . .
Scagelieae . . .
Scagelothamnieae . . .
Sphondylothamnieae . . .
Wrangelieae . . .
Compsothamnioideae
Compsothamnieae . . .
Delesseriopseae . . .
Halosieae . . .
Lasiothalieae . . .
Monosporeae . . .
Rhodothamnieae . . .
Spermothamnieae . . .
Spongoclonieae . . .
Warrenieae . . .
Liagorothamnieae . . .
Skeletonelleae . . .
. . .
Dasyaceae . . .
Delesseriaceae
Delesserioideae
Apoglosseae . . .
Claudeae . . .
Delesserieae . . .
Grinnellieae . . .
Hemineureae . . .
Hypoglosseae . . .
. . .
Nitophylloideae Martensieae . . .Nitophylleae . . .
Phycodryoideae
Cryptopleureae . . .
Myriogrammeae . . .
Phycodryeae . . .
Schizoserideae . . .
Dicroglosseae . . .
. . .
Rhodomelaceae
Amansieae
Adamsiella
Amansia
Aneurianna
Enantiocladia
Epiglossum
Halopithys
Kentrophora
Kuetzingia
Lenormandia
Nanopera
Neurymenia
Osmundaria
Protokuetzingia
Rytiphlaea
Vidalia
Brongniartelleae . . .
Lophothalieae . . .
Neotenophyceae . . .
. . .
Sarcomeniaceae Sarcomenioidea Sarcomenieae . . .. . .
Spyridiaceae Spyrideae . . .
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Figure 4.2. HSQC mask showing the common correlations in green and the unusual
correlations in red.
this alga by the same group lead to the isolation of two N-methyl compounds (104 and
105), reported in 1992.108 In 1982 the halogenated cyclopentene 106 was reported from a
Western Australian collection of V. spiralis.109 Vidalol A (107) and B (108) were reported
in 1991 from the Caribbean red alga Vidalia obtusaloba, and were found to have anti-
inflammatory activity.110 Vidalenolone (109), a novel phenolic compound, was reported
along with the known compounds lanosol (110) and 4-hydroxybenzyl alcohol (111) from
the tropical red alga Vidalia sp. in 2002.111 In 2006 two new sulfated bromophenols (112
and 113) were reported along with three known lanosol derivatives (114, 115 and 116), a
sterol (117) and a glycoside (118).112 Finally, in 2006, the known lanosol derivative 119
was reported from Osmundaria serrata.113
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4.2 Isolation
A large-scale extraction of approximately 500 g of Northland collections of O. colensoi
was performed. Following two steps of bench-top reversed-phase chromatography
(PSDVB), four fractions were examined by 1H, COSY, HSQC and HMBC NMR
experiments in an attempt to identify functional groups and fragments of molecules.
Analysis of the NMR spectra revealed deshielded aromatic non-protonated carbons and
shielded aromatic singlet protons, suggesting highly substituted phenols. Examination of
the more recent Marine Natural Products reviews, published yearly in Natural Products
Reports, revealed a similarity to a series of bromophenols isolated from various red
algae.114–117
Known Bromophenols
Further purification by HPLC (C18) lead to the isolation of the common bromophenol
lanosol (110), the methyl ether of lanosol (114), an aldehyde derivative (120), a butenone
derivative (121) and rhodomelol (122). Compounds 110 and 114 have been previously
reported from species of Vidalia and Osmundaria respectively, while 120 has only been
reported from other genera of red algae.111,112 Both 121 and 122 have been reported once
each from Polysiphonia lanosa and Rhodomela confervoides respectively.118,119
The NMR assignments of lanosol and many of its derivatives are well documented in the
literature, therefore it is unnecessary to give a detailed structural elucidation of lanosol
(110) and its derivatives 114 and 120 isolated during this study. Full NMR data for these
compounds can be found in Appendix B.
The butenone derivative 121 was reported in 2004 along with several other bromophe-
nols.118 A detailed analysis of the NMR data obtained in this study led to the reassignment
of several 13C resonances. Specifically, the assignment of the 13C resonances for C-6 and
C-8 were interchanged, as were that of C-4 and C-5. The revised NMR data is presented
in both CD3OD (Table 4.2) and (CD3)2CO (Table 4.3).
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Table 4.2. 13C (150 MHz) and 1H (600 MHz) NMR data (CD3OD) for
(3E)-4-(2,3-dibromo-4,5-dihydroxyphenyl)-3-butene-2-one (121).
13C 1H HMBC
Pos δ (ppm) mult 1JCH (Hz) δ (ppm) mult J (Hz) COSY (1H to 13C)
1 127.6 C
2 119.6 C
3 114.8 C
4 149.0 C
5 146.6 C
6 113.0 CH 161 7.18 s 2,3*,4,5,7
7 145.1 CH 158 7.95 d 16.1 8 2,5*,6,8,9
8 128.1 CH 159 6.52 d 16.1 7 1,7,9,10
9 200.8 C
10 27.3 CH3 127 2.37 s 7,8,9
*Long-range correlation.
Table 4.3. 13C (150 MHz) and 1H (600 MHz) NMR data ((CD3)2CO) for
(3E)-4-(2,3-dibromo-4,5-dihydroxyphenyl)-3-butene-2-one (121).
13C 1H HMBC
Pos δ (ppm) mult 1JCH (Hz) δ (ppm) mult J (Hz) COSY (1H to 13C)
1 127.9 C
2 118.9 C
3 114.3 C
4 147.9 C
5 146.0 C
6 113.3 CH 159 7.33 s 2,3,4,5,7
7 142.7 CH 159 7.86 d 16.1 8 1*,2,5*,6,8,9
8 128.8 CH 159 6.54 d 16.1 7 1,2*,7,9,10
9 197.6 C
10 27.7 CH3 126 2.33 s 7,8,9
*Long-range correlation.
Rhodomelol (122) was reported along with its methyl ester, methylrhodomelol (123), in
1985.119 The only NMR assignments of 122 and 123 were reported on semi-synthetic
derivatives. As a result, the NMR data reported for rhodomelol was incomplete and
therefore a detailed analysis of the NMR spectra obtained in this study was performed.
The full NMR assignment of 122 is presented in CD3OD (Table 4.4) and (CD3)2CO (Table
4.5). The position of the diastereotopic proton resonances of CH2-10 were assigned based
on both their chemical shift and the 3JHH coupling constants observed with H-11. The
chemical shift of H-10a is expected to be slightly higher upfield than H-10b due to the
shielding effect of the hydroxyl group on C-11. In addition, the dihedral angle of the
vicinal protons H-10a and H-11 is closer to 90◦ than that of H-10b and H-11, therefore a
smaller coupling constant is expected.
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Table 4.4. 13C (150 MHz) and 1H (600 MHz) NMR data (CD3OD) for rhodomelol (122).
13C 1H HMBC
Pos δ (ppm) mult 1JCH (Hz) δ (ppm) mult J (Hz) COSY (1H to 13C) NOE
1 128.2 C
2 117.9 C
3 113.6 C
4 144.9 C
5 145.7 C
6 119.2 CH 165 7.03 s 2,3,4,5,8 7a,7b,12
7a 41.7 CH2
128 3.37 d 14.9 7b 4,2,5*,6,8,9,13 6,7b,12
7b 133 3.11 d 14.7 7a 4,2,5*,6,8,9,13 6,7a
8 79.4 C
9 109.0 C
10a 76.6 CH2
151 4.09 dd 9.7,3.1 10b,11 9,11,12 10b,11
10b 151 4.24 dd 9.8,5.9 10a,11 9,12 10a,11
11 75.5 CH 166 4.41 dd 5.6,3.4 10a,10b 9,10,12 10a,10b,12
12 88.2 CH 154 4.59 s 9,10,11,13 6,7a,11
13 176.5 C
*Long-range correlation.
Table 4.5. 13C (150 MHz) and 1H (600 MHz) NMR data ((CD3)2CO) for rhodomelol
(122).
13C 1H HMBC
Pos δ (ppm) mult 1JCH (Hz) δ (ppm) mult J (Hz) COSY (1H to 13C)
1 128.4 C
2 117.8 C
3 112.8 C
4 144.3 C
5 144.7 C
6 119.1 CH 164 7.12 s 1,2,3,4,5,7
7a 41.1 CH2
127 3.39 d 14.8 7b 1,2,5,6,8,9,13
7b 132 3.18 d 15.0 7a 1,2,6,8,9,13
8 78.7 C
9 108.6 C
10a 76.3 CH2
150 4.18 dd 9.8,5.6 10b,11 9,12
10b 150 4.09 dd 9.7,3.1 10a,11 9,11,12
11 75.2 CH 154 4.45 dd 5.5,3.2 10a,10b 9,10,12
12 87.1 CH 165 4.65 s 9,10,11,13
13 174.2 C
A New Bromophenol
A more detailed review of the bromophenols was performed and the known structures
compared to the NMR data obtained from the semi-purified fractions with a particular
emphasis on analysing fragments of molecules in the semi-purified fractions. The aim of
this technique was to look for fragments that did not appear to be present in compounds
reported in the literature. The HMBC experiment in particular is a very useful tool, as it
111
allows the identification of non-protonated carbons. By examining features such as methyl
splitting patterns in the 1H NMR spectrum, and the positioning of diagnostic functional
groups such as ketones through HMBC correlations, structural fragments were identified.
This analysis lead to the identification in the semi-purified fractions of the known bro-
mophenol compounds described previously. But, more interestingly, it also highlighted
the presence of a compound that appeared to display different spectral characteristics to all
previously reported bromophenols. Specifically, an isolated diastereotopic methylene pair
was found to connect with several carbon environments that did not appear in any of the
known compounds. Figure 4.3 shows the 1H, COSY, HSQC and HMBC NMR spectra
of the fraction. Of particular interest were the HMBC correlations from the methylene
pair (red) to the deshielded methylene pair (green) and the strongly deshielded methine
(blue). Further purification by HPLC (C18) lead to the isolation of a novel bromophenol,
colensolide A (124).
(a) 1H NMR spectrum (b) COSY spectrum
(c) HSQC spectrum (d) HMBC spectrum
Figure 4.3. NMR spectra of a semi-purified fraction of O. colensoi showing correlations
of interest.
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4.3 Colensolide A
Colensolide A (124) was isolated as a colourless oil (3.5 mg in total). The observation
of characteristic pseudomolecular ion clusters ([M + H]+ : [M + 2 + H]+ : [M + 4 + H]+;
1 : 2 : 1) by HRESIMS indicated a molecular formula of C13H15N3O4Br2 (417.9386
[M − H2O + H]+, ∆ 2.6 ppm and 435.9496 [M + H]+, ∆ 1.5 ppm), requiring seven
double-bond equivalents. The 13C NMR spectrum contained 13 distinct resonances while
the multiplicity-edited HSQC spectrum in CD3OD, as well as establishing direct
1H to
13C connectivity, accounted for 11 of the 15 protons indicating the likely presence of
four exchangeable protons. This was partially confirmed by the observation of 13 of
the 15 protons when the 1H spectrum was recorded in d6-DMSO. Identifiable features
in the CD3OD NMR spectra included one carbonyl resonance (δC 163.9), two strongly
deshielded aromatic resonances [(δC 145.2) and (δC 146.4)], four aromatic resonances
[(δC 114.4), (δC 116.2), (δC 116.4, δH 6.98) and (δC 130.9)], a strongly deshielded methine
(δC 77.7, δH 4.74), two slightly deshielded methylenes [(δC 55.1, δH 3.86 and 3.68) and
(δC 49.0, δH 2.79 and 2.67)], an aliphatic methylene (δC 38.6, δH 2.12 and 2.00) and an
oxymethyl group (δC 51.0, δH 3.28).
Construction of the Bromophenol Substructure
Analysis of the HMBC spectrum of 124 led to the construction of the 2,3-dibromo-
4,5-dihydroxybenzyl substructure. HMBC correlations from the aromatic methine (C-6:
δC 116.4, δH 6.98) to five aromatic non-protonated carbons (C-1: δC 130.9, C-2: δC 116.2,
C-3: δC 114.4, C-4: δC 146.4 and C-5: δC 145.2) established a penta-substituted benzene
moiety. The strongly deshielded nature of C-4 and C-5 is consistent with oxygen
attachment at both these carbons. This is supported by the relatively shielded nature
of the carbon resonances of positions C-2, C-3 and C-6. Strong HMBC correlations from
both proton resonances of a deshielded methylene (C-7: δC 55.1, δH 3.86 and 3.68) to the
aromatic non-protonated carbons C-1 and C-2 and the aromatic methine C-6 indicated the
attachment of this methylene to C-1. Weak allylic COSY correlations between H-6 and
both proton resonances of CH2-7 supported this attachment. This assignment partially
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accounts for the deshielded nature of C-7 although the observed 1H and 13C shifts could
not be entirely explained on this basis. Weak, long-range HMBC correlations from
H-7a to C-3 and C-5 established the order of the carbon chain around the aromatic ring,
indicating C-4 to be para to the methylene attachment.
Crosspeak intensities in HMBC experiments depend in part on the magnitude of the long-
range coupling.120 In aromatic systems, two- and four-bond couplings (2JCH and 4JCH
respectively) tend to be small, while three-bond couplings (3JCH) are large.121 However,
hydroxy substitution at the carbon involved increases the magnitude of the 2JCH value.67
This precedent supports the order of the carbon resonances around the aromatic ring.
HMBC correlations from H-6 to C-1 and C-3 were weak (two- and four-bond coupling,
respectively), while strong correlations were observed to C-2 and C-4 (both three-bond
couplings), and to C-5, a large two-bond coupling due to hydroxyl substitution. The
relatively shielded chemical shifts of the remaining non-protonated aromatic carbon
resonances (C-2: δC 114.4 and C-3: δC 116.2) suggested bromine attachment at these
two positions (Figure 4.4).
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Figure 4.4. Selected COSY and HMBC correlations establishing bromophenol
substructure of colensolide A (124).
Finally, the 13C chemical shifts of the benzene ring compared favourably with the
known compounds containing this 2,3-dibromo-4,5-dihydroxybenzyl moiety isolated in
this study (see Table 4.6).
Construction of the Bicyclic Substructure
COSY correlations from a slightly deshielded methylene (C-14: δC 38.6, δH 2.12 and
2.00) to a more strongly deshielded methylene (C-15: δC 49.0, δH 2.79 and 2.67) indicated
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Table 4.6. A comparison of 13C chemical shifts of positions 1-6 in colensolide A (124),
lanosol (110), lanosol methyl ether (114) and rhodomelol (122).
5
4
3
2
1
6
OH
HO
Br
Br
7
13C [δ (ppm)]
Pos mult 124 110 114 122
1 C 131.2 134.1 131.0 128.2
2 C 116.2 114.1 115.3 117.9
3 C 114.4 114.2 114.5 113.6
4 C 146.5 146.2 145.3 144.9
5 C 145.2 144.6 146.3 145.7
6 CH 116.4 114.8 115.8 119.2
the connection between these two centres in an isolated spin system. The high 1JCH values
H-15a: 143 Hz, H-15b: 133 Hz and deshielded chemical shift of C-15 was indicative of
nitrogen attachment. This was confirmed by the observation of a downfield shift of the
carbon and proton resonances and significant increase in the 1JCH values H-15a: 151 Hz,
H-15b: 148 Hz when colensolide A (124) was exposed to TFA in an NMR tube to form
acidified colensolide A (125). NMR data for 125 are presented in Table 4.10.
The deshielded nature of the carbon and proton resonances of the C-7 methylene and the
relatively large 1JCH values of H-7a and H-7b (136 and 135 Hz, respectively) again were
indicative of nitrogen attachment at this position. Once more, the NMR spectrum of the
acidified derivative 125 showed a downfield shift of the carbon and proton resonances
and significant increase in the 1JCH values (H2-7: 147 Hz), supporting this assignment.
HMBC correlations from H-15a to a nitrogen (N-8: δN −319.3), from H-15b to C-7,
and from both proton resonances of CH2-7 to C-15 indicated that C-7 and C-15 were
connected through the same nitrogen. Selective excitation of the methylene protons H-7a
and H-7b showed NOE enhancements to H-15a and H-15b, confirming this connectivity
(Figure 4.5).
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Figure 4.5. Selected COSY and HMBC correlations and NOE enhancements
establishing part of the bicyclic substructure of colensolide A (124).
HMBC correlations from both proton resonances of CH2-7 to a strongly deshielded
methine (C-9: δC 77.7, δH 4.74) completed the substitution around the tertiary amine.
This was confirmed by a significant increase in the 1JCH value for C-9 in the NMR
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spectrum of the acidified derivative (164 Hz in 124 increased to 175 Hz in 125), and
HMBC correlations from H-9 to C-7, N-8 and C-15. The strongly deshielded nature of
C-9 along with the very large 1JCH value indicated connectivity to another heteroatom.
An HMBC correlation from H-9 to a second nitrogen (N-10: δN −291.1), along with
a COSY correlation between H-9 and H-10 when the spectrum was recorded in d6-
DMSO, supported this aminal assignment (Figure 4.6). Table 4.7 shows the chemical shift
differences observed around the tertiary amine when colensolide A (124) was acidified to
125.
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Figure 4.6. Selected COSY and HMBC correlations establishing more of the bicyclic
substructure of colensolide A (124).
Table 4.7. Chemical shift differences of colensolide A (124) and acidified colensolide A
(125).
7
9
15N8
7
9
15N8
H
124 125
Colensolide A (124) Acidified colensolide A (125) Difference
δH δC or δN δH δC or δN δH δC or δN
Pos mult δ (ppm) δ (ppm) 1JCH (Hz) δ (ppm) δ (ppm) 1JCH (Hz) δ∆ (ppm) δ∆ (ppm) ∆1JCH (Hz)
7a CH2
3.86 55.1 136 4.50 56.7 146 0.64 1.6 107b 3.68 135 0.82 11
8 N or NH+ −319.3 −298.9 20.4
9 CH 4.74 77.7 164 5.39 81.4 175 0.65 3.7 11
15a CH2
2.79 49.0 143 3.48 50.9 151 0.69 1.9 915b 2.67 133 3.40 148 0.73 15
Further HMBC correlations from H-9 to a shielded carbonyl (C-11: δC 163.9) suggested
an amide moiety. HMBC correlations from both proton resonances of CH2-15 to a
strongly deshielded non-protonated carbon (C-13: δC 99.7) positioned this carbon next
to the C-14 methylene. An HMBC correlation from the oxymethyl (C-16: δC 51.0,
δH 3.28) to C-13 and HMBC correlations from both proton resonances of CH2-14 to a
third nitrogen (N-12: δN −280.5) accounted for the strongly deshielded nature of C-13,
as a hemi-aminal ether.
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The 15N HSQC spectra recorded in d6-DMSO showed that both N-10 and N-12 were
secondary amides [(N-10: δN −290.6, δH 7.12) and (N-12: δN −279.6, δH 7.32)]. HMBC
correlations were observed from H-10 to C-9 and C-11 and from H-12 to C-11 and C-13,
suggested a urea moiety connecting N-10 and N-12 through the C-11 carbonyl. This
assignment was supported by the observed chemical shifts of both N-10 and N-12 being
consistent with amides, which generally occur in the range −210 to −300 ppm; urea
occurs at−302.8 ppm.122 Finally, an HMBC correlation between H-9 and C-13 completed
the connectivity of these two centres and created the bicyclic substructure containing an
imidazolone moiety (Figure 4.7).
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Figure 4.7. Selected HMBC correlations establishing the bicyclic substructure of
colensolide A (124).
All detected carbon and nitrogen resonances were now accounted for. The observed
chemical shift of N-8 (δN −319.3) is consistent with an alkylamine which generally occurs
in the range of −310 to −380 ppm,122 while the acidified counterpart (δH −298.9) is
consistent with an ammonium ion (−290 to −360).123 The presence of the benzene ring
and the bicyclic system accounted for six double-bond equivalents and the seventh was
accounted for by the presence of the carbonyl carbon of the imidazolone moiety. The
final two protons from the molecular formula unaccounted for were satisfied by assigning
positions C-4 and C-5 as hydroxyls, assigning the ring as an orthohydroquinone.
The relative configuration of colensolide A (124) was assigned on the basis of NOE
enhancements observed in a series of 1D-NOESY experiments. Selective excitation of the
methine proton H-9 showed NOE enhancements to H-14a, H-15a and H3-16. Selective
excitation of H-14a showed NOE enhancements to its geminal partner H-14b, H-9, H-15a
and H3-16, while selective excitation of H-14b showed NOE enhancements to its geminal
partner H-14a and H-15b. This series of NOE enhancements determined the cis-fused
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bicyclic ring system with H-9, H3-16, H-14a and H-15a on the same face of the five
membered ring (Figure 4.8).
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9
Ha Ha
HN
NH
H O
CH316
Hb Hb
O
14
Figure 4.8. Selected NOE enhancements used to determine the relative configuration of
colensolide A (124).
Selective excitation of the methyl protons H3-16 showed expected NOE enhancements to
H-9 and H-14a, and interestingly, weakly to H-14b. This is not unreasonable due to the
free rotation of the C-13–OMe bond and the relative angles of the two methylene protons
in the five membered ring. Optical rotation measurements were negligible ([α]25D −2 to
−6 (c 0.35, MeOH)), which may imply a racemic mixture of the two enantiomers. The
final structure of colensolide A is therefore shown in 124. NMR data for 124 is presented
in both CD3OD (Table 4.8) and d6-DMSO (Table 4.9).
4.4 Synthetic Derivatives of Colensolide A
Methylation of Colensolide A (124)
The exchangeable hydroquinone protons of 124 were not observed when the 1H NMR
spectrum was acquired in d6-DMSO so synthetic derivatives were prepared to confirm
the proposed structure. Colensolide A (124) was subjected to TMSCHN2 for 45 min.
The NMR spectra of the product of the reaction were similar to those of 124 with the
additional presence of a second oxymethyl signal (C-17: δC 60.7, δH 3.80) and the upfield
shift of C-1, C-3, C-4, C-5 and C-6 (δC 136.9, δC 122.3, δC 151.6, δC 146.7 and δC 118.3
respectively), all consistent with the formation of a methyl ether on an aromatic ring.
An HMBC correlation from H3-17 to C-5 confirmed methylation of the C-5 hydroxyl to
form 5-0-methylcolensolide A (126). The unexpected mono-methylation was attributed to
119
Ta
bl
e
4.
8.
15
N
(6
0
M
H
z)
,1
3 C
(1
50
M
H
z)
an
d
1 H
(6
00
M
H
z)
N
M
R
da
ta
(C
D
3O
D
)f
or
co
le
ns
ol
id
e
A
(1
24
).
13
C
or
15
N
1 H
H
M
B
C
Po
s
δ
(p
pm
)
m
ul
t
1 J
C
H
(H
z)
δ
(p
pm
)
m
ul
t
J
(H
z)
C
O
SY
(1
H
to
13
C
or
15
N
)
N
O
E
55
4433
22
11 66
O
H
H
OBr
Br
77
99
13131
414
1515
N 88 H
N 1010
1111
N
H
1212
O
O
M
e
1616
H
H
aa
H
bb
H
bb
H
aa
12
4
1
13
0.
9
C
2
11
6.
2
C
3
11
4.
4
C
4
14
6.
4
C
5
14
5.
2
C
6
11
6.
4
C
H
16
1
6.
98
s
7a
* ,7
b*
1,
2,
3,
4,
5,
7
7a
,7
b,
9,
15
a,
15
b
7a
55
.1
C
H
2
13
6
3.
86
d
14
.2
6* ,
7b
1,
2,
3* ,
5* ,
6,
9,
15
6,
7b
,9
,1
5a
,1
5b
7b
13
5
3.
68
d
14
.4
6* ,
7a
1,
2,
6,
9,
15
6,
7b
,9
,1
5a
,1
5b
8
−3
19
.3
N
9
77
.7
C
H
16
4
4.
74
s
7* ,
8,
10
,1
1,
13
,1
4,
15
6,
7a
,7
b,
14
a,
15
a,
16
10
−2
91
.1
N
H
11
16
3.
9
C
12
−2
80
.5
N
H
13
99
.7
C
14
a
38
.6
C
H
2
13
0
2.
12
dd
d
12
.2
,1
0.
1,
6.
8
14
b,
15
a,
15
b
8,
12
,1
3,
15
9,
14
b,
15
a,
16
14
b
13
1
2.
00
dd
d
12
.2
,5
.2
,2
.1
14
a,
15
a,
15
b
8,
9,
12
,1
3
14
a,
15
b,
16
15
a
49
.0
C
H
2
14
3
2.
79
dd
d
9.
1,
6.
6,
2.
2
14
a,
14
b,
15
b
8,
9,
13
,1
4
6,
9,
7a
,7
b,
14
a,
15
b
15
b
13
3
2.
67
td
9.
8,
5.
1
14
a,
14
b,
15
a
7,
9,
13
,1
4
6,
7a
,7
b,
14
b,
15
a
16
51
.0
C
H
3
14
1
3.
28
s
13
9,
14
a,
14
b*
*L
on
g-
ra
ng
e
co
rr
el
at
io
n.
120
Ta
bl
e
4.
9.
15
N
(6
0
M
H
z)
,1
3 C
(1
50
M
H
z)
an
d
1 H
(6
00
M
H
z)
N
M
R
da
ta
(d
6-
D
M
SO
)f
or
co
le
ns
ol
id
e
A
(1
24
).
13
C
or
15
N
1 H
H
M
B
C
Po
s
δ
(p
pm
)
m
ul
t
1 J
X
H
(H
z)
δ
(p
pm
)
m
ul
t
J
(H
z)
C
O
SY
(1
H
to
13
C
or
15
N
)
55
4433
22
11 66
O
H
H
OBr
Br
77
99
13131
414
1515
N 88 H
N 1010
1111
N
H
1212
O
O
M
e
1616
H
H
aa
H
bb
H
bb
H
aa
12
4
1
12
9.
7
C
2
11
4.
1
C
3
11
3.
3
C
4
14
5.
1
C
5
14
3.
4
C
6
11
5.
4
C
H
16
2
6.
98
s
7a
* ,7
b*
1* ,
2,
3,
4,
5,
7
7a
53
.5
C
H
2
13
5
3.
72
d
14
.8
6* ,
7b
1,
2,
3* ,
5* ,
6,
9,
15
7b
13
6
3.
52
d
14
.8
6* ,
7a
1,
2,
3* ,
5* ,
6,
9,
15
8
−3
19
.6
N
9
75
.8
C
H
16
2
4.
54
s
10
8,
10
,1
1,
13
,1
4* ,
15
10
−2
90
.6
N
H
94
7.
12
s
9,
12
9,
11
,1
2,
13
11
16
0.
6
C
12
−2
79
.6
N
H
94
7.
32
s
10
9,
10
,1
1,
13
13
97
.5
C
14
a
37
.3
C
H
2
13
2
1.
99
dd
d
11
.9
,1
0.
0,
6.
4
14
b,
15
a,
15
b
13
,1
5
14
b
13
5
1.
93
dd
d
11
.9
,5
.4
,2
.2
14
a,
15
a,
15
b
8,
9,
12
,1
3,
15
15
a
48
.6
C
H
2
14
5
2.
66
dd
d
9.
2,
6.
4,
2.
2
14
a,
14
b,
15
b
9,
13
,1
4
15
b
13
5
2.
51
td
9.
7,
5.
8
14
a,
14
b,
15
a
7* ,
9,
13
,1
4
16
49
.9
C
H
3
14
2
3.
14
s
13
*L
on
g-
ra
ng
e
co
rr
el
at
io
n.
121
Ta
bl
e
4.
10
.1
3 C
(1
50
M
H
z)
an
d
1 H
(6
00
M
H
z)
N
M
R
da
ta
(C
D
3O
D
)f
or
ac
id
ifi
ed
co
le
ns
ol
id
e
A
(1
25
).
13
C
1 H
H
M
B
C
Po
s
δ
(p
pm
)
m
ul
t
1 J
C
H
(H
z)
δ
(p
pm
)
m
ul
t
J
(H
z)
C
O
SY
(1
H
to
13
C
)
N
O
E
55
4433
22
11 66
O
H
H
OBr
Br
77
99
13131
414
1515
N 88 H
N 1010
1111
N
H
1212
O
O
M
e
1616
H
H
aa
H
bb
H
bb
H
aa
H
12
5
1
12
2.
5
C
2
11
8.
7
C
3
11
5.
2
C
4
14
8.
1
C
5
14
7.
1
C
6
11
8.
6
C
H
16
2
7.
07
s
1,
2,
4,
5
7
56
.7
C
H
2
14
6
4.
50
br
.s
1,
2,
6,
15
8
−2
98
.9
N
H
+
9
81
.4
C
H
17
5
5.
39
br
.s
8,
11
,1
3,
15
6,
7,
14
a,
15
b,
16
10
*
N
H
11
16
1.
4
C
12
−2
80
.4
N
H
13
97
.4
C
14
a
67
.7
C
H
2
13
3
2.
45
m
14
b,
15
a,
15
b
13
,1
5
15
a
14
b
13
7
2.
36
dt
13
.9
,5
.6
14
a,
15
a,
15
b
8,
9,
12
,1
3,
15
15
b
15
a
50
.9
C
H
2
15
1
3.
48
dt
11
.6
,5
.8
14
a,
14
b,
15
b
9,
13
,1
4
6,
7,
9,
14
a,
15
b
15
b
14
8
3.
40
dd
d
11
.6
,9
.3
,6
.5
14
a,
14
b,
15
a
9,
13
,1
4
6,
7,
14
b,
15
a
16
51
.3
C
H
3
14
3
3.
32
s
13
9,
14
a
*N
ot
ob
se
rv
ed
.
122
steric hindrance. It is proposed that the TMS group on the reactive diazomethane group
was blocked from the C-4 hydroxyl by the the adjacent bromine atom and previously
methylated C-5 phenol. NMR data for 126 are presented in Table 4.11.
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Methylation of 5-O-Methylcolensolide A (126)
Following the failure to exhaustively methylate the hydroxy groups of colensolide A,
further methylation was attempted. 5-O-Methylcolensolide A (126) was exposed to MeI
for several hours. The NMR spectra of the product of the reaction were similar to those of
126 with the additional presence of a third oxymethyl signal (C-18: δC 56.7, δH 3.88) and
the further upfield shift of C-4 (δC 154.0) consistent with the formation of a methyl ether.
An HMBC correlation from H3-18 to C-4 confirmed methylation of the C-4 hydroxyl to
form 4,5-di-O-methylcolensolide A (127). NMR data for 127 are presented in Table 4.12.
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4.5 Biological Activity
Colensolide A (124), 4,5-di-O-methylcolensolide A (127), lanosol (110), lanosol methyl
ether (114), lanosol aldehyde (120), lanosol butenone (121) and rhodomelol (122)
were evaluated for cytotoxicity against the human leukaemia cell line HL-60 and for
antibacterial activity against the MC2155 strain of Mycobacterium smegmatis at the
School of Biological Sciences, VUW. Lanosol butenone (121) was the only metabolite
tested to show activity against HL-6076 while lanosol methyl ether (114), lanosol
butenone (121) and rhodomelol (122) all exhibited antibacterial activity (see Table
4.13).77
Table 4.13. Biological activity of colensolide A (124), 4,5-di-O-methylcolensolide A
(127), lanosol (110), lanosol methyl ether (114), lanosol aldehyde (120), lanosol
butenone (121) and rhodomelol (122).
Compound
IC50 (µM)
HL-60* M. smegmatis MC2155†
124 Inactive Inactive
127 Inactive Inactive
110 Inactive Inactive
114 Inactive 7.8
120 Inactive Inactive
121 8.0 26.1
122 Inactive 28.1
*Tested up to 10 µM.
†Tested up to 100 µM.
126
4.6 Bromophenols
In the 1970s, the scientific community generally considered the some 200 natural
organohalogen compounds reported to date to be isolation artifacts or abnormalities
in nature. Over thirty years later and with numbers now exceeding 3800, opinions
have changed.124 The single largest source of biogenic organohalogens are marine
organisms,124 which synthesise a wide range of compounds, from simple haloalkanes
to complex phenols, terpenes, pyrroles and indoles.114–117,124 In many cases, these
halogenated marine metabolites possess biological activities of pharmacological interest,
including antifungal, antibacterial, antiviral, and anti-inflammatory activities.95
The marine environment is a rich source of various important anions, including sulfate,
chloride, bromide and iodide, in concentrations of 885, 19 000, 65 and 0.06 mg L−1
respectively.125 Despite the obvious excess of chloride over bromide, marine plants and
animals make use of the facile oxidation of bromide to bromine (or hypobromite) and
biobromination processes to produce an impressive array of organobromine metabolites.
The main enzymes responsible for the incorporation of halogen atoms in organic
compounds in nature are haloperoxidases, which catalyse the formation of halogenated
organic compounds at the expense of hydrogen peroxide. The bromoperoxidase enzymes
responsible for bromide oxidation have been isolated from nearly 100 species of terrestrial
and marine organisms, and chloroperoxidase and other peroxidases also have the ability
to oxidise bromide.126 Rhodophyta in particular have been known to be a rich source of
bromine for many years, and by the 1920s many algae were known to concentrate it.127
This fact was exploited during World War II when bromine was extracted on an industrial
scale from Rhodomela larix for use in chemical warfare agents.125
Examples of such brominated compounds are the simple phenols that have been isolated
from taxonomically diverse seaweeds such as the brown algae Fucus vesiculosus128
and Leathesia nana,129–131 and the red algae Lenormandia prolifera,132 Odonthalia
corymbifera,133 Polysiphonia lanosa,134 and Rhodomela larix.135 Bromophenols are
widespread in the marine environment, which has been attributed to the phenol moiety’s
propensity to undergo electrophilic bromination.126
127
Lanosol (110) is the most abundant and widely distributed of the bromophenols.136
Found in low levels in fungi, 110 is more common in the Rhodomelaceae (Rhodophyta),
particularly in the genera Polysiphonia, Rhodomela and Osmundaria.113,125 Weinstein
et al. suggested that lanosol and some of its derivatives are artifacts of the extraction
procedure, where the solvents H2O, MeOH and EtOH produce lanosol, and the methyl
(114) and ethyl ether (119) forms respectively.133 The potassium disulfate salt of lanosol
(115) is thought to be the natural component in the seaweed.133,134 It was proposed
that lanosol accumulates in nature as the moderately labile disulfate ester and thus
may be readily converted to the toxic, free lanosol.134 Antialgal activity experiments
using lanosol disulfate showed no influence of growth rate or the cell density of test
organisms compared to the highly toxic lanosol.134 Etherification or esterification of
phenolic hydroxyl groups is a common biological method of detoxification and it was
proposed that this would explain the inactivity of lanosol disulfate in the antialgal tests.134
Similarly, the sulfate groups may have the role of stabilising the hydroxyl groups, as
proposed for phenols and nitriles.125
There is significant variation in the bromination and hydroxylation of natural bromophe-
nols. This review will focus on those bromophenols containing the 2,3-dibromo-4,5-
dihydroxybenzyl moiety, of which there are 49 reported to date. The first reported
bromophenol was dipotassium 2,3-dibromobenzyl alcohol 4,5-disulfate (128) which
was isolated from the red alga Polysiphonia lanosa in 1966.137 Lanosol (110) was
reported in the same paper as an acid hydrolysis product of 128. In 1972 this disulfate
was re-isolated from an extract of a French collection of P. lanosa, although the
positioning of the sulfate groups was revised to the 4,7-disulfate (115).138 Three further
isolations of 115 from three different red algae genera have been reported.112,133,139
The author could not find an original paper reporting the first isolation of lanosol
(110), though a 1953 paper reported antibacterial activity from U.S.A. sources of
Rhodomela larix in which a bromophenolic compound was reported to be the likely
source.140 Lanosol has since been reported from a further 11 species of red algae
(eight genera),111,134,136,139,141–146 and two brown algae.128,129,131 A variety of activities
have been reported, including antialgal,134 antifeedant,139 α-glucosidase inhibition,143
cytotoxicity145 and isocitrate lyase (ICL) inhibitory.146 In 1967, two lanosol derivative
128
(114 and 120) were reported from R. larix.135 Compound 114 has since been reported
from a further 12 species of red algae (seven genera),112,133,136,139,142,144–149 and two
brown algae.128,129,131 Various activities have been reported including potent growth
stimulatory activity,148 potent feeding deterrent activity,139 cytotoxicity145 and ICL
inhibitory activity.146 Compound 120 has since been reported from a further five
species of red algae (four genera),136,142,144,145 and a brown alga.129,131 A third lanosol
derivative (129) was isolated from P. lanosa in 1972.150 The structure was confirmed
in 1974, following the isolation from another red alga.151 The cytotoxic activity of
129 was reported in 2004.145 In 1977, two diphenols (116 and 130) were reported
from the Japanese red alga Rhodomela larix.142 Compound 116 has since been reported
from a further four species of red algae (three genera),112,129,131,139,144,152 and a brown
alga,129,131 while 130 has been reported from a further three species of red algae (two
genera),139,144,146,147,152 and one brown alga.129,131 Both 116 and 130 have been reported
to have antifeedant and cytotoxic activity.129,139,152 The diphenol ether 131, a cytotoxic,
antifeedant and α-glucosidase inhibiting compound, was reported from the Japanese
red alga R. larix in 1980 and has since been reported from two other species of red
algae (two genera),143,144,152 and a brown alga.129,131 In 1985, rhodomelol (122) and
methylrhodomelol (123) were reported from Polysiphonia lanosa.119 Rhodomelol was
reported to have anti-HIV-1 integrase activity in a 1997 study.153 Vidalol A (107) and B
(108) were reported in 1991 from the Caribbean red alga Vidalia obtusaloba, and were
found to have anti-inflammatory activity.110 In 1997 the antifeedant diphenol 132 was
reported from the Japanese red alga Odonthalia corymbifera.139
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A resurgence of bromophenol isolation started in 2003. A study of the Chinese red
alga Rhodomela confervoides resulted in five new compounds (133–137).144,152,154,155
Surprisingly, several of these metabolites were reported as novel compounds in as
many as three different papers by the same authors.144,152,154,155 Bromophenols 133
and 134 are both reported to have antibacterial activity.152 Compound 133 has since
been reported from the red alga Odonthalia corymbifera, and is reported to have ICL
inhibitory activity,146 while 134 has also been isolated from a brown alga and was
found to have cytotoxic activity.129,131 In 2004, the same group reported six more
bromophenols from the same extract of R. confervoides (121, 138–142),118 and also
reported the isolation of eight bromophenols from the Chinese brown alga Leathesia
nana (143–150).129–131 Compound 145 was reported to have cytotoxic activity. Again,
three of the compounds were reported in as many as three separate papers.129–131
In 2005, this Chinese group reported the isolation of the first nitrogen-containing
compounds in this class of bromophenols, once again from the R. confervoides extract,
including three pyrodeoxyguanosine acid derivatives (151–153) and one deoxyguanosine
derivative (154).156 All were found to be inactive against several human cancer cell
lines at 10 µg/mL.156 Further nitrogen-containing compounds, this time γ-ureidobutyrate
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derivatives (155–158), were reported from the R. confervoides extract in 2006, along with
the simple bromophenol 159 and bromophenol sulfates 160 and 161.157 Compounds 159–
161 were found to be cytotoxic against several human cancer cell lines, whilst 155–158
were found to be inactive.157 The most recent paper from this Chinese group in 2007
reported the isolation of three nucleoside base bromophenol derivatives (162–164) from
the R. confervoides extract.158 Finally, two sulfated bromophenols (112 and 113) were
reported in 2006 from the Brazilian red alga Osmundaria obtusiloba.112
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4.7 Biogenesis of Colensolide A
The presence of nitrogen-containing sidechains in bromophenols is not unprecedented,
though it is only a recent discovery. Ten such compounds have been reported to date, all
from an extract of the red alga Rhodomela confervoides as detailed in Section 4.6.156–158
Attempts to mimic these compounds semi-synthetically by known alkylation methods
were unsuccessful, leading to the hypothesis that there is an unprecedented enzymatic
catalysed nitrogen alkyation process in the biosynthesis of these metabolites.158
The nitrogen-containing moiety of colensolide A (124) may have its origins from
oxygenated histidine. A study reported in 2006 on sensitiser-mediated photo-oxidation of
histidine (165) proposes a reaction scheme for the formation of the bicyclic sidechain via
oxidation by singlet oxygen (molecular oxygen in its 1∆g state; 1O2).159 It is suggested
that these reactions occur via the formation of short-lived peroxide species that decay
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to give complex mixtures of products. The study reported that these compounds are
believed to arise via internal nucleophilic cyclisation of the amine function onto the
oxidised imidazole ring formed from the decomposition of the initial peroxide species
(see Scheme 4.2). Previous studies have demonstrated that both free histidine residues
and those in proteins, are major targets for oxidation by 1O2. The sequence of reactions
is similar to those proposed to account for the formation of cyclised products during the
1O2-mediated oxidation of tyrosine and tryptophan, where a similar internal cyclisation
of the free amine group onto the oxygenated ring system has also been characterised.160
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Scheme 4.2. Simplified reaction scheme for formation of histidine photo-product as
proposed by Agon et al.159
NMR analysis of crude reaction mixtures of free histidine photo-oxidation products
illuminated for 20 min in phosphate-buffered D2O showed production of the two cis-
fused isomers of the bicyclic ring.159 Decarboxylation of the bicyclic product observed
by Agon et al. would give the desired bicyclic moiety observed in colensolide A (124).
The inclusion of the bromophenol ring could occur before or after the histidine oxidation.
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4.8 Summary
A novel technique was used to identify potentially novel compounds in semi-purified
mixtures using 1D and 2D NMR spectroscopy. This strategy is useful if a series of known
compounds are present in an extract as it helps identify leads in an organism that would
otherwise likely be discarded. In this case, analysis of semi-purified mixtures led to the
identification of a class of known bromophenols. By considering these known structures
and analysing the 1H, COSY, HSQC and HMBC NMR spectra of the mixtures, it was
possible to highlight and guide isolation of the novel nitrogenous bromophenol compound
colensolide A (124).
Colensolide A was a minor constituent of the algal extract, and therefore any bioassay
guided isolation would have been misled by the mild activity of the known major
metabolites. This method is clearly useful in the search for novel compounds, especially
in the presence of biologically active, well known, major constituents.
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Chapter 5
Conclusion
The challenge for natural product chemists is to find new and novel secondary metabolites
through informed selection of a suitable organism and use of a robust system to guide
isolation and purification. Over the course of this study, a recently neglected phylum,
Rhodophyta, was re-examined using the unique NMR based screening and isolation
technique employed by the VUW Marine Natural Products group. It was found that
the spectroscopic comparison is very much phylum specific, suggesting that the power
of the method is enhanced by restricting the analysis to related organisms. This is an
important point to note if the technique is to be applied to other natural systems. An
interesting extension of this work would be to examine a second seaweed phylum, such as
the brown algae (Phaeophyta), to compare any chemical similarities between the primary
metabolites of two phyla. Several efforts are underway to improve the spectroscopic
screening technique utilised in this study, including the potential use of HMBC NMR
spectroscopy and the possibility of employing a more sophisticated comparison method
such as principal component analysis instead of simple averaging.
Several challenges were faced during the structural elucidation of the new compounds
isolated during this study, which required the use of advanced NMR techniques. The use
of HSQC-TOCSY experiments and 3JHH coupling constants were essential with respect to
the labillaride compounds, while the 1H to 15N HMBC experiment and 1JCH values were
crucial in the elucidation of colensolide A (124).
Organisms can sometimes be found to contain a well-known class of compounds not
previously reported from the specific genus or species being examined. In such cases,
the challenge for the natural product chemist is to detect potentially new and novel
compounds in mixtures containing a plethora of structurally similar, known metabolites.
In this study, a novel technique was used to identify potentially novel compounds in semi-
purified mixtures using NMR spectroscopy. The HMBC experiment was found to be
particularly suited to such analysis through identification of diagnostic functional groups
136
and structural fragments.
There has recently been a change in attitude with regard to natural product chemistry, with
Nature as a source for potential pharmaceuticals coming back into favour in the form of
libraries of purified metabolites as opposed to the crude extracts previously assembled
for single assay analysis. The use of narrowly focused bioassay guided isolation is
not particularly appropriate in the quest to create such libraries, and new methods of
isolation such as the unbiased spectroscopic based technique are required to produce new
compounds of structural diversity. However, caution must be taken, even when using
such spectroscopic techniques, in order to ensure that the metabolite in question is in fact
responsible for any subsequent activity detected from such a library. The false activity
observed for the seemingly pure sample of labillaride E (64) illustrates the potential of this
problem. As libraries of metabolites are assembled, no matter what the method guiding
isolation, the problem remains that the novel activity may be associated with an impurity.
One possible solution may be to test the fractions around that of the natural product to act
as a control, however this would become impractical with the larger libraries.
Throughout the course of this study it was found that having a range of structurally related
compounds can be incredibly beneficial. The initial bioassay results for labillaride E (64)
could easily have been accepted as an effect of the significant change in structure with
respect to the other labillarides, were it not for the isolation of three other exceptionally
similar structures with seemingly massive differences in biological activity. The sole
isolation of the tainted sample of 64 would likely have led to a detailed synthesis only to
find that the activity was in fact not associated with 64, as was found with phakellistatin 11
(101),100,101 a less than ideal method to confirm biological activity.
137
Chapter 6
Experimental
6.1 General Experimental
NMR spectra were recorded using a Varian Unity Inova 300 (300 MHz for 1H and 75 MHz
for 13C), Inova 500 (500 MHz for 1H and 125 MHz for 13C), or DirectDrive 600 (600 MHz
for 1H, 150 MHz for 13C and 60 MHz for 15N) spectrometers. Spectra recorded using the
Varian DirectDrive 600 were collected with a Varian inverse-detected triple resonance
HCN cold probe operating at 25 K. Both the 300 and 500 MHz instruments had both
inverse-detected and normal-detected broadband probes available. All directly-detected
1H and 13C chemical shifts (δ) were internally referenced to the residual solvent peak.161
Indirectly-detected 15N shifts were referenced to the unified TMS scale with a Ξ ratio
of 10.136767.162 All HRESIMS data was obtained using either a PE Biosystem Mariner
5158 TOF mass spectrometer or a Micromass Q-TOF Premier mass spectrometer. Optical
rotations were recorded on a Perkin-Elmer 241 polarimeter.
MPLC and HPLC purifications were performed with a Rainin Dynamax SD-200 HPLC
system or a Varian SD-1 HPLC system. UV detection for HPLC runs was obtained with
a Varian Prostar 335 Diode Array detector. MPLC solvents were either HPLC grade
or glass-distilled prior to use. All solvents used in HPLC were HPLC grade. H2O
used for MPLC and HPLC was glass-distilled and deionised using a MilliQ system.
All solvent mixtures are reported as % vol in vol. Normal-phase HPLC was performed
using a custom-packed Phenomenex DIOL column [analytical (4 × 250 mm, 5 µm) or
semi-preperative (10 × 250 mm, 5 µm)]. Reversed-phase HPLC was performed using a
Phenomenex Prodigy C18 column [analytical (4.6 × 250 mm, 5 µm) or semi-preperative
(10 × 250 mm, 10 µm)]. TLC analysis were performed using Macherey-Nagal Alufoilen
SIL G/UV254 plates. TLC plates were visualised by one or more of (1) absorbance under
UV light (λ = 254 nm), (2) fluorescence under UV light (λ = 350 nm), (3) dipping in
5% H2SO4 in MeOH then heating, (3) dipping in 5% H2SO4 in MeOH then dipping
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in 0.1% vanillin in EtOH then heating. Reversed-phase chromatography on PSDVB
was performed using HP20 (Mitsubishi), HP20S or HP20SS (Supelco), or Amberchrom
CG-161M (Tosohaas). Normal-phase chromatography was performed using YMC S-50
gel DIOL or Kieselgel 60 (230-400 mesh ASTM). All solvents used for bench-top
chromatography were glass distilled. All reagents used were obtained commercially (at
least reagent grade) and distilled where necessary.
All red algae analysed in the study were identified by Dr. Joe Zuccarello, Senior Lecturer,
School of Biological Sciences, Victoria University of Wellington.
6.2 Isolation of Costatone from Plocamium costatum
The seaweed identified as Plocamium costatum was collected by hand using SCUBA
from Albert Reef, Doubtless Bay, New Zealand (34◦ 25.2′ S, 173◦ 31.2′ E) in December
2003. The sample was frozen immediately and kept at−18 ◦C until extraction. A voucher
specimen has been deposited at the School of Chemical and Physical Sciences, Victoria
University of Wellington, New Zealand.
P. costatum (126 g wet weight) was extracted for 18 h in 400 mL MeOH. The extract
was filtered and the algal material re-extracted for 18 h with a further 400 mL MeOH.
The extracts were combined and cyclic loaded∗ to 25% of the original volume on to a
reversed-phase PSDVB column (HP20, 160 mL). The column was successively eluted
with 500 mL volumes of H2O, 30% and 75% Me2CO in H2O and Me2CO. The 75%
Me2CO in H2O elution was backloaded on to a reversed-phase PSDVB column (HP20,
80 mL) and successively eluted with 300 mL volumes of H2O and MeOH. The MeOH
eluent was concentrated to dryness under reduced pressure to yield 1.1 g of material.
Approximately one tenth of this material was passed through a normal-phase column
(silica, 30 mL) eluted successively with 90 mL volumes of 20%, 30%, 40% and 50%
CH2Cl2 in pet. ether, CH2Cl2 and 50% MeOH in CH2Cl2. A total of 10 fractions were
collected. Fraction 4 (30% CH2Cl2 in pet. ether) was concentrated to dryness under
reduced pressure to yield costatone (44) (51 mg).
∗For a detailed discussion of cyclic loading, please see page 14.
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Costatone (44)
Amorphous white solid; [α]25D −48.0 (c 1.12, CH2Cl2); NMR data see Table B.1;
HRESIMS, obsd. m/z 390.8499 : 392.8437 : 394.8438 : 396.8445 : 398.8486 (9 : 24 : 22 :
8 : 1) [M − H]−, C10H11O2Br2Cl –2 requires 390.8508 : 392.8486 : 394.8463 : 396.8438 :
398.8415, ∆ 2.4 ppm.
6.3 Isolation of Indoles from Ballia callitricha
The seaweed identified as Ballia callitricha was collected by hand using SCUBA from
Owhiro Bay, Wellington, New Zealand in January 2005. The sample was frozen
immediately and kept at−18 ◦C until extraction. A voucher specimen has been deposited
at the School of Chemical and Physical Sciences, Victoria University of Wellington, New
Zealand.
B. callitricha (664 g wet weight) was extracted for 18 h in 2.5 L MeOH. The extract
was filtered and the algal material re-extracted for 18 h with a further 2.5 L MeOH. The
extracts were combined and cyclic loaded to 10% of the original volume on to a reversed-
phase PSDVB column (HP20, 400 mL). The column was eluted successively with 1.2 L
volumes of H2O, 20%, 40%, 60% and 80% Me2CO in H2O and Me2CO. The 40%
Me2CO in H2O elution was backloaded on to a reversed-phase PSDVB column (HP20,
150 mL) and eluted successively with 500 mL volumes of H2O and MeOH. The MeOH
eluent was concentrated to dryness under reduced pressure to yield 136 mg of material.
Approximately half (62 mg) of this material was passed through a normal-phase column
(silica, 25 mL) eluted successively with 100 mL volumes of 50% pet. ether in CH2Cl2,
CH2Cl2, 1%, 2%, 5%, 10% and 20% EtOAc in CH2Cl2 and 50% MeOH in CH2Cl2.
The 1% EtOAc in CH2Cl2 fraction was concentrated to dryness under reduced pressure.
The resulting material was passed through a normal phase column (DIOL, 10 mL) eluted
successively with 30 mL volumes of pet. ether, 10%, 25%, 50% and 75% CH2Cl2 in pet.
ether, CH2Cl2 and 50% MeOH in CH2Cl2. A total of 53 fractions were collected.
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Fractions 41-43 (75% CH2Cl2 in pet. ether to CH2Cl2) were combined and concentrated
to dryness under reduced pressure to yield 1H-indole-3-carboxaldehyde (45) (0.4 mg).
Fraction 53 was concentrated to dryness under reduced pressure. The resulting material
was separated on a semi-preparative C18 reversed-phase HPLC column with 50% CH3CN
in H2O as the mobile phase at a flow rate of 4.6 mL/min to yield (E)-N-formyl-3-(1H-
indol-3-yl)prop-2-enamide (46) (0.3 mg) with a retention time of 4.1 min.
1H-indole-3-carboxaldehyde (45)
Yellow oil; NMR data see Table B.2; HRESIMS, obsd. m/z 168.0424 [M + Na]+,
C9H7NONa
+ requires 168.0420, ∆ 2.4 ppm.
(E)-N-formyl-3-(1H-indol-3-yl)prop-2-enamide (46)
Amorphous yellow solid; NMR data see Table 2.1; HRESIMS, obsd. m/z 237.0634
[M + Na]+, C12H10N2O2Na
+ requires 237.0635, ∆ 0.2 ppm.
6.4 Isolation of Labillarides A to K from Phacelocarpus
labillardieri
Initial Extraction of P. labillardieri
The seaweed identified as Phacelocarpus labillardieri was collected by hand using
SCUBA from Rimariki Island, New Zealand (35◦ 25.2′ S, 174◦ 26.9′ E) in December
2003. The sample was frozen immediately and kept at−18 ◦C until extraction. A voucher
specimen has been deposited at the School of Chemical and Physical Sciences, Victoria
University of Wellington, New Zealand.
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P. labillardieri (98 g wet weight) was extracted for 18 h in 400 mL MeOH. The extract
was filtered and cyclic loaded on to a reversed-phase PSDVB column (HP20, 80 mL).
The column was eluted successively with 250 mL volumes of H2O, 30% and 75%
Me2CO in H2O and Me2CO. The 75% Me2CO in H2O elution was backloaded on to
a PSDVB column (HP20, 40 mL) and eluted successively with 150 mL volumes of H2O
and Me2CO. The Me2CO eluent was concentrated to dryness under reduced pressure
to yield 1.2 g of material. Approximately one sixth (200 mg) of this material was passed
through a normal phase column (DIOL, 30 mL) eluted successively with 100 mL volumes
of CH2Cl2, 1%, 2%, 5%, 10% and 50% EtOAc in CH2Cl2, and 50% MeOH in CH2Cl2.
A total of 47 fractions were collected. Fraction 2 (CH2Cl2) was concentrated to dryness
under reduced pressure and passed through a normal phase column (DIOL, 30 mL). The
column was eluted successively with 100 mL volumes of pet. ether, 10%, 25% and 50%
CH2Cl2 in pet. ether, CH2Cl2 and 50% MeOH in CH2Cl2. A total of 41 fractions were
collected. Fraction 31 (50% CH2Cl2 in pet. ether) was concentrated to dryness under
reduced pressure to yield labillaride C (62) (19.5 mg).
The remainder of the original Me2CO fraction was divided into six equal portions which
were each passed through a normal phase column (DIOL, 8 mL). The columns were
eluted with 30 mL of CH2Cl2, followed by 50 mL 50% MeOH in CH2Cl2. Two of
the CH2Cl2 fractions were combined and reduced to dryness under reduced pressure and
passed through a normal phase MPLC column (DIOL, 250 mL). The column was eluted
at a flow rate of 5 mL/min with pet. ether for 150 min, from pet. ether to 25% CH2Cl2 in
pet. ether at a solvent gradient of 25.0%/min, 25% CH2Cl2 in pet. ether for 149 min, from
25% CH2Cl2 in pet. ether to 50% CH2Cl2 in pet. ether at a solvent gradient of 25.0%/min,
50% CH2Cl2 in pet. ether for 149 min, from 50% CH2Cl2 in pet. ether to CH2Cl2 at a
solvent gradient of 50.0%/min, CH2Cl2 for 149 min, from CH2Cl2 to 50% CH2Cl2 in
EtOAc at a solvent gradient of 50%/min and 50% CH2Cl2 in EtOAc for 149 min. A total
of 22 fractions were collected over 750 min.
Fractions 17-18 (CH2Cl2 to 50% CH2Cl2 in EtOAc) were combined and concentrated to
dryness under reduced pressure. The resulting material was passed through a normal
phase column (DIOL, 30 mL) and the column was eluted successively with 100 mL
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volumes of 20%, 40%, 60% and 80% CH2Cl2 in pet. ether, CH2Cl2 and 50% MeOH in
CH2Cl2. A total of 75 fractions were collected. Fractions 14-18 (20% to 40% CH2Cl2 in
pet. ether) were combined and concentrated under reduced pressure to yield labillaride A
(60) (4.6 mg).
Fraction 19 (50% CH2Cl2 in EtOAc) was concentrated to dryness under reduced pressure
and the resulting material was passed through a normal phase column (DIOl, 250 mL).
The column was eluted at a flow rate of 5 mL/min with 70% CH2Cl2 in pet. ether for
200 min, from 70% CH2Cl2 in pet. ether to CH2Cl2 at a solvent gradient of 30.0%/min
and CH2Cl2 for 100 min. A total of 31 fractions were collected over 300 min. Fractions
29-31 (CH2Cl2) were combined and concentrated to dryness under reduced pressure
and the resulting material was passed through a normal phase column (DIOL, 30 mL).
The column was eluted successively with 100 mL volumes of 50% and 70% CH2Cl2 in
pet. ether, CH2Cl2 and 50% MeOH in CH2Cl2. A total of 44 fractions were collected.
Fractions 6-7 (50% CH2Cl2 in pet. ether) were combined and concentrated to dryness
under reduced pressure to yield labillaride A (60) (19.6 mg). Fractions 36-38 (CH2Cl2)
were combined and concentrated to dryness under reduced pressure to yield a mixture of
labillaride C (62) and labillaride D (63) (2.6 mg).
The 50% MeOH in CH2Cl2 fractions from the original six DIOL columns were combined
and concentrated to dryness under reduced pressure. The resulting material was divided
into two equal portions which were each passed through a normal phase column (DIOL,
30 mL). The columns were eluted successively with 30 mL volumes of CH2Cl2, 1%, 2%,
5%, 10% and 50% EtOAc in CH2Cl2 and 50% MeOH in CH2Cl2. A total of 81 fractions
were collected for each run.
Fractions 12-25 and 23-31 from each of the runs respectively were combined and
concentrated to dryness under reduced pressure. The resulting material was backloaded
on to 5 mL Amberchrom and the column was eluted successively with 15 mL volumes
of 20%, 30%, 40%, 50%, 60%, 70% and 80% MeOH in H2O, MeOH and Me2CO. The
80% MeOH in H2O fraction was concentrated to dryness under reduced pressure and
the resulting material was passed through a normal phase column (DIOL, 30 mL). The
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column was eluted successively with 90 mL volumes of CH2Cl2, 1%, 2%, 5%, 10%,
20% and 50% THF in CH2Cl2 and 50% MeOH in CH2Cl2. A total of 92 fractions were
collected. Fractions 27-35 (1-2% THF in CH2Cl2) were combined and concentrated to
dryness under reduced pressure. The resulting material was separated on an analytical
DIOL normal phase HPLC column with 7% IPA in hexanes as the mobile phase at a flow
rate of 1 mL/min to yield labillaride E (64) (1.6 mg) a retention time of 37.5 min.
Fractions 26-40 and 32-43 from each of the runs respectively were combined and
concentrated to dryness under reduced pressure. The resulting material was passed
through a normal phase column (DIOL, 30 mL) eluted successively with 90 mL volumes
of CH2Cl2, 1%, 2%, 5%, 10%, 20% and 50% THF in CH2Cl2 and 50% MeOH in CH2Cl2.
A total of 64 fractions were collected. Fractions 26-40 were combined and concentrated
to dryness under reduced pressure. The resulting material was cyclic loaded on to 1.5 mL
Amberchrom which was transferred to the top of a prepacked Amberchrom column (300
× 11 mm internal diameter). The column was eluted at a flow rate of 5 mL/min with
40% MeOH in H2O for 10 min, from 40% to 80% MeOH in H2O at a solvent gradient
of 0.67%/min, 80% MeOH in H2O for 10 min, from 80% MeOH in H2O to MeOH at
a solvent gradient of 2.00%/min and MeOH for 10 min. A total of 110 fractions were
collected at a rate of 5 mL/fraction. Fractions 76-85 were combined and concentrated to
dryness under reduced pressure. The resulting material was separated on an analytical
DIOL normal phase HPLC column with 7% IPA in hexanes as the mobile phase at a flow
rate of 1 mL/min to yield labillaride H (67) (1.2 mg) and a labillaride E (64) (0.4 mg) with
retention times of 33.2 and 36.0 min respectively.
Large-scale Extraction of P. labillardieri
The remainder of the collection of Phacelocarpus labillardieri screened above (268 g
wet weight) was extracted for 18 h in 2 L MeOH. The extract was filtered and the algal
material re-extracted for 18 h with a further 2 L MeOH. The second extract was filtered
and the algal material re-extracted for 18 h with a third 2 L MeOH. The extracts were
combined and cyclic loaded to 25% of the original volume on to a reversed-phase PSDVB
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column (HP20, 1 L). The column was eluted successively with 3 L volumes of H2O, 20%,
40%, 60% and 80% Me2CO in H2O and Me2CO. The 80% Me2CO in H2O elution was
backloaded on to a PSDVB column (HP20, 500 mL) and eluted successively with 1.5 L
volumes of H2O and Me2CO. The Me2CO eluent was concentrated to dryness under
reduced pressure and the material was passed through a normal phase column (DIOL,
250 mL). The column was eluted at a flow rate of 8 mL/min with CH2Cl2 for 110 mins,
from CH2Cl2 to 50% MeOH in CH2Cl2 at a solvent gradient of 50%/min, and 50% MeOH
in CH2Cl2 for 94 min. A total of five fractions were collected over 205 min. Fractions
3-4 (CH2Cl2) were combined and concentrated to dryness under reduced pressure and
the resulting material was passed through a normal phase column (DIOL, 250 mL). The
column was eluted at a flow rate of 16 mL/min with 25% CH2Cl2 in pet. ether for 36 mins,
from 25% CH2Cl2 in pet. ether to CH2Cl2 at a solvent gradient of 1%/min, and CH2Cl2
for 36 min. A total of 18 fractions of 128 mL were collected.
Fraction 2 (25% CH2Cl2 in pet. ether) was concentrated to dryness under reduced
pressure. The resulting material was passed through a normal phase column (DIOL,
30 mL) eluted successively with 100 mL volumes of 5% CH2Cl2 in pet. ether and CH2Cl2.
A total of 33 fractions were collected. Fractions 12-14 (25% CH2Cl2 in pet. ether) were
combined and concentrated to dryness under reduced pressure. The resulting material was
separated on an analytical DIOL normal phase HPLC column with 1% IPA in hexanes as
the mobile phase at a flow rate of 1 mL/min to yield labillaride B (61) (3.6 mg) and a
labillaride A (60) (1.5 mg) with retention times of 7.2 and 10.5 min respectively.
Fractions 4-5 were combined and concentrated to dryness under reduced pressure. The
resulting material was separated repeatedly on a semi-preparative DIOL normal phase
HPLC column with 10% IPA in hexanes as the mobile phase at a flow rate of 6.25 mL/min
to yield labillaride D (63) (7.6 mg) and a labillaride C (62) (53.0 mg) with retention times
of 10.2 and 11.7 min respectively.
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Second Large-scale Extraction of P. labillardieri
The seaweed identified as Phacelocarpus labillardieri was collected by hand using
SCUBA from Rimariki Island, New Zealand (35◦ 25.5′ S, 174◦ 26.9′ E) in November
2006. The sample was frozen immediately and kept at−18 ◦C until extraction. A voucher
specimen has been deposited at the School of Chemical and Physical Sciences, Victoria
University of Wellington, New Zealand.
P. labillardieri (245 g wet weight) was extracted for 18 h in 1.8 L MeOH. The extract
was filtered and the algal material re-extracted for 18 h with a further 1.8 L MeOH. The
extracts were combined and cyclic loaded to 25% of the original volume on to a reversed-
phase PSDVB column (HP20, 500 mL). The column was eluted successively with 2 L
volumes of H2O, 30% and 75% Me2CO in H2O and Me2CO. The 75% Me2CO in H2O
elution was backloaded on to a PSDVB column (HP20, 240 mL) and eluted successively
with 750 mL volumes of H2O and Me2CO. The Me2CO eluent was concentrated to
dryness under reduced pressure and the resulting material was passed through a normal
phase column (DIOL, 250 mL). The column was eluted at a flow rate of 4.5 mL/min
with CH2Cl2 for 220 mins, from CH2Cl2 to 50% MeOH in CH2Cl2 at a solvent gradient
of 10%/min, and 50% MeOH in CH2Cl2 for 220 min. A total of eight fractions were
collected over 445 min.
Fraction 1 (CH2Cl2) was concentrated to dryness under reduced pressure to yield 268 mg
of material of which approximately one fifth was passed through a normal phase column
(DIOL, 25 mL). The column was eluted at a flow rate of 3 mL/min with pet. ether for
8 min, from pet. ether to 5% CH2Cl2 in pet. ether at a solvent gradient of 0.12%/min, 5%
CH2Cl2 in pet. ether for 17 min, from 5% CH2Cl2 in pet. ether to CH2Cl2 at a solvent
gradient of 11.9%/min, and CH2Cl2 for 25 min. A total of 62 fractions were collected
over 100 min. Fraction 6 was concentrated to dryness under reduced pressure. The
resulting material was separated on an analytical C18 reversed-phase HPLC column with
90% MeCN in H2O as the mobile phase at a flow rate of 1 mL/min to yield labillaride J
(69) (2.0 mg) with a retention time of 17.3 min. Fractions 7-10 were combined and
concentrated to dryness under reduced pressure to yield labillaride I (68) (9.1 mg).
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Fractions 33-37 were combined and concentrated to dryness under reduced pressure to
yield labillaride B (61) (2.9 mg).
The remainder of the original fraction 1 was divided into four equal portions which were
each passed through a normal phase column (DIOL, 25 mL). The first column was eluted
at a flow rate of 3 mL/min with pet. ether for 100 min, from pet. ether to 10% CH2Cl2 in
pet. ether at a solvent gradient of 0.15%/min, 10% CH2Cl2 in pet. ether for 16 min, from
10% CH2Cl2 in pet. ether to CH2Cl2 at a solvent gradient of 5.63%/min, and CH2Cl2
for 25 min. The second and third columns were eluted at a flow rate of 3 mL/min with
pet. ether for 16 mins, from pet. ether to 10% CH2Cl2 in pet. ether at a solvent gradient
of 0.15%/min, 10% CH2Cl2 in pet. ether for 16 min, from 10% CH2Cl2 in pet. ether to
CH2Cl2 at a solvent gradient of 5.63%/min, and CH2Cl2 for 25 min. The fourth column
was eluted at a flow rate of 2 mL/min with pet. ether for 24 mins, from pet. ether to 10%
CH2Cl2 in pet. ether at a solvent gradient of 0.10%/min, 10% CH2Cl2 in pet. ether for
24 min, from 10% CH2Cl2 in pet. ether to CH2Cl2 at a solvent gradient of 3.75%/min,
and CH2Cl2 for 38 min. A total of 133, 86, 99 and 86 fractions for each run respectively
were collected at a rate of 5 mL/fraction.
Fractions 11-18, 12-23, 12-23 and 13-24 (pet. ether, 0.6% to 3.3%, 0.6% to 3.3% and
0.9% to 3.6% CH2Cl2 in pet. ether respectively) from each of the runs respectively were
combined and concentrated to dryness under reduced pressure to yield labillaride I (68)
(33.7 mg).
Fractions 86-93, 49-61, 50-61 and 50-60 (5.6% to 7.3%, 9.4% to 10.0%, 9.6% to 10.0%
and 9.9% to 10.0% CH2Cl2 in pet. ether respectively) from each of the runs respectively
were combined and concentrated to dryness under reduced pressure. The resulting
material was separated repeatedly on a semi-preparative DIOL normal phase HPLC
column with 2% Me2CO in hexanes as the mobile phase at a flow rate of 6.25 mL/min to
yield labillaride K (70) (0.4 mg) with a retention time of 13.9 min.
Fractions 110-133, 67-86, 70-99 and 67-86 (55.0% to 100%, 50.5% to 100%, 77.6%
to 100% and 75.6% to 100% CH2Cl2 in pet. ether respectively) from each of the runs
respectively were combined and concentrated to dryness under reduced pressure. The
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resulting material was passed through a normal phase column (DIOL, 5 mL) eluted
successively with 100 mL volumes of 5% CH2Cl2 in pet. ether and CH2Cl2. The 5%
CH2Cl2 in pet. ether fraction was concentrated to dryness under reduced pressure and was
separated repeatedly on a semi-preparative DIOL normal phase HPLC column with 1%
IPA in hexanes as the mobile phase at a flow rate of 6.25 mL/min to yield labillaride A
(60) (0.8 mg) with a retention time of 10.6 min.
Fractions 3 and 4 (CH2Cl2 to 50% MeOH in CH2Cl2) of the original DIOL column were
combined and reduced to dryness under reduced pressure to yield 1.3 g of material of
which approximately one quarter was passed through a normal phase column (DIOL,
250 mL). The column was eluted at a flow rate of 10 mL/min with 10% IPA in pet. ether
for 100 min. A total of two fractions were collected over 100 min. Fraction 2 with a
retention time of 46 to 86 min was separated on a semi-preperative DIOL normal phase
HPLC column with 5% IPA in hexanes as the mobile phase at a flow rate of 6.25 mL/min
to yield labillaride C (62) (69.6 mg) and a mixture of labillaride C (62) and labillaride D
(63) with retention times of 17.1 and 14.6 min respectively. The mixture was separated
repeatedly on a semi-preperative DIOL normal phase HPLC column with 10% IPA in
hexanes as the mobile phase at a flow rate of 6.25 mL/min to yield labillaride D (63)
(3.2 mg) with a retention time of 7.9 min.
Fraction 7 (50% MeOH in CH2Cl2) of the original DIOL column was divided into four
equal portions which were each passed through a normal phase column (DIOL, 25 mL).
The columns were eluted successively with 100 mL volumes of CH2Cl2, 2% and 10%
EtOAc in CH2Cl2 and 50% MeOH in CH2Cl2. The 2% EtOAc in CH2Cl2 fractions were
combined and concentrated to dryness under reduced pressure. The resulting material
was separated on a semi-preparative DIOL normal phase HPLC column with 10% IPA in
hexanes as the mobile phase at a flow rate of 6.25 mL/min. A total of four fractions were
collected over 20 min. Fraction 4 with a retention time of 13.8 to 15.3 min was separated
on an analytical DIOL normal phase HPLC column with 7% IPA in hexanes as the mobile
phase at a flow rate of 1 mL/min to yield labillaride F (65) (0.5 mg) and labillaride G (66)
(0.4 mg) with retention times of 26.7 and 28.0 min respectively.
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Ethanol Extraction of P. labillardieri
Phacelocarpus labillardieri (24 g wet weight) was extracted for 18 h in 150 mL EtOH.
The extract was filtered and the algal material re-extracted for 18 h with a further 150 mL
EtOH. The extracts were combined and cyclic loaded to 25% of the original volume on
to a reversed-phase PSDVB column (HP20, 20 mL). The column was eluted successively
with 60 mL volumes of H2O, 30% and 75% Me2CO in H2O and Me2CO. The 75%
Me2CO in H2O elution was backloaded on to a reversed-phase PSDVB column (HP20,
20 mL) and eluted successively with 100 mL volumes of H2O and Me2CO. The Me2CO
eluent was concentrated to dryness under reduced pressure and the resulting material was
passed through a normal phase column (DIOL, 25 mL). The column was eluted at a flow
rate of 5 mL/min with CH2Cl2 for 20 mins, from CH2Cl2 to 50% EtOH in CH2Cl2 at a
solvent gradient of 10%/min, and 50% EtOH in CH2Cl2 for 20 min. A total of 10 fractions
were collected over 45 min.
Fraction 1 (CH2Cl2) was concentrated to dryness under reduced pressure and the resulting
material was passed through a normal phase column (DIOL, 25 mL). The column was
eluted at a flow rate of 5 mL/min with pet. ether for 5 min, from pet. ether to 5% CH2Cl2
in pet. ether at a solvent gradient of 0.17%/min, 5% CH2Cl2 in pet. ether for 10 min, from
5% CH2Cl2 in pet. ether to CH2Cl2 at a solvent gradient of 19.0%/min, and CH2Cl2 for
15 min. A total of 69 fractions were collected over 65 min. No labillaride I (68), or its
ethyl ester equivalent, was detected.
Acetylation of Labillaride H (67) to 3,8-Diacetyl-labillaride H (73)
A solution of 67 (100 µg, 0.3 µmol) in 500 µL of freshly distilled Ac2O and 500 µL
of freshly distilled pyridine was stirred under argon at RT overnight. The reaction
was quenched with H2O (1 mL) and the resulting mixture was cyclic loaded on to
2 mL Amberchrom and eluted with 100 mL H2O, followed by 10 mL Me2CO. The
Me2CO fraction was concentrated to dryness under reduced pressure to yield 3,8-diacetyl-
labillaride H (73) (0.1 mg).
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Attempted Preparation of Mosher’s esters of Labillarides E (64) and
H (67)
To a solution of 64 or 67 (150 µg, 0.4 µmol) in 1 mL 0.02 M DMAP in CH2Cl2 (0.6 mg,
24.5 µmol), either (R)- or (S)-MPTACl (1.5 µL, 8.1 µmol) was added under argon and the
mixture stirred at RT overnight. The reaction mixture was concentrated to dryness under
reduced pressure, then 1 mL Me2CO added and the reaction was quenched with 1mL of
H2O. The resulting mixture was cyclic loaded on to 2 mL Amberchrom and washed with
10 mL of 1 M HCl, 1 M NaOH, and finally brine. The column was then eluted with 6 mL
Me2CO and this fraction was concentrated to dryness under reduced pressure. The NMR
spectra of reaction products showed complex mixtures of several products which, due to
the small sample mass, was too complex to interpret.
Labillaride A (60)
Colourless oil; [α]25D −15.4 (c 0.07, MeOH); UV (hexanes) λmax 236 nm, 290 nm;
NMR data see Table 3.3; HRESIMS, obsd. m/z 343.2280 [M + H]+, C22H31O3 requires
343.2268, ∆ 3.6 ppm.
Labillaride B (61)
Colourless oil; UV (hexanes) λmax 290 nm; NMR data see Table 3.5; HRESIMS, obsd.
m/z 423.1522 : 425.1503 (1 : 1) [M + H]+, C22H32O3Br
+ requires 423.1529 : 425.1512,
∆ 1.7 ppm.
Labillaride C (62)
Colourless oil; [α]25D +268.0 (c 0.10, MeOH); UV (hexanes) λmax 295 nm; NMR data
see Table 3.6; HRESIMS, obsd. m/z 343.2259 [M + H]+, C22H31O3 requires 343.2268, ∆
2.7 ppm.
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Labillaride D (63)
Colourless oil; [α]25D −93.0 (c 0.31, MeOH); UV (hexanes) λmax 295 nm; NMR data see
Table 3.7; HRESIMS, obsd. m/z 365.2093 [M + Na]+, C22H30O3Na requires 365.2093,∆
0.0 ppm.
Labillaride E (64)
Colourless oil; [α]25D +135.2 (c 0.04, MeOH); UV (hexanes) λmax 300 nm; NMR data see
Tables 3.9 (CDCl3) and 3.10 (C6D6); HRESIMS, obsd. m/z 375.2163 [M + H]
+, C22H31O5
requires 375.2166, ∆ 0.7 ppm, obsd. m/z 397.2005 [M + Na]+, C22H30O5Na requires
397.1986, ∆ 4.8 ppm.
Labillaride F (65)
Colourless oil; [α]25D +111.7 (c 0.04, MeOH); UV (hexanes) λmax 300 nm; NMR data see
Table 3.11; HRESIMS, obsd. m/z 375.2162 [M + H]+, C22H31O5 requires 375.2166, ∆
1.2 ppm, obsd. m/z 397.1990 [M + Na]+, C22H30O5Na requires 397.1986, ∆ 1.1 ppm.
Labillaride G (66)
Colourless oil; [α]25D +99.7 (c 0.03, MeOH); UV (hexanes) λmax 300 nm; NMR data see
Table 3.12; HRESIMS, obsd. m/z 375.2158 [M + H]+, C22H31O5 requires 375.2166, ∆
2.1 ppm, obsd. m/z 397.1986 [M + Na]+, C22H30O5Na requires 397.1986, ∆ 0.2 ppm.
Labillaride H (67)
Colourless oil; [α]25D +93.5 (c 0.10, MeOH); UV (hexanes) λmax 300 nm; NMR data see
Table 3.13; HRESIMS, obsd. m/z 397.1991 [M + Na]+, C22H30O5Na requires 397.1991,
∆ 0.0 ppm.
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Labillaride I (68)
Colourless oil; [α]25D −7.3 (c 0.79, MeOH); UV (pet. ether) λmax 280 nm; NMR data see
Table 3.16; HRESIMS, obsd. m/z 375.2531 [M + H]+, C23H35O
+
4 requires 375.2530, ∆
0.4 ppm.
Labillaride J (69)
Colourless oil; [α]25D −55.3 (c 0.19, MeOH); UV (CH3CN) λmax 278 nm; NMR data see
Table 3.17; HRESIMS, obsd. m/z 317.2470 [M + H]+, C21H33O
+
2 requires 317.2475, ∆
1.5 ppm.
Labillaride K (70)
Colourless oil; [α]25D −15.4 (c 0.03, MeOH); UV (hexanes) λmax 237 nm, 300 nm;
NMR data see Table 3.19; HRESIMS, obsd. m/z 317.2489 [M + H]+, C21H33O
+
2 requires
317.2475, ∆ 4.5 ppm, obsd. m/z 339.2298 [M + Na]+, C21H32O2Na
+ requires 339.2295,
∆ 1.1 ppm.
Degradation product (75)
Colourless oil; UV (hexanes) λmax 280 nm; NMR data see Table 3.20; HRESIMS, obsd.
m/z 353.2087 [M + Na]+, C21H30O3Na
+ requires 353.2087, ∆ 0.1 ppm.
6.5 Isolation of Bromophenols from Osmundaria colensoi
The seaweed identified as Osmundaria colensoi was collected by hand using SCUBA
from Taheke Reef, Cavalli Island, New Zealand (34◦ 57.8′ S, 173◦ 59.0′ E) in December
2003, and Rimariki Island and Cape Brett, New Zealand (35◦ 25.4′ S, 174◦ 26.9′ E)
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in November 2006. The samples were frozen immediately and kept at −18 ◦C until
extraction. A voucher specimen has been deposited at the School of Chemical and
Physical Sciences, Victoria University of Wellington, New Zealand.
O. colensoi (496 g wet weight) was extracted for 18 h in 2.5 L MeOH. The extract was
filtered and the algal material re-extracted for 18 h with a further 2.5 L MeOH. The
extracts were combined and cyclic loaded to 10% of the original volume on to a reversed-
phase PSDVB column (HP20, 400 mL). The column was eluted successively with 1.2 L
volumes of H2O, 20%, 40%, 60% and 80% Me2CO in H2O and Me2CO. The 40% Me2CO
in H2O elution was backloaded on to a reversed-phase PSDVB column (HP20, 160 mL)
and eluted successively with 500 mL volumes of H2O and MeOH. The MeOH eluent was
concentrated to dryness under reduced pressure to yield 860 mg of material. The resulting
material was triturated in MeOH (80 mL) and the soluble fraction was cyclic loaded on to
20 mL of HP20SS which was transferred to the top of a reversed-phase PSDVB column
(HP20S, 250 mL). The column was eluted at a flow rate of 10 mL/min with 40% MeOH
in H2O for 55 mins, from 40% to 80% MeOH in H2O at a solvent gradient of 0.32%/min,
80% MeOH in H2O for 50 mins, from 80% MeOH in H2O to MeOH at a solvent gradient
of 0.4%/min, and MeOH for 80 min. A total of 43 fractions were collected over 360 min.
Fractions 5-11 (47% to 64% MeOH in H2O) were combined and backloaded on to a
reversed-phase PSDVB column (HP20SS, 20 mL) and eluted successively with 100 mL
volumes of H2O and MeOH. The MeOH eluent was concentrated to dryness under
reduced pressure. The resulting material was separated on an analytical C18 reversed-
phase HPLC column with 50% MeOH in 0.1 M HCOOH as the mobile phase at a flow
rate of 1 mL/min to yield rhodomelol (122) (1.8 mg) with a retention time of 4.9 min
Fractions 12-16 (64% to 76% MeOH in H2O) were combined and backloaded on
to a reversed-phase PSDVB column (HP20SS, 20 mL) and eluted successively with
100 mL volumes of H2O and MeOH. The MeOH eluent was concentrated to dryness
under reduced pressure. The resulting material was separated on a semi-preparative C18
reversed-phase HPLC column with 60% MeOH in 0.2 M HCOOH as the mobile phase at
a flow rate of 5 mL/min. A total of five fractions were collected over 15 min. Fraction 4
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with a retention time of 4.6 min was backloaded on to a reversed-phase PSDVB column
(Amberchrom, 2 mL) and eluted with 50 mL of H2O, followed by 10 mL of MeOH. The
MeOH eluent was concentrated to dryness under reduced pressure to yield lanosol (110)
(46.3 mg). Fractions 1-2 with retention times 0 to 2.9 and 2.9 to 3.3 min respectively
were combined and backloaded on to a reversed-phase PSDVB column (Amberchrom,
2 mL) and eluted with 50 mL H2O, followed by 10 mL of MeOH. The MeOH eluent was
concentrated to dryness under reduced pressure. The resulting material was separated
on a semi-preparative C18 reversed-phase HPLC column with 50% MeOH in 0.2 M
HCOOH as the mobile phase at a flow rate of 4.75 mL/min. A total of four fractions
were collected over 12.5 min. Fraction 2 with a retention time of 4.0 min was backloaded
on to a reversed-phase PSDVB column (Amberchrom, 2 mL) and eluted with 50 mL
H2O, followed by 10 mL of MeOH. The MeOH eluent was concentrated to dryness under
reduced pressure and the resulting material was combined with a subsequent fraction as
described below.
Fractions 17-20 (76% to 80% MeOH in H2O) were combined and backloaded on
to a reversed-phase PSDVB column (HP20SS, 20 mL) and eluted successively with
100 mL volumes of H2O and MeOH. The MeOH eluent was concentrated to dryness
under reduced pressure. The resulting material was separated on a semi-preparative C18
reversed-phase HPLC column with 60% MeOH in 0.2 M HCOOH as the mobile phase at
a flow rate of 5 mL/min. A total of four fractions were collected over 15 min.
Fraction 1 with a retention time of 0 to 7.5 min was backloaded on to a reversed-phase
PSDVB column (Amberchrom, 2 mL) and eluted with 50 mL H2O, followed by 10 mL of
MeOH. The MeOH eluent was concentrated to dryness under reduced pressure. The
resulting material was separated repeatedly on a semi-preparative C18 reversed-phase
HPLC column with 50% MeOH in 0.2 M HCOOH as the mobile phase at a flow rate
of 4.75 mL/min. A total of six fractions were collected over 15 min. Fraction 2 with
a retention time of 4.9 min was backloaded on to a reversed-phase PSDVB column
(Amberchrom, 2 mL) and eluted with 50 mL H2O, followed by 10 mL of MeOH. The
MeOH eluent was concentrated to dryness under reduced pressure. The resulting material
was combined with the fraction detailed above and was separated on a semi-preparative
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C18 reversed-phase HPLC column with 40% MeOH in 0.2 M HCOOH as the mobile
phase at a flow rate of 4.75 mL/min to yield colensolide A (124) (3.5 mg) with a retention
time of 5.4 min.
Fraction 3 with a retention time of 9.6 to 10.3 min was backloaded on to a reversed-phase
PSDVB column (Amberchrom, 2 mL) and eluted with 50 mL H2O, followed by 10 mL
of MeOH. The MeOH eluent was concentrated to dryness under reduced pressure. The
resulting material was separated on a semi-preparative C18 reversed-phase HPLC column
with 60% MeOH in 0.2 M HCOOH as the mobile phase at a flow rate of 5 mL/min to
yield 2,3-dibromo-4,5-dihydroxybenzyl methyl ether (114) (1.5 mg) and 2,3-dibromo-
4,5-dihydroxybenzaldehyde (120) (1.4 mg) with retention times of 10.1 and 11.1 min
respectively.
Fractions 26-30 (82% to 97% MeOH in H2O) of the original HP20S column were
combined and backloaded on to a reversed-phase PSDVB column (HP20SS, 20 mL) and
eluted successively with 100 mL volumes of H2O and MeOH. The MeOH eluent was
concentrated to dryness under reduced pressure. The resulting material was separated
on a semi-preparative DIOL normal phase HPLC column with 20% IPA in hexanes
as the mobile phase at a flow rate of 5 mL/min to yield (3E)-4-(2,3-dibromo-4,5-
dihydroxyphenyl)-3-butene-2-one (121) (4.6 mg) with a retention time of 7.5 min.
Acidification of colensolide A (124)
To a sample of 124 (1.7 mg, 3.9 µmol) in CD3OD (250 µL) in a 3 mm NMR tube, TFA
(0.5 µL, 6.7 µmol) was added to yield acidified colensolide A (125) (1.7 mg).
Methylation of Colensolide A (124) to 5-O-Methylcolensolide A (126)
To a sample of 124 (1.1 mg, 2.5 µmol) in 500 µL of dry CH3CN, 2.0 M TMSCHN2 in
diethyl ether (50 µL, 100 µmol) was added. The reaction was left to stir under argon
at RT for 45 min and then quenched with 2% AcOH (2 mL) and left overnight. The
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resulting mixture was cyclic loaded on to 2 mL Amberchrom and eluted with 100 mL
H2O, followed by 10 mL aliquots of 20%, 40%, 60% and 80% Me2CO in H2O and
Me2CO. The 80% Me2CO in H2O fraction was concentrated to dryness under reduced
pressure to yield 5-O-methylcolensolide A (126) (0.7 mg).
Methylation of 5-O-Methylcolensolide A (126) to 4,5-Di-O-methyl-
colensolide A (127)
To a sample of 126 (0.7 mg, 1.6 µmol) in 500 µL of dry CH3CN with K2CO3 (2.1 mg,
15.2 µmol), MeI (10 µL, 160.6 µmol) was added. The reaction was left to stir under
argon at RT for 24 h and then quenched with H2O (2 mL). The resulting mixture was
cyclic loaded on to 2 mL Amberchrom and eluted with 100 mL H2O, followed by 10 mL
MeOH. The MeOH fraction was concentrated to dryness under reduced pressure and the
resulting material was separated on a analytical DIOL normal phase HPLC column with
20% IPA in hexanes as the mobile phase at a flow rate of 1 mL/min to yield 4,5-di-O-
methylcolensolide A (127) (0.2 mg) with a retention time of 7.7 min.
Lanosol (110)
Amorphous brown solid; NMR data see Tables B.3 (CD3OD) and B.4 ((CD3)2CO);
HRESIMS, obsd. m/z 278.8646 : 280.8626 : 282.8600 (1 : 2 : 1) [M − H2O + H]+,
C7H5O2Br
+
2 requires 278.8651 : 280.8631 : 282.8611, ∆ 1.6 ppm.
2,3-Dibromo-4,5-dihydroxybenzyl methyl ether (114)
Yellow oil; NMR data see Tables B.5 (CD3OD) and B.6 ((CD3)2CO).
2,3-Dibromo-4,5-dihydroxybenzaldehyde (120)
Yellow oil; NMR data see Tables B.7 (CD3OD) and B.8 ((CD3)2CO).
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(3E)-4-(2,3-Dibromo-4,5-dihydroxyphenyl)-3-butene-2-one (121)
Yellow amorphous solid; NMR data see Tables 4.2 (CD3OD) and 4.3 ((CD3)2CO).
Rhodomelol (122)
Brown oil; NMR data see Tables 4.4 (CD3OD) and 4.5 ((CD3)2CO).
Colensolide A (124)
Yellow oil; [α]25D −2 to −6 (c 0.35, MeOH); UV (MeOH) λmax 293 nm; NMR data see
Tables 4.8 (CD3OD) and 4.9 (d6-DMSO); HRESIMS, obsd. m/z 417.9386 : 419.9374 :
421.9368 (1 : 2 : 1) [M − H2O + H]+, C13H14N3O3Br+2 requires 417.9396 : 419.9377 :
421.9358, ∆ 2.6 ppm, obsd. m/z 435.9496 : 437.9468 : 439.9474 (1 : 2 : 1) [M + H]+,
C13H16N3O4Br
+
2 requires 435.9502 : 437.9482 : 439.9464, ∆ 1.5 ppm.
5-O-Methylcolensolide A (126)
Colourless oil; NMR data see Table 4.11; HRESIMS, obsd. m/z 449.9666 : 451.9641 :
453.9628 (1 : 2 : 1) [M + H]+, C14H18N3O4Br
+
2 requires 449.9659 : 451.9639 : 453.9621,
∆ 1.7 ppm.
4,5-Di-O-methyloxycolensolide A (127)
Colourless oil; NMR data see Table 4.12; HRESIMS, obsd. m/z 463.9824 : 465.9803 :
467.9762 (1 : 2 : 1) [M + H]+, C15H20N3O4Br
+
2 requires 463.9821 : 465.9801 : 467.9783,
∆ 0.6 ppm.
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Appendix A
Existing Sponge Screening Protocol∗
Preparation
Equipment Needed (per Screen)
• 1 x Screen column loaded with 80 mL of HP20 equilibrated in distilled MeOH
• 1 x Backloading column loaded with 40 mL of HP20 equilibrated in distilled MeOH
NMR Standard
Prepare a standard of 1,3,5-tribromobenzene in CDCl3 by dissolving 78.9 mg of 1,3,5-
tribromobenzene in 5 mL of CDCl3.
Procedure
1. Voucher Sample Preparation
• Take a voucher specimen of ca. 10 g of sponge material ensuring that both the
ectoderm and the endoderm are represented.
• Label and store the voucher sample in 75% IPA in H2O.
2. Extraction
• Extract ca. 100 g of sponge material in 400 mL of distilled MeOH overnight.
• Filter the first extract and set aside. Re-extract the sponge material (and any
filter paper/celite as necessary) in 400 mL of distilled MeOH overnight.
∗Last updated: 13/11/06
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• Filter the second extract.
• Keep all sponge material (and any filter paper/celite as necessary) until the
screen is complete at which time it may be discarded.
3. Cyclic Loading
• Pass the second extract through the screen column with a flow rate of ca.
10 mL/min.
• Pass the first extract through the screen column with a flow rate of ca.
10 mL/min. Combine the eluent with that of the second extract.
• Dilute the combined eluents with 800 mL of distilled H2O. Pass the diluted
eluents back through the screen column at a flow rate of ca. 10 mL/min.
• Dilute the eluent with 1.6 L of distilled H2O. Pass the diluted eluent back
through the screen column at a flow rate of ca. 10 mL/min.
• The eluent should be kept until the screen is complete at which time it may be
discarded.
4. Elution
• Elute the screen column with 250 mL of distilled H2O at a flow rate of ca.
10 mL/min. The H2O eluent can be discarded immediately.
• Elute the screen column with 250 mL of 30% distilled Me2CO in distilled
H2O (75 mL Me2CO to 175 mL H2O) at a flow rate of ca. 10 mL/min.
• Elute the screen column with 250 mL of 75% distilled Me2CO in distilled
H2O (187.5 mL Me2CO to 62.5 mL H2O) at a flow rate of ca. 10 mL/min.
• Elute the screen column with 250 mL of distilled Me2CO at a flow rate of ca.
10 mL/min.
5. Backloading the 75% Acetone Fraction
• Dilute the 75% Me2CO fraction with 250 mL of distilled H2O. Pass the diluted
eluent through the backloading column at a flow rate of ca. 8 mL/min.
• Dilute the eluent with 500 mL of distilled H2O. Pass the diluted eluent back
through the backloading column at a flow rate of ca. 8 mL/min.
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• The eluent should be kept until the screen is complete at which time it may be
discarded.
• Elute the backloading column with 150 mL of distilled Me2CO.
6. Processing the 75% Acetone Fraction
• Evaporate the Me2CO eluent of the backloading column to dryness and
transfer to a pre-weighed sample vial. Evaporate to dryness and record the
mass.
• Sub-sample approximately 30 mg of material for NMR analysis if necessary.
• Prepare an NMR sample in ca. 700 µL of CD3OD in a 5 mm NMR tube.
• Add 10 µL of the 1,3,5-tribromobenzene standard (representing 507 nmol of
1,3,5-tribromobenzene) to the NMR tube.
7. NMR Analysis of the 75% Acetone Fraction
• Run a 1H spectrum of the sample on the 600 MHz instrument using the
standard Screen1H parameter set. (Experiment time: ca. 4 min)
• Make a note “Standard Added” in the sample text.
• Run a COSY spectrum of the sample using the standard ScreenCOSY
parameter set. (Experiment time: ca. 20 min)
• Run an HSQC spectrum of the sample using the standard ScreenHSQC
parameter set. (Experiment time: ca. 4 h)
• Process appropriately and export HSQC phasefile.
• Add HSQC phasefile to HSQC mask.
• Apply HSQC mask to HSQC phasefile.
8. Assigning Hit Values to the Screen
• Threshold set at 3%.
• Signal strength
– An arbitrary value indicating how the strength of the interesting peaks.
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– Weak – 1. Medium – 2. Strong – 3 (remember to consider the sub-
sampling factor if necessary).
• Number of interesting peaks
– Indicates how many red peaks in the HSQC. Something exhibiting more
than 20 non-masked peaks will score a 10.
• Uniqueness of interesting peaks
– An arbitrary value indicating whether non-masked peaks represent some-
thing interesting (1-10).
• Available mass
– The total mass of the available sponge material (including that used for
the screen) in kg is multiplied by 10 and rounded to the nearest integer. If
more than 1 kg of sponge material is available the score is 10.
• Recollectability
– Collected locally – 3. Collected from Northland – 2. Other – 1.
• Sum all 5 hit values. A score of 20 would be considered average.
9. Backloading the 30% Acetone Fraction
• Dilute the 30% Me2CO fraction with 250 mL of distilled H2O. Pass the diluted
eluent through the backloading column at a flow rate of ca. 8 mL/min.
• Dilute the eluent with 500 mL of distilled H2O. Pass the diluted eluent back
through the backloading column at a flow rate of ca. 8 mL/min.
• The eluent should be kept until the screen is complete at which time it may be
discarded.
• Elute the backloading column with 150 mL of distilled MeOH.
10. Processing the 30% Acetone Fraction
• Evaporate the MeOH eluent of the backloading column to dryness and transfer
to a pre-weighed sample vial. Evaporate to dryness and record the mass.
• Sub-sample approximately 30 mg of material for NMR analysis if necessary.
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• Prepare an NMR sample in ca. 700 µL of CD3OD in a 5 mm NMR tube.
11. NMR Analysis of the 30% Acetone Fraction
• Run a 1H spectrum of the sample on the 600 MHz instrument using the
standard Screen1H parameter set. (Experiment time: ca. 4 min)
12. Processing the 100% Acetone Fraction
• Evaporate the Me2CO eluent of the screen column to dryness and transfer to
a pre-weighed sample vial. Evaporate to dryness and the record mass.
• Sub-sample approximately 30 mg of material for NMR analysis if necessary.
• Prepare an NMR sample in ca. 700 µL of CDCl3 in a 5 mm NMR tube.
13. NMR Analysis of the 100% Acetone Fraction
• Run a 1H spectrum of the sample on the 600 MHz instrument using the
standard Screen1H parameter set. (Experiment time: ca. 4 min)
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Standard NMR Parameter Sets for Screening
Screen1H (Standard Pulse-acquire)
Acquisition: acquisition delay 10 ms
nutation angle 60◦
acquisition time 4 s (38462 complex points)
steady-state scans none
number of transients 64
temperature 20 ◦C
spectral width 14 ppm to −2 ppm
total time ca. 4 min
Processing: fourier number 65536 complex points
weighting none
ScreenCOSY (Absolute Value Gradient COSY)
Acquisition: acquisition delay 2 s
gradient strength 10 Gcm−1
gradient duration 1 ms
gradient stabilisation delay 500 µs
number of increments 512
acquisition time 213 ms (1153 complex points)
steady state scans 16
number of transients 1
temperature 20 ◦C
spectral width (F2 & F1) 9 ppm to 0 ppm
total time ca. 20 min
Processing: fourier number (F2 & F1) 2048 complex points
weighting (F2 & F1) sinebell
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ScreenHSQC (Adiabatic Gradient-enhanced HSQC)
Acquisition: steady-state gradient strength 13 Gcm−1
steady-state gradient duration 2 ms
acquisition delay 1.5 s
TANGO gradient strength 10 Gcm−1
TANGO gradient duration 2 ms
adiabatic sweep pulse bandwidth 300 ppm
encoding gradient strength 10 Gcm−1
encoding gradient time 4 ms
decoding gradient strength −6 Gcm−1
decoding gradient time 2.4 ms
number of increments 512
acquisition time 213 ms (1153 complex points)
broadband 13C decoupling shape WURST40
broadband 13C decoupling bandwidth 200 ppm
steady state scans 64
number of transients 8
temperature 20 ◦C
spectral width in F2 9 ppm to 0 ppm
spectral width in F1 160 ppm to 0 ppm
1JCH selection 140 Hz
total time ca. 4 h
Processing: fourier number in F2 2048 complex points
fourier number in F1 1024 complex points
weighting (F2 & F1) gaussian
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Appendix B
NMR Data for the Known Compounds
Costatone
Table B.1. 13C (150 MHz) and 1H (600 MHz) NMR data (CDCl3) for costatone (44).
13C 1H HMBC
Pos δ (ppm) mult 1JCH (Hz) δ (ppm) mult J (Hz) COSY (1H to 13C)
O
2
3
4
5
6
7
1
HO
Br
10 8
Cl
Cl
9Br
b
a
44
1 51.7 CH 176 5.81 s 2,3,6
2 97.1 C
OH 3.17 s 1,2,3,4
3 125.7 C
4 132.2 C
5a 35.1 CH2
137 2.61 ddq 17.0,11.6,2.5 5b,6,9 3,4,6,7
5b 134 2.36 dq 16.9,1.6 5a,6,9 3,4
6 67.7 CH 150 5.22 ddq 11.2,3.3 5a,5b 2,4,5,7,8,10
7 137.2 C
8 113.5 CH 201 5.90 br.s 10 6,7,10
9 14.0 CH3 125 1.89 m 5a,5b 2,3,4
10 16.2 CH3 128 1.87 m 8 6,7,8
1H-Indole-3-carboxaldehyde
Table B.2. 13C (150 MHz) and 1H (600 MHz) NMR data (CDCl3) for
1H-indole-3-carboxaldehyde (45).
13C or 15N 1H HMBC
Pos δ (ppm) mult δ (ppm) mult J (Hz) COSY (1H to 13C)
5
6
7
8
9
4
N
H1
2
3
3'
O
H
45
1 * NH 8.73 br.s 2
2 135.3 CH 7.86 d 3.1 1 3,3′,8,9
3 119.9 C
4 122.2 CH 8.33 d 8.8 5 3,6,8
5 123.2 CH 7.33 td 7.1, 1.6 4,6 7,9
6 124.6 CH 7.34 td 7.2, 1.9 5,7 4,8
7 111.6 CH 7.45 m 6 5,9
8 136.7 C
9 124.5 C
3′ 185.3 CH 10.08 s 2,3,9
*Not observed.
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Lanosol
3
4
5
6
1
2Br
HO
OH
7
OH
Br
110
Table B.3. 13C (150 MHz) and 1H (600 MHz) NMR data (CD3OD) for lanosol (110).
13C 1H HMBC
Pos δ (ppm) mult δ (ppm) mult (1H to 13C)
1 134.1 C
2 114.1 C
3 114.2 C
4 146.2 C
5 144.6 C
6 114.8 CH 7.01 s 1,2,4,5,7
7 65.6 CH2 4.56 s 1,2,5
*,6
*Long-range correlation.
Table B.4. 13C (150 MHz) and 1H (600 MHz) NMR data ((CD3)2CO) for lanosol (110).
13C 1H HMBC
Pos δ (ppm) mult 1JCH δ (ppm) mult (1H to 13C)
1 134.6 C
2 113.3 C
3 113.4 C
4 145.5 C
5 143.8 C
6 114.5 CH 163 7.18 s 1,2,4,5,7
7 65.0 CH2 144 4.56 s 1,2,5
*,6
*Long-range correlation.
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2,3-Dibromo-4,5-dihydroxybenzyl methyl ether
3
4
5
6
1
2Br
HO
OH
7
OMe
8
Br
114
Table B.5. 13C (150 MHz) and 1H (600 MHz) NMR data (CD3OD) for
2,3-dibromo-4,5-dihydroxybenzyl methyl ether (114).
13C 1H HMBC
Pos δ (ppm) mult δ (ppm) mult (1H to 13C)
1 131.0 C
2 115.3 C
3 114.5 C
4 145.3 C
5 146.3 C
6 115.8 CH 6.92 s 1,2,3*,4,5,7
7 74.5 CH2 4.42 s 6,8
8 58.5 CH3 3.39 s 7
*Long-range correlation.
Table B.6. 13C (150 MHz) and 1H (600 MHz) NMR data ((CD3)2CO) for
2,3-dibromo-4,5-dihydroxybenzyl methyl ether (114).
13C 1H HMBC
Pos δ (ppm) mult 1JCH δ (ppm) mult (1H to 13C)
1 131.3 C
2 114.5 C
3 113.7 C
4 145.7 C
5 144.7 C
6 115.6 CH 164 7.05 s 1,2,3*,4,5,7
7 75.1 CH2 144 4.39 s 1,2,3
*,5*,6,8
8 58.4 CH3 139.9 3.38 s 7
*Long-range correlation.
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2,3-Dibromo-4,5-dihydroxybenzaldehyde
3
4
5
6
1
2Br
HO
OH
7 H
Br O
120
Table B.7. 13C (150 MHz) and 1H (600 MHz) NMR data (CD3OD) for
2,3-dibromo-4,5-dihydroxybenzaldehyde (120).
13C 1H HMBC
Pos δ (ppm) mult δ (ppm) mult (1H to 13C)
1 128.3 C
2 122.2 C
3 114.8 C
4 152.5 C
5 146.6 C
6 114.4 CH 7.34 s 1,2,3*,4,5,7
7 192.7 CH 10.13 s 1,5,6
*Long-range correlation.
Table B.8. 13C (150 MHz) and 1H (600 MHz) NMR data ((CD3)2CO) for
2,3-dibromo-4,5-dihydroxybenzaldehyde (120).
13C 1H HMBC
Pos δ (ppm) mult 1JCH δ (ppm) mult (1H to 13C)
1 128.3 C
2 121.6 C
3 114.4 C
4 151.4 C
5 145.8 C
6 114.5 CH 166 7.42 s 1,2,3*,4,5,7
7 191.3 CH 184 10.15 s 1,5,6
*Long-range correlation.
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Appendix C
1H NMR Spectra of the Known Compounds
Costatone
1H NMR spectrum of costatone (44) (600 MHz, CDCl3)
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1H-Indole-3-carboxaldehyde
1H NMR spectrum of 1H-indole-3-carboxaldehyde (45) (600 MHz, CDCl3)
170
(E)-N-Formyl-3-(1H-indol-3-yl)prop-2-enamide
1H NMR spectrum of (E)-N-formyl-3-(1H-indol-3-yl)prop-2-enamide (46)
(600 MHz, CD3OD)
171
Lanosol
1H NMR spectrum of lanosol (110) (600 MHz, CD3OD)
172
2,3-Dibromo-4,5-dihydroxybenzyl methyl ether
1H NMR spectrum of 2,3-dibromo-4,5-dihydroxybenzyl methyl ether (114)
(600 MHz, (CD3)2CO)
173
2,3-Dibromo-4,5-dihydroxybenzaldehyde
1H NMR spectrum of 2,3-dibromo-4,5-dihydroxybenzaldehyde (120)
(600 MHz, (CD3)2CO)
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(3E)-4-(2,3-Dibromo-4,5-dihydroxyphenyl)-3-butene-2-one
1H NMR spectrum of (3E)-4-(2,3-dibromo-4,5-dihydroxyphenyl)-3-butene-2-one (121)
(600 MHz, CD3OD)
175
Rhodomelol
1H NMR spectrum of rhodomelol (122) (600 MHz, CD3OD)
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Appendix D
NMR Spectra of Labillaride A
1H NMR spectrum of labillaride A (60) (600 MHz, CDCl3)
177
13C NMR spectrum of labillaride A (60) (150 MHz, CDCl3)
178
COSY NMR spectrum of labillaride A (60) (600 MHz, CDCl3)
179
HSQC NMR spectrum of labillaride A (60) (600 MHz, CDCl3)
180
HMBC NMR spectrum of labillaride A (60) (600 MHz, CDCl3)
181
HSQC-TOCSY NMR spectrum of labillaride A (60) (600 MHz, CDCl3)
182
Appendix E
NMR Spectra of Labillaride B
1H NMR spectrum of labillaride B (61) (600 MHz, CDCl3)
183
13C NMR spectrum of labillaride B (61) (150 MHz, CDCl3)
184
COSY NMR spectrum of labillaride B (61) (600 MHz, CDCl3)
185
HSQC NMR spectrum of labillaride B (61) (600 MHz, CDCl3)
186
HMBC NMR spectrum of labillaride B (61) (600 MHz, CDCl3)
187
HSQC-TOCSY NMR spectrum of labillaride B (61) (600 MHz, CDCl3)
188
Appendix F
NMR Spectra of Labillaride C
1H NMR spectrum of labillaride C (62) (600 MHz, CDCl3)
189
13C NMR spectrum of labillaride C (62) (150 MHz, CDCl3)
190
COSY NMR spectrum of labillaride C (62) (600 MHz, CDCl3)
191
HSQC NMR spectrum of labillaride C (62) (600 MHz, CDCl3)
192
HMBC NMR spectrum of labillaride C (62) (600 MHz, CDCl3)
193
HSQC-TOCSY NMR spectrum of labillaride C (62) (600 MHz, CDCl3)
194
Appendix G
NMR Spectra of Labillaride D
1H NMR spectrum of labillaride D (63) (600 MHz, CDCl3)
195
13C NMR spectrum of labillaride D (63) (75 MHz, CDCl3)
196
COSY NMR spectrum of labillaride D (63) (600 MHz, CDCl3)
197
HSQC NMR spectrum of labillaride D (63) (600 MHz, CDCl3)
198
HMBC NMR spectrum of labillaride D (63) (600 MHz, CDCl3)
199
HSQC-TOCSY NMR spectrum of labillaride D (63) (600 MHz, CDCl3)
200
Appendix H
NMR Spectra of Labillaride E
1H NMR spectrum of labillaride E (64) (600 MHz, CDCl3)
201
13C NMR spectrum of labillaride E (64) (150 MHz, CDCl3)
202
COSY NMR spectrum of labillaride E (64) (600 MHz, CDCl3)
203
HSQC NMR spectrum of labillaride E (64) (600 MHz, CDCl3)
204
HMBC NMR spectrum of labillaride E (64) (600 MHz, CDCl3)
205
HSQC-TOCSY NMR spectrum of labillaride E (64) (600 MHz, CDCl3)
206
1H NMR spectrum of labillaride E (64) (600 MHz, C6D6)
207
Appendix I
NMR Spectra of Labillaride F
1H NMR spectrum of labillaride F (65) (600 MHz, C6D6)
208
13C NMR spectrum of labillaride F (65) (150 MHz, C6D6)
209
COSY NMR spectrum of labillaride F (65) (600 MHz, C6D6)
210
HSQC NMR spectrum of labillaride F (65) (600 MHz, C6D6)
211
HMBC NMR spectrum of labillaride F (65) (600 MHz, C6D6)
212
HSQC-TOCSY NMR spectrum of labillaride F (65) (600 MHz, C6D6)
213
Appendix J
NMR Spectra of Labillaride G
1H NMR spectrum of labillaride G (66) (600 MHz, C6D6)
214
13C NMR spectrum of labillaride G (66) (150 MHz, C6D6)
215
COSY NMR spectrum of labillaride G (66) (600 MHz, C6D6)
216
HSQC NMR spectrum of labillaride G (66) (600 MHz, C6D6)
217
HMBC NMR spectrum of labillaride G (66) (600 MHz, C6D6)
218
HSQC-TOCSY NMR spectrum of labillaride G (66) (600 MHz, C6D6)
219
Appendix K
NMR Spectra of Labillaride H
1H NMR spectrum of labillaride H (67) (600 MHz, C6D6)
220
13C NMR spectrum of labillaride H (67) (150 MHz, C6D6)
221
COSY NMR spectrum of labillaride H (67) (600 MHz, C6D6)
222
HSQC NMR spectrum of labillaride H (67) (600 MHz, C6D6)
223
HMBC NMR spectrum of labillaride H (67) (600 MHz, C6D6)
224
HSQC-TOCSY NMR spectrum of labillaride H (67) (600 MHz, C6D6)
225
Appendix L
1H NMR Spectrum of 3,8-Diacetyl-labillaride H
1H NMR spectrum of 3,8-diacetyl-labillaride H (73) (600 MHz, C6D6)
226
Appendix M
NMR Spectra of Labillaride I
1H NMR spectrum of labillaride I (68) (600 MHz, CDCl3)
227
13C NMR spectrum of labillaride I (68) (150 MHz, CDCl3)
228
COSY NMR spectrum of labillaride I (68) (600 MHz, CDCl3)
229
HSQC NMR spectrum of labillaride I (68) (600 MHz, CDCl3)
230
HMBC NMR spectrum of labillaride I (68) (600 MHz, CDCl3)
231
HSQC-TOCSY NMR spectrum of labillaride I (68) (600 MHz, CDCl3)
232
Appendix N
NMR Spectra of Labillaride J
1H NMR spectrum of labillaride J (69) (600 MHz, CDCl3)
233
13C NMR spectrum of labillaride J (69) (150 MHz, CDCl3)
234
COSY NMR spectrum of labillaride J (69) (600 MHz, CDCl3)
235
HSQC NMR spectrum of labillaride J (69) (600 MHz, CDCl3)
236
HMBC NMR spectrum of labillaride J (69) (600 MHz, CDCl3)
237
HSQC-TOCSY NMR spectrum of labillaride J (69) (600 MHz, CDCl3)
238
Appendix O
NMR Spectra of Labillaride K
1H NMR spectrum of labillaride K (70) (600 MHz, CDCl3)
239
13C NMR spectrum of labillaride K (70) (150 MHz, CDCl3)
240
COSY NMR spectrum of labillaride K (70) (600 MHz, CDCl3)
241
HSQC NMR spectrum of labillaride K (70) (600 MHz, CDCl3)
242
HMBC NMR spectrum of labillaride K (70) (600 MHz, CDCl3)
243
Appendix P
NMR Spectra of the Degradation Product
1H NMR spectrum of the degradation product (75) (600 MHz, CDCl3)
244
13C NMR spectrum of the degradation product (75) (150 MHz, CDCl3)
245
COSY NMR spectrum of the degradation product (75) (600 MHz, CDCl3)
246
HSQC NMR spectrum of the degradation product (75) (600 MHz, CDCl3)
247
HMBC NMR spectrum of the degradation product (75) (600 MHz, CDCl3)
248
HSQC-TOCSY NMR spectrum of the degradation product (75) (600 MHz, CDCl3)
249
Appendix Q
NMR Spectra of Colensolide A
1H NMR spectrum of colensolide A (124) (600 MHz, CD3OD)
250
13C NMR spectrum of colensolide A (124) (150 MHz, CD3OD)
251
COSY NMR spectrum of colensolide A (124) (600 MHz, CD3OD)
252
HSQC NMR spectrum of colensolide A (124) (600 MHz, CD3OD)
253
HMBC NMR spectrum of colensolide A (124) (600 MHz, CD3OD)
254
1H to 15N HMBC NMR spectrum of colensolide A (124) (600 MHz, CD3OD)
255
Appendix R
1H NMR Spectrum of Acidified Colensolide A
1H NMR spectrum of acidified colensolide A (125) (600 MHz, CD3OD)
256
Appendix S
1H NMR Spectrum of 5-O-Methylcolensolide A
1H NMR spectrum of 5-O-methylcolensolide A (126) (600 MHz, CD3OD)
257
Appendix T
1H NMR Spectrum of 4,5-Di-O-methylcolensolide A
1H NMR spectrum of 4,5-di-O-methylcolensolide A (127) (600 MHz, CD3OD)
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